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Abstract 
The	aim	of	this	study	was	to	establish	a	novel	version	of	powerful	“barcode	virus”	as	a	tool	 for	 studying	 the	 replication	and	 transmission	dynamics	of	 influenza	virus	 in	vitro	and	in	vivo.	Five	 barcoded	 APR8	 viruses	 were	 firstly	 used	 to	 investigate	 infection	 kinetics	 (e.g.	single-	and	multi-hit	events,	particle	clumping	and	temporal	aspects	of	co-infection)	 in	
vitro.	This	work	demonstrated	that	the	majority	of	infectious	events	in	cell	culture	were	single-hit	events,	but	a	significant	number	of	infections	were	initiated	by	more	than	one	virus	 particles	 (consistent	 with	 virus	 aggregation	 during	 release).	 Reassortment	 was	found	to	occur	efficiently	and	ubiquitously	when	near-isogenic	viruses	co-infected	cells.	The	 timing	 of	 asynchronous	 co-infection	 revealed	 that	 super-infection	was	 possible	 if	the	second	virus	encountered	the	cell	within	4	hr	of	the	first	virus.	The	super-infecting	virus	 showed	 accelerated	 replication	 and	 enhanced	 yield,	 suggesting	 the	 second	 virus	can	 take	 advantage	 of	 the	 already	 initiated	 replication	 machinery.	 Beyond	 this	 time	point	(coincident	with	the	onset	of	progeny	release	from	the	first	virus)	the	second	virus	was	blocked	by	the	initial	infecting	viruses.	Five	 virus	 libraries	 carrying	 ~2000	 individually	 identifiable	 variants	 were	 then	generated	 for	 in	vivo	 study.	 Amplification	 of	 the	 viral	 libraries	 in	Madin-Darby	 canine	kidney	 (MDCK)	 cells	 was	 achieved	 without	 substantial	 bottlenecking	 or	 preferential	selection	 of	 specific	 sequences.	 Thirdly,	 two	 pilot	 studies	 in	 pigs	 demonstrated	 that	intranasal	 inoculation	 resulted	 in	 substantial	 bottlenecking	 and	 a	 relatively	 small	proportion	of	the	inoculum	gave	rise	to	productive	infection.	Consequently,	distinct	viral	populations	were	 found	 in	 different	 nostrils	 and	 could	 persist	 over	 the	 course	 of	 the	infection	due	to	anatomical	partitioning.	Distinct	sub-populations	could	be	distinguished	in	 other	 tissue	 sites	 (e.g.	 trachea	 and	 lung).	 Super-infection	 of	 individual	 pigs	 could	occur	around	2	days	following	primary	exposure.	The	identity	of	the	donor	pigs	could	be	determined	by	the	barcode	identities.	In	the	first	pilot	study,	around	600	variants	were	seen	 in	 each	 donor	 pig	 directly	 inoculated	 with	 approximately	 6000	 variants	 of	 the	
barcoded	viruses.	When	a	pig	was	co-housed	with	3	donors,	a	typical	transmission	dose	of	73-151	variants	were	seen.	To	further	study	the	transmission	dose	between	a	single	donor	and	recipient,	a	transmission	dose	defined	as	around	30-60	on	2	days	post	contact	(d.p.c)	and	20-50	on	3	d.p.c	was	observed.	To	 conclude,	 my	 PhD	 project	 has	 developed	 a	 powerful	 tool	 with	 a	 wide	 range	 of	applications	 in	 influenza	biology,	 particularly	 for	 studying	 transmission	dynamics	 in	 a	natural	host	system.	
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Chapter	1	 General	introduction	
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1.	General	introduction	on	influenza	virus	
1.1	Threat	of	influenza	A	virus	Influenza	 is	 a	 contagious	 disease	 that	 represents	 a	 serious	 health	 threat	 to	humans	 and	 animals.	 Influenza	 A	 viruses	 (IAV)	 can	 infect	 a	 wide	 variety	 of	species	because	all	known	subtypes	(except	H17	and	H18	from	bats)	have	been	found	in	wild	waterfowl	and	sea	birds,	which	as	such	provide	a	global	reservoir	for	 these	 viruses	 in	 nature.	 From	 this	 reservoir	 novel	 viruses	 can	 emerge	 to	infect	 mammalian	 species,	 as	 these	 viruses	 exhibit	 only	 partial	 restriction	 of	their	host	range.	Influenza	is	therefore	a	potential	threat	to	humans,	pigs,	horses,	sea	mammals,	 ferrets,	mink	 as	well	 as	many	 terrestrial	 bird	 species	 [1].	 In	 the	past	 century,	 several	 dramatic	 episodes	 of	 large-scale	mortality	 caused	 by	 IAV	have	occurred	to	humans	and	domesticated	animal	species.	Striking	examples	of	the	above	include	the	influenza	pandemic	in	1918	that	killed	an	estimated	40-50	million	people	worldwide;	 the	 recent	 transmissions	of	 highly	pathogenic	 avian	H5N1	 influenza	 virus	 (AIV)	 to	 human	 resulted	 in	 a	 case-fatality	 rate	 of	approximately	 60%	 (but	mercifully	 few	 cases	 due	 to	 the	 absence	 of	 human	 to	human	 transmission)	 [1]	 and	 the	 destruction	 of	 over	 400	 million	 birds.	 The	“swine	 flu”	 influenza	 in	 2009	 was	 the	 most	 recent	 pandemic,	 which	 has	subsequently	established	itself	as	a	new	seasonal	influenza	strain	in	humans	and	swine	 [2].	 In	 addition	 to	 the	 very	 prominent	 economic,	 public	 and	 livestock	health	burdens	of	influenza	during	the	relatively	rare	pandemics,	the	combined	annual	 impact	 of	 seasonal	 epidemics	 on	 livestock	 production	 and	 human	productivity	 (caused	 by	 sick	 days,	 medications	 and	 emergency	 visits)	 is	 also	significant.		
1.2	Influenza	A	virus	Influenza	 virus	 belongs	 to	 the	 family	 of	 Orthomyxoviridae	 [3]	 that	 have	 a	negative-sense,	 single-stranded,	 segmented	 RNA	 genome.	 Influenza	 virus	 is	usually	 named	 according	 to	 the	 scheme:	 Genus/host	 species	 (omitted	 if	human)/location/sample	number/year,	for	example,	A/Puerto	Rico/8/34.		
		 3	
Influenza	A	viruses	are	divided	into	various	subtypes	based	on	two	proteins	on	the	 surface	 of	 the	 virus:	 the	 hemagglutinin	 (H)	 and	 the	 neuraminidase	 (N).	Currently,	 there	 are	 18	 different	 hemagglutinin	 subtypes	 (H1-H18)	 and	 11	different	 neuraminidase	 subtypes	 (N1-N11)	 for	 influenza	 virus	 [4,	 5].	Theoretically,	18	HA	and	11NA	subtype	could	generate	198	subtypes	of	influenza,	but	 only	 certain	 subtypes	 are	 found	 in	 nature	 [6].	 Based	 on	 phylogenetic	analyses	and	previous	findings,	viruses	of	all	known	combinations	of	HA	and	NA	(H1-H14	and	N1-N9)	are	present	in	avian	species	[7].	
1.3	Virion	structure	Influenza	A	virion	is	a	roughly	spherical	particle	(diameter	in	the	order	of	80-100	nm),	although	filamentous	particles	with	elongated	viral	structures	(>	300	nm	–	20	µm	long)	have	been	frequently	observed	in	isolates	that	have	not	undergone	long-term	adaptation	in	cell	culture	[8].	The	virus	is	an	enveloped	virus	(shown	in	Figure	1.1)	whose	outer	 layer	 is	a	 lipid	membrane	 taken	 from	the	host	cell.	‘Spikes’	 inserted	into	the	lipid	membrane	are	the	major	antigenic	viral	proteins	HA	 (haemagglutinin)	 and	 NA	 (neuraminidase).	 M2	 ion	 channel	 protein	embedded	in	the	lipid	membrane	is	the	target	of	the	antiviral	adamantine	drugs.	Underneath	the	lipid	membrane	is	the	matrix	protein	(M1),	which	forms	a	shell	and	provides	 strength	 and	 rigidity	 to	 the	 lipid	 envelope.	Within	 the	 interior	of	the	virus	particle	is	the	viral	genetic	material	consisting	of	eight	segments.		Each	RNA	segment	 is	encapsulated	by	nucleoprotein	(NP)	and	 is	associated	with	the	viral	 RNA	 polymerase	 complex	 composed	 of	 the	 polymerase	 basic	 1	 (PB1),	polymerase	 basic	 2	 (PB2)	 and	 polymerase	 acid	 (PA),	which	 together	 form	 the	ribonucleoprotein	(RNP)	complex.	The	non-structural	protein	NS1	is	not		present	in	 the	 virion	 but	 is	 abundant	 in	 the	 infected	 cells,	 while	 the	 non-structural	protein	NS2	was	originally	thought	to	be	absent	from	virus	but	was	subsequently	found	in	low	copy	numbers	in	the	virion	[9].					
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Figure	1.	1	Influenza	A	virus	a:	The	virion	envelope	is	a	lipid	bilayer	traversed	by	the	glycoproteins	(HA	and	NA)	and	a	transmembrane	ion	channel	M2.	M1	forms	a	shell	located	under	the	lipid	bilayer	and	is	associated	with	NS2	protein	(NEP)	and	the	eight	RNP	segments,	which	together	constitute	the	viral	“core”.	Figure	from	Filed	virology[1].	b:	A	high	magnification	negatively-stained	electronmicrograph	image	of	a	thin	section	through	a	single	particle	showing	eight	internal	segments.	Figure	from	Noda	et.	al	[10].	
1.4	Genome	structure	of	IAV	The	genome	of	influenza	virus	consists	of	eight	negative-sense	RNA	segments.	It	has	 been	 now	 established	 that	 the	 incorporation	 of	 the	 8	 different	ribonucleoprotein	(RNPs)	into	virions	is	not	random	[11].	However,	it	is	believed	that	 free	 mixing	 of	 RNP	 segments	 allows	 the	 generation	 of	 progeny	 viruses	containing	 novel	 combinations	 of	 genes	 (i.e.,	 genetic	 reassortment)	when	 cells	are	 doubly	 infected	 with	 two	 different	 viruses.	 Eight	 influenza	 A	 viral	 RNA	segments	 encode	10	 canonically	 recognized	proteins,	which	 are	 PB1,	 PB2,	 and	PA	 polymerases,	 HA,	 NP,	 NA,	Ml	 and	M2	 proteins,	 and	 NS1	 and	 NS2	 proteins.	Additional	proteins	(presently	totalling	at	 least	14)	can	be	produced	as	a	result	of	 alternative	 reading	 frames	 (e.g.	 PB1-F2),	 alternative	 start	 sites	 (PB1-N40),	splice	 variants	 (M42)	 and	 ribosomal	 frame-shifting	 (PA-X),	 but	 their	 existence	varies	from	one	strain	to	anther[11].		
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Figure	1.	2	Structure	of	influenza	viruses	A.	[12]	
(a)	 diagram	 of	 a	 typical	 vRNA	 segment.	 A	 large	 ORF	 is	 flanked	 by	 noncoding	 regions	 (lines)	 containing	terminal	 promoter	 sequences	 (green	 boxes)	 that	 form	 the	 polymerase	 binding	 site	 and	 are	 essentially	identical	in	all	segments.	Red	wedges	strands	for	specific	packaging	signals	(b)	image	of	an	RNP	negatively	stained	with	 uranyl	 acetate	 from	 the	 paper	 by	 Jennings	 et	al[13].	 (c,	 d)	 Possible	 cartoon	models	 of	 RNP	structure.	NP	and	the	polymerase	are	represented	as	blue	and	yellow	spheres	respectively,	while	vRNA	is	represented	 as	 a	 line	 colored	 according	 to	 (a)	 from	 the	 paper	 by	 Portela	 et	al.[14]	 B)	 Schematic	 of	 the	influenza	A	virus	genome.	The	bold	black	lines	represent	the	3’	and	5’	untranslated	non-coding	regions.	The	blue	and	pink	boxes	represent	the	major	protein	coding	regions.	The	main	functions	of	each	segment	are	listed	below.	PB2:	component	of	RNA	polymerase	complex,	host	mRNA	cap-binding	activity;	PB1-F2:	pro-apoptotic	activity;	PB1:	component	of	RNA	polymerase,	nucleotide	chain	elongation;	PA:	component	of	RNA	polymerase	complex,	host	mRNA	endonuclease	activity;	HA	surface	glycoprotein,	receptor	binding,	 fusion	activity,	major	neutralizing	antigen;	NP;	RNA	binding	nucleoprotein,	RNA	replication,	RNA	nuclear	import;	NA	 surface	 glycoprotein,	 neuraminidase	 activity;	 M1:	 major	 internal	 structural	 protein,	 interaction	 with	vRNP	and	viral	 glycoproteins,	nuclear	export,	budding;	M2:	 transmembrane	protein,	 ion	 channel	 activity,	virus	entry	and	uncoating,	assembly;	NS1:	multi-functional	protein,	vial	IFN	antagonist;	NEP/NS2:	nuclear	export	of	vRNPs	[1,	15-23].	
2.	Viral	replication	cycle	of	IAV	
There	are	four	main	stages	of	the	replication	cycle	of	IAV	including	attachment,	fusion	and	uncoating,	transcription	and	replication,	as	well	as	assembly	and	release.		
2.1	Attachment	The	IAV	can	bind	to	susceptible	cells	by	the	interaction	of	its	HA	with	sialic	acid	(SA)	moieties	at	the	ends	of	the	glycan	chains	of	glycoproteins	and	glycolipids	on	the	surface	of	the	cell	to	initiate	the	infection.	Viruses	from	different	host	species	bind	preferentially	to	different	forms	of	SA	receptors	on	the	cells.	 In	particular,	avian	virus	(AIV)	prefers	to	bind	SA-α2,3-galactose	while	human	IAV	prefers	to	target	 to	 SA-α2,6-galactose	 terminated	 receptors.	 These	 receptor	 types	 show	distinct	tissue	distributions	in	humans,	which	correlate	with	strain	susceptibility.	Pigs	 were	 reported	 to	 contain	 both	 receptor	 types	 in	 their	 upper	 and	 lower	respiratory	tracts	[24],	which	 is	consistent	with	their	susceptibility	to	both	AIV	and	human	IAV.	Generally,	all	 subtypes	of	AIV	have	been	verified	 to	bind	α2,3	 linked	receptors,	especially	H5	and	H7.	In	the	duck	reservoir,	α2,3	linked	sialic	acids	are	dominant	in	the	gut	epithelium,	consistent	with	the	AIV	tropism	for	the	digestive	tract	[25].	Human	 H1	 and	 H3	 isolates	 showed	 significant	 preference	 for	 α2,6	 linkage	binding	 compared	 to	 isolates	 of	 these	 sub-types	 from	 aquatic	 birds.	 The	investigation	of	the	distribution	of	sialic	acid	within	human	respiratory	tract	has	
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found	that	1)	preferential	α2,6	linkage	receptors	are	expressed	in	the	upper	part	(nose,	paranasal	sinuses,	pharynx);	2)	the	proportion	of	α2,3	linkages	gradually	increases	in	the	median	part	(trachea,	bronchi);	and	3)	equal	receptors	are	found	for	both	linkage	types	in	the	lower	respiratory	tract	(bronchioles,	alveoli).	These	findings	 help	 to	 explain	why	 it	 is	 difficult	 for	H5	 subtype	 to	 infect	 human	 but	severe	lung	infection	can	be	observed	once	the	infection	is	established	[26,	27].	A	general	 preference	 for	 α2,6	 linkage	 by	 swine	 H1	 isolates	 was	 observed.	 The	distribution	of	receptors	in	pigs	showed	a	preferential	α2,	6	expression	in	their	lower	 respiratory	 that	 while	 divergent	 findings	 were	 made	 in	 the	 upper	respiratory	tract	from	other	studies	[28-30].		
2.2	Fusion	and	uncoating		After	 binding	 to	 cell	 and	 endocytosis,	 IAV	 requires	 a	 low	 pH	 to	 initiate	 fusion	with	 endosomal	membranes.	 In	 its	 native	 conformation	 HA	 is	 a	 trimer	 of	 two	sub-units	 (HA1	 and	 HA2)	 derived	 from	 the	 HA0	 precursor	 that	 undergoes	proteolytic	 cleavage	 during	 virus	 egress.	 Normal	 endosome	 acidification	(through	 the	 action	 of	 host	 V-type	 proton	 ATPase	 activity	 [31])	 triggers	 a	dramatic	 conformational	 change	 of	 the	 HA,	 which	 releases	 the	 hydrophobic	fusion-peptide	 sequence	 at	 the	 N-terminus	 of	 HA2.	 HA1	 maintains	 receptor	binding	 while	 the	 fusion	 peptide	 inserts	 into	 the	 endosomal	 membrane	 [32].	With	 the	 increasing	 number	 of	HA	molecules	 participating	 in	 this	 process,	 the	viral	 and	 endosomal	 membranes	 are	 brought	 into	 close	 proximity,	 a	 “fusion	pore”	forms	and	the	viral	core	(M1+RNPs)	is	released	into	the	cytoplasm	where	it	uncoats/dissociates	[11].	Effective	uncoating	requires	the	ion	channel	activity	of	 the	 M2	 protein	 that	 allows	 protons	 to	 enter	 the	 virion	 core	 during	 the	endosomal	 acidification	 stage	 before	 fusion	 occurs.	 This	 allows	 the	 tight	association	of	RNPs	and	M1	to	be	relaxed	[33]	and	the	RNPs	can	be	transported	to	the	nucleus	upon	fusion.			The	RNPs	can	be	detected	in	the	nucleus	10	min	after	virus	attachment[34].	The	RNPs	(10-20nm)	enter	the	nucleus	by	an	active	nuclear	import	mechanism.	The	import	mechanism	is	an	energy-driven	process	that	is	initiated	upon	recognition	of	 a	 nuclear	 localization	 signal	 (NLS)	 in	 NP	 by	 members	 of	 the	 karyopherin	
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family	(Importin	α1/α2)	[35]	and	Hsp40	[36]	
2.3.	Transcription	and	replication	vRNA	 replication	 of	 influenza	 occurs	 in	 the	 nucleus	 and	 requires	 the	 vRNP	complex	(the	structure	shown	in	figure	1c)		[11].	The	vRNA	serves	as	a	template	for	both	mRNA	and	cRNA	synthesis.	Each	of	the	3-polymerase	sub-units	plays	a	crucial	role.	The	process	starts	with	PB2	binding	to	the	5’	cap	of	nascent	host	cell	mRNA.	PA	then	endonucleolytically	cleaves	this	mRNA	10	–	13	nt	downstream	of	the	cap.	This	short	capped	oligonucleotide	is	then	repositioned	in	the	active	site	of	PB1	where	it	acts	as	a	primer	to	initiate	synthesis	of	a	viral	mRNA	using	the	vRNA	template	associated	with	the	polymerase.	Polyadenylation	 is	achieved	by	reiterative	stuttering	on	a	poly	uridine	tract	adjacent	to	the	5’	end	of	the	vRNA.		cRNA	molecules	 are	 not	 primed	 in	 this	way	 (they	have	 a	 5’	 triphosphate	 from	initiating	with	ATP)	 and	 are	 full-length	 read-through	 complementary	 copies	 of	vRNA,	not	prematurely	terminated	and	polyadenylated	as	mRNAs	are	[11].	cRNA	serves	as	 template	 for	 synthesizing	new	negative-sense	of	genomic	vRNA	via	a	similar	mechanism	[11].		Acidic	nuclear	phosphoprotein	32	family	member	A	(ANP32A)	is	one	of	a	family	of	 small,	 evolutionarily	 conserved	 proteins	 [37]	 and	 it	 was	 identified	 as	 an	important	cellular	co-factor	related	to	host	specificity	[38].	The	chicken	ANP32A	mutant	without	a	33	amino	acid	insert	in	its	C	terminus	was	unable	to	stimulate	avian	polymerase	and	reduce	viral	replication	[39].	Similarly,	 the	expression	of	chicken	 ANP32A	 is	 required	 for	 efficient	 replication	 of	 avian	 flu	 in	 human	cells[39].	Also,	Sygiyama	reported	 that	ANP32A	and	anp32B	were	 identified	as	viral	polymerase	interacting	proteins	that	regulate	influenza	virus	RNA	synthesis	from	cRNA	[40].	Other	cellular	factors	including	RAF-2p48/UAP56,	Tat-SF1,	and	heat	shock	protein	90	(Hsp90)	play	the	role	of	stimulating	vRNA	synthesis.	RAF-2p48/UAP56	 and	 Tat-SF1	 are	 the	 splicing	 factors	 for	 mRNA	 and	 molecular	chaperone	to	 interact	 with	 NP	 to	 form	 the	 NP-vRNA	 complex	 [41,	 42].	 Hsp90	interacts	 with	 PB2	 to	 stimulate	 viral	 RNA	 synthesis	 [43].	 Another	 factor,	 the	minichromosome	maintenance	 complex	 (MCM),	was	 reported	 to	 play	 a	 role	 in	the	stabilization	between	initial	nascent	cRNA	and	polymerase	to	aid	full-length	
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cRNA	 elongation	 [44].	 In	 contrast,	 another	 study	 found	 that	 MCM	 was	unnecessary	 for	 vRNPs	 to	 achieve	 efficiently	 full-length	 cRNA	 and	 mRNA	synthesis	 [45]	 but	 the	 concentration	 of	 nucleotides	 was	 important	 for	transcription	[45].	The	mechanism	 responsible	 for	 regulating	 viral	 gene	 expression	 is	 still	 poorly	understood.	However,	 there	 is	evidence	 for	 temporal	control.	Viral	mRNAs	and	proteins	NP	and	NS1	were	observed	at	 early	 stages	whereas	 the	 expression	of	HA,	NA	 and	M1	was	 delayed	 [46,	 47].	 NP	 is	 required	 for	 replication,	while	NS	functions	 to	 combat	 the	 host	 immune	 system.	 Therefore,	 both	 of	 them	 are	expressed	at	an	early	 stage	of	viral	 life	 cycle.	 	M1	has	an	 important	 role	 in	 the	inhibition	 of	 viral	 transcription	 [48]	 and	 it	 exports	 the	RNPs	 from	 the	 nucleus	[49],	therefore	occurring	at	a	later	stage	of	viral	replication.		Several	factors	are	responsible	for	selective	synthesis	of	influenza	proteins,	such	as	 GRSF-1[50]	 and	 P58IPK	 [51].	 GRSF-1	 functions	 as	 a	 mediator	 for	 selective	mRNA	translation.	P58IPK	[51]	has	been	shown	to	reduce	viral	mRNA	translation	and	 increase	 levels	 of	 eIF2	 α	 phosphorylation	 in	 the	 cells	 derived	 form	P58IPK−/−	mice.	
2.4	Assembly	and	release	Following	 replication,	 RNPs	 assembled	 in	 the	 nucleus	 are	 exported	 into	 the	cytoplasm	by	M1	and	NEP/NS2	[52].	M1	works	as	the	bridge	between	NEP/NS2	and	the	RNPs,	while	NEP/NS	proteins	possess	nuclear	export	activities.	Accurate	assembly	 and	 packaging	 of	 all	 8	 vRNA	 segments	 is	 essential	 to	 efficiently	produce	 an	 infectious	 virion.	 Although	 there	 is	 evidence	 for	 some	 low	 level	 of	“random”	packaging	[53,	54],	or	packaging	of	more	than	eight	RNA	segments	to	achieve	a	full	complement	,	a	selective	model	for	packaging	is	supported	by	the	weight	of	evidence	and	is	now	widely	accepted	[55-57].	It	suggests	that	each	of	the	8	vRNA	segments	contains	a	unique	packaging	signal	that	enables	one	of	each	of	the	eight	segments	to	be	included	into	each	virion	(although	DIs	and	missing	segments	 are	 not	 uncommon).	 Several	 groups	 have	 reported	 electron	microscopy	 images	 of	 seven	 RNPs	 surrounding	 a	 central	 segment	 observed	during	virion	budding	[58].		
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HA	and	NA	proteins	are	post-translationally	processed	and	transported	through	the	ER	and	Golgi	along	with	the	M2	protein	to	the	cell	surface	where	they	remain	embedded	in	the	cell	membrane,	pointing	outside	of	the	cell	[11].	A	viral	core	of	nucleocapsids	is	encased	in	a	shell	of	M1	protein	and	buds	outward	through	the	cell	 membrane,	 enclosing	 itself	 within	 a	 section	 of	 membrane	 as	 its	 own	envelope	complete	with	the	viral	surface	glycoproteins	[59].	The	progeny	virus	particles	require	NA	in	order	to	be	released.	NA	removes	sialic	acid	on	the	viral	and	 host	 cell	 glycoproteins	 to	 prevent	 particles	 from	 aggregating	 or	 rebinding	the	cell	membrane	[60].	Proteolytic	processing	of	HA0	to	HA1/HA2	can	occur	at	several	stages	depending	on	 the	 virus	 strain.	Highly	pathogenic	 strains	 of	 avian	 influenza	 (HPAI)	have	 a	polybasic	cleavage	site	between	HA1	and	HA2,	which	is	processed	by	furin-like	enzymes	expressed	ubiquitously	in	tissues	and	are	present	and	active	in	the	ER.	Virions	 are	 thus	 released	 in	 a	 mature	 fusion-competent	 form	 from	 many	different	tissues	that	enables	these	viruses	to	propagate	systemically	and	cause	severe	diseases.	Most	other	strains	have	cleavage	sites	with	 fewer	basic	amino	acids,	which	are	processed	by	more	selective	proteases	with	more	limited	tissue	distribution.	In	the	case	of	human	and	swine	influenza	strains,	this	limits	them	to	replication	 in	 the	 respiratory	 tract.	 Other	 avian	 strains	 are	 limited	 to	 the	respiratory	and	digestive	tracts	for	the	same	reason.	
3.	Virus	evolution	
The	 understanding	 of	 the	 evolution	 of	 influenza	 viruses	 is	 important	 for	preventing	 or	 reducing	 the	 occasional	 catastrophic	 pandemics.	 All	 8	 segments	evolve	 under	 selection	 but	 this	 is	most	 prominent	 in	 the	 surface	 glycoprotein	genes.	 Diversity	 is	 generated	 by	 the	 error-prone	 viral	 polymerase	 (point	mutations)	and	selection	results	 in	the	accumulation	of	molecular	changes.	The	segmented	nature	of	the	virus	allows	very	efficient	exchange	of	these	segments	by	 gene	 reassortment.	 	 This	 also	 enables	 sub-optimal	 or	 defective-interfering	particles	 to	 persist	 in	 virus	 populations.	 Each	 of	 these	 mechanisms	 may	contribute	to	the	evolution	of	influenza	viruses.	
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3.1	Point	mutations	(Antigenic	drift)	Generation	of	diversity	by	mutation	is	fundamental	to	all	evolution	mechanisms.	The	 lack	 of	 proofreading	 of	 influenza	 virus	 RNA	 polymerase	 resulted	 in	replication	 errors	 on	 the	 order	 of	 1	 in	 103-104	 bases	 [61].	 The	 virus	 therefore	exists	 as	 a	 quasi-species	 population	 where	 every	 virus	 has	 one	 or	 more	mutations.	 This	 gives	 it	 the	 capacity	 for	 very	 rapid	 evolution.	 HA	 plays	 an	essential	 role	 in	 receptor	 recognition	 and	 entry.	 It	 is	 the	 major	 target	 for	neutralizing	antibodies	produced	by	the	host	immune	response.	For	influenza	to	continue	to	circulate	 in	the	face	of	host	population	immunity,	 it	has	to	undergo	continuous	antigenic	adaptation.	Immune	escape	is	achieved	by	the	selection	of	mutants	with	amino	acid	substitutions	 in	antigenic	sites	mainly	on	HA	and	NA.		Even	with	the	minimal	change	in	the	surface	protein	structure,	the	host	immune	protection	may	no	longer	be	effective.		Point	mutations	 also	 have	 an	 impact	 on	 drug	 therapies.	 Mutations	 in	 NA	 (e.g.	H274Y)	enhance	resistance	to	neuraminidase	inhibitors	such	as	oseltamivir	after	it	 was	 introduced	 into	 clinical	 use	 against	 N1	 and	 N2	 strains.	 Other	 examples	include	R292K,	E119V,	and	I222K	mutations	in	NA	protein	that	rapidly	appeared	in	response	to	treating	zoonotic	cases	of	H7N9	virus	strains	[62,	63].	Progressive	accumulation	of	point	mutations	 in	HA	(and	 to	a	 lesser	extent	NA)	through	antigenic	selection	(antigenic	drift)	is	the	main	reason	why	new	variants	occur	 to	 cause	 annual	 influenza	 outbreaks.	 Antigenic	 drift	 over	 1-5	 year	 can	make	 a	 strain	 considerably	 different	 from	 the	 original	 epidemic	 or	 typically	prevalent	virus.	However,	residual	herd	immunity	means	that	such	variants	are	very	unlikely	to	lead	to	pandemics	[11].	The	gene	pool	of	influenza	A	viruses	in	aquatic	 birds	 provides	 all	 the	 genetic	 diversity	 required	 for	 the	 emergence	 of	pandemic	 influenza	 viruses	 for	 humans,	 birds	 and	 other	 animals.	 Point	mutations	play	a	role	 in	 this	process.	Mutations	 in	HA	can	change	 the	receptor	preference	 and	 enable	 cross	 species	 infection.	 Some	 signature	mutations	 have	been	 identified.	For	 instance,	Gly186Val	mutation	 in	H7	sub-type	HA	enhanced	the	affinity	 for	binding	human	sialic	 acid	 receptors	 [64].	Remarkably,	 the	K58I	and	G219S	mutations	in	HA	increased	the	overall	binding	ability	to	α-2,3	and	α-
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2,6	SA	of	 the	A/	H7N9	virus	 [65].	Mutations	 in	other	genes	are	 important	 (e.g.	PB2	 E627K,	 involved	 in	 host	 switching	 from	 avian	 to	 mammalian	 hosts	 by	altering	the	interaction	with	a	crucial	host	factor,	ANP32A).	The	1918	pandemic	is	 believed	 to	 have	 arisen	 from	 the	 completely	 “successful”	 adaptation	 of	 an	avian	strain.	Even	partial	adaptation	through	point	mutation	is	a	major	concern	as	 it	may	 facilitate	 cross-species	 infection	which	 opens	 the	 door	 to	 influenza’s	most	powerful	evolutionary	mechanism	-	gene	reassortment.	
3.2	Gene	reassortment	Reassortment	 is	 the	 exchange	 of	 viral	 gene	 segments	 in	 cells	 infected	simultaneously	 with	 two	 different	 influenza	 viruses	 (a	 form	 of	 modular	evolution).	 Because	 influenza	 genomes	 are	 segmented,	 reassortment	 is	 an	extremely	 efficient	 mechanism	 for	 the	 introduction	 of	 genetic	 novelty	 into	 a	population.	In	contrast,	RNA	recombination	is	extremely	inefficient	for	influenza	virus.	 If	 reassortment	 results	 in	 the	 introduction	 of	 a	 novel	HA	 or	NA	 subtype	unlike	 what	 has	 not	 been	 seen	 previously	 by	 the	 host	 population	 (“antigenic	shift”),	 new	virus	 can	 completely	 escape	 the	neutralizing	 antibodies	present	 in	the	 population.	 In	 the	 absence	 of	 this	 herd	 immunity,	 a	 rapid	 and	 highly	contagious	virus	like	influenza	would	potentially	infect	a	very	large	proportion	of	the	 population,	 if	 it	 is	 capable	 of	 efficient	 person	 to	 person	 spread	 (causing	 a	pandemic).	The	 importance	of	reassortment	to	the	generation	of	new	influenza	virus	 was	 demonstrated	 by	 the	 pandemics	 of	 1957	 and	 1968,	 which	 derived	from	avian	and	human	reassortment	[66,	67].	Additionally,	the	outbreak	of	H5N1	in	 1997	 caused	 fatal	 infection	 in	 humans	 and	 also	 a	 profound	 impact	 on	 the	poultry	 industry.	This	virus	 is	a	multiple	reassortant	among	avian	virus	strains	[68,	 69].	 The	 2009	 pandemic	 H1N1	 virus,	 which	 caused	widespread	 infection,	was	proven	to	be	a	triple	human	/avian/	swine	reassortant	[70].		
4.	Etiology	and	pathogenesis	in	animals	
IAV	is	a	major	cause	of	morbidity	and	mortality	worldwide	and	also	represents	a	serious	 health	 risk/burden	 to	 a	wide	 range	 of	 hosts,	 including	 human,	 aquatic	birds,	domestic	poultry,	horses	and	swine	[11].	My	PhD	study	aims	to	explore	the	
		 12	
transmission	 parameters	 of	 swine	 influenza	 (SIV)	 and	 therefore	 the	 following	introduction	will	focus	primarily	on	that	species.	
4.1.	The	relevance	of	SIV	to	swine	health		Influenza	 as	 a	 disease	 of	 pigs	 was	 first	 recognized	 in	 1930,	(A/swine/Iowa/15/30[H1N1])	[71].	SIV	has	become	enzootic	and	is	a	prevalent	respiratory	disease	pathogen	 [72].	 Currently,	H1N1,	H3N2	and	H1N1	 subtypes	are	 endemic	 in	 European	 pig	 populations,	 with	 some	 regional	 variation	 in	distribution	 and	 prevalence	 [73].	 SIV	 can	 cause	 a	 spectrum	 of	 clinical	 signs,	ranging	from	unapparent	disease,	to	fever	and	overt	respiratory	signs.	Typically,	there	 is	 low	 mortality	 and	 rapid	 recovery	 in	 pigs	 [74,	 75].	 This	 respiratory	disease	can	nevertheless	severely	affect	pork	production	efficiency.		Importantly,	the	 severity	 of	 disease	 can	 be	 increased	 significantly	 by	 secondary	 bacterial	infection	[75].	From	the	famers’	point	of	view,	SIV	is	not	only	a	significant	cause	of	 swine	 respiratory	 disease	 but	 also	 can	 introduce	 serious	 reproductive	problems	to	sows	including	abortions.		The	economic	losses	are	estimated	to	be	£23	per	sow	per	year	plus	downstream	issues	for	animal	welfare	[76].	Moreover,	controlling	 SIV	 is	 becoming	 increasingly	 important	 as	 it	 becomes	 essential	 for	farmers	 to	 reduce	 antibiotic	 usage	 to	 meet	 European	 Union	 directives	 [77].	Therefore,	 offering	 clear	 economic	 and	 welfare	 benefits	 is	 of	 significance	 for	convincing	livestock	keepers	to	prevent	and	control	influenza.	However,	despite	all	these	problems,	vaccination	of	non-breeding	pigs	is	not	routinely	undertaken,	and	over	50%	of	adult	pigs	were	seropositive	by	surveillance	for	SIV	 in	the	UK	[78].	
4.2	The	relevance	of	SIV	to	human	health	Swine	 can	 serve	 as	 ‘mixing	 vessels’,	 contributing	 to	 the	 crossing	 of	 species	barriers	[24].	Wild	waterfowl	are	the	natural	reservoir	of	influenza	A	viruses.	It	is	 well-known	 that	 most	 avian	 IAV	 preferentially	 bind	 SAα2,3Gal	 (avian	receptor)	 while	 human	 IAV	 preferentially	 bind	 to	 SAα2,6Gal	 (mammalian	receptor)-terminated	glycan	chains	[79,	80].	Both	receptors	have	been	found	in	the	respiratory	tract	of	swine	[81].	“Reverse-zoonotic”	infections	from	humans	to	swine	are	relatively	common.	Swine	susceptibility	to	avian	and	human	influenza	
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A	 viruses	 continues	 to	 provide	 opportunities	 for	 the	 introduction	 of	 new	influenza	genes	into	SIV	and	thence	potentially	into	humans.	Where	this	process	involves	 a	 change	 in	 the	 HA	 and/or	 NA	 serotype,	 (antigenic	 shift)	 human	pandemic	viruses	may	arise.	The	H2N2	and	H3N2	pandemics	are	thought	to	have	emerged	using	pigs	as	an	intermediate	host	[82].		Zoonotic	 infections	 from	SIV	to	humans	have	happened	relatively	rarely.	A	 few	examples	include	an	H3N2	SIV	that	was	isolated	from	a	7month	baby	[83]	and	an	H1N1	 SIV	 outbreak	 at	 Ohio	 country	 fair	 [84].	 Transmission	 of	 SIV	 to	 humans	could	happen	without	direct	contact,	but	in	the	majority	of	cases	(61%)	exposure	to	 the	 pigs	 was	 a	 factor	 [85].	 While	 other	 factors	 might	 result	 in	 high	 SIV	seroconversion	 rates	 in	 humans,	 occupational	 exposure	 to	 swine	 resulted	 in	23%	seropositivity	[86,	87].	Such	exposure	suggests	humans	too	can	be	mixing	vessels	for	the	evolution	of	influenza	viruses.	
4.3	SIV	pathogenesis	The	 pathogenesis	 of	 SIV	 has	 been	 well	 characterized	 [88].	 The	 virus	 was	amplified	in	epithelial	cells	of	the	upper/lower	respiratory	tract	including	nasal	mucosa,	ethmoid	region,	 trachea	and	 lungs	of	pig	 [89].	 	 Infectious	virus	can	be	isolated	from	lung	tissue,	lymph	nodes	in	the	respiratory	tract,	bronchoalveolar	lavage	fluid,	nasal,	and	oropharyngeal	swabs	[90].	In	most	experimental	studies,	the	virus	was	 isolated	from	1	day	post	 infection	(d.p.i)	 to	approximately	8	d.p.i	[91-94].	 Some	 studies	 have	 reported	 that	 SIV	 preferably	 amplified	 at	 lower	rather	 than	 higher	 respiratory	 sites.	 The	 viral	 titer	 and	 immunohistochemical	studies	 revealed	 that	 there	were	more	viral	 antigen-positive	 cells	 in	bronchial,	bronchiolar	 and	 alveolar	 epithelia	 cell	 than	nasal	mucosa	 [88].	 It	 has	not	been	proven	 that	 SIV	 can	amplify	outside	of	 respiratory	 sites.	Only	 a	 low	amount	of	virus	was	reported	to	be	 isolated	 from	the	brain	stem	[95].	A	 few	studies	have	demonstrated	that	viruses	can	be	detected	by	PCR	from	faeces	and	intestines	but	virus-positive	cells	have	not	been	found	[95-98].		
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4.4	Tissue-specific	selection		Differences	 between	 tissues,	 along	 with	 neutral	 processes	 of	 migration	 and	genetic	drift,	may	have	important	effects	on	viral	evolution.	It	has	been	reported	that	most	 human	 IAV	 primarily	 amplify	 in	 the	 upper	 human	 respiratory	 tract	containing	a	higher	proportion	of	a	2,6-linked	sialic	acids	than	the	lower	airways	containing	a	higher	proportion	of	a	2,3-linked	sialic	acids	 [26].	The	differences	between	 receptors	may	 also	 affect	 the	 transmission	 of	 viruses.	 For	 instance,	 a	previous	 study	 reported	 IAV	 variants	 in	 upper	 respiratory	 tract	 are	 more	transmissible	 [99].	 Additionally,	 in	 the	 absence	 of	 tissue-specific	 selection,	spatial	 structure	can	also	 limit	genetic	exchange	between	different	parts	of	 the	airways	 [100].	 It	 was	 also	 reported	 that	 distinct	 oseltamivir	 sensitive	 and	resistant	viral	populations	of	H1N1	were	found	in	the	right	and	left	 lungs	of	an	immunosuppressed	patient	[101].		
4.5	Parameters	for	establishing	an	animal	transmission	study	A	previous	study	has	assessed	the	parameters	required	to	establish	SIV	infection	successfully	by	intranasal	or	intra-tracheal	inoculation	[95].	The	kinetics	of	virus	replication	 in	 the	 respiratory	 tract	 and	 the	 severity	 of	 lung	 inflammation	 are	highly	related	to	 the	 inoculation	route	and	dose.	 Intra-tracheal	 inoculation	was	demonstrated	 to	 produce	 typical	 lower	 respiratory	 disease,	 high	 fever	 and	lethargy	in	pigs	[95].	Intra-nasal	inoculation	can	produce	a	slower	increase	of	the	viral	load	in	lung	and	milder,	less	specific	signs	like	nasal	discharge,	sneezing	and	low	 fever	 [102].	 High	 dose	 (>106	 infectious	 units)	 resulted	 in	 virus	 shedding	from	the	nasal	cavity	in	all	intra-nasally	challenged	animals,	whereas	a	low	dose	(103	infectious	units)	did	not	[103].	Airborne	transmission	is	affected	by	the	size	of	the	droplets	and	the	transmission	distance.	Cough	droplets	within	the	velocity	range	 of	 10-25	 m/s	 can	 be	 transmitted	 over	 more	 than	 2	 meters	 [104].	 The	majority	of	total	airborne	particles	released	were	fine	droplets	(<	5	μm)	that	can	persist	 in	 the	 air	 for	 prolonged	 periods	 [105].	 However,	 virus-laden	 particles	were	predominantly	>	4	µm.	As	a	twofold	increase	in	the	aerodynamic	diameter	would	 lead	 to	 an	 approximately	 eightfold	 increase	 in	 mass,	 it	 is	 possible	 that	larger	particles	may	contain	more	virions	than	do	the	fine	droplet	nuclei	[106].	
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5.	Transmission	and	evolutionary	dynamics	
Viral	 evolution	 is	 a	 consequence	 of	 mutations	 that	 arise	 within	 and	 spread	between	 infected	 hosts.	 The	 transmission	 bottleneck	 determines	 how	much	 of	the	viral	diversity	generated	in	one	host	passes	to	another	during	transmission.	It	 therefore	 plays	 an	 important	 role	 in	 linking	within-host	 processes	 to	 larger	evolutionary	trends	[107].		
5.1	Measuring	transmission	bottlenecks	The	transmission	dynamics	within	and	between	susceptible	host	populations	is	poorly	understood.	An	 important	question	 in	understanding	virus	transmission	is	quantifying	the	number	of	viruses	involved	in	transmission	and	the	degree	of	“bottle-necking”	 that	 occurs	 when	 virus	 disseminates	 from	 its	 primary	 site	 of	replication	 to	 other	 tissues	 and	 eventually	 on	 to	 the	 next	 host.	 Transmission	bottlenecks	occur	in	pathogen	populations	when	only	a	few	individual	pathogens	are	 transmitted	 from	 one	 infected	 host	 to	 another	 in	 the	 initiation	 of	 a	 new	infection.	 Two	 measurement	 strategies	 have	 been	 employed	 to	 analyse	transmission	 bottlenecks.	 A	 recently	 developed	 approach	 uses	 a	 defined	population	of	viruses	that	are	tagged	with	genetic	markers	to	trace	the	number	of	distinct	markers	that	pass	from	donor	to	recipient.	In	ferret	and	guinea	pig	for	aerosol	 transmission	 around	 7-25	 tagged	 variants	 were	 observed	 in	 direct	transmission	by	using	a	population	of	100	tagged	viruses	[108].		The	other	approach	uses	variants	generated	from	natural	infection	to	determine	size	by	looking	for	the	donor-recipient	paired	variants.	Murcia	et	al.	has	reported	that	 although	 immune	 status	 is	 believed	 to	 affect	 the	 transmission	 bottleneck	size,	striking	loose	transmission	bottlenecks	were	observed	in	their	equine	and	pig	study	[109-111].	In	human	studies,	a	very	tight	bottleneck	size	of	1-2	distinct	genomes	was	determined	from	seasonal	H3N2	influenza	virus	between	2010	and	2015	[112].	However,	a	conflicting	result	was	obtained	from	another	study	that	suggested	 that	 around	 100-200	 distinct	 genomes	 were	 estimated	 for	 the	bottleneck	 size	 of	 H3N2	 and	 pandemic	 H1N1	 during	 the	 first	 wave	 of	 the	2009H1N1	 epidemic	 [113].	 The	 large	 discrepancy	 in	 these	 previous	 studies	
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highlights	 the	 need	 to	 provide	 a	 powerful	 tool	 to	 determine	 transmission	bottleneck	sizes.	There	 is	 a	 possible	 limitation	 for	 using	 naturally	 generated	 variants	 within	population	 to	 determine	 the	 bottleneck	 size.	 Previous	 studies	 on	 transmission	dynamics	 [18][19]	 (i.e.,	 estimating	 the	number	of	 transmitted	variants	 and	 the	extent	of	preferential	transmission,	and	identifying	the	source	of	infection)	have	been	undertaken	on	HIV-1.	However,	it	is	difficult	to	answer	these	questions	on	influenza	virus	using	 the	 same	methods,	 as	 relatively	 few	new	mutations	were	generated	in	influenza	virus	over	the	course	of	the	experiments	in	comparison	to	HIV-1.	Viruses	such	as	HIV	and	hepatitis	C	virus	can	avoid	 the	 immune	system	and	 the	 infections,	 they	 cause	 last	 for	 years	 or	 decades.	 However,	 the	 SIV	shedding	peak	usually	lasts	for	2-4	d.p.i,	which	provides	very	limited	time	for	de	
novo	mutations	to	occur.	Studies	on	dogs	and	horses	have	reaffirmed	the	limited	within-host	genetic	diversity	of	natural	infections	[114,	115].	Therefore,	the	less	diversified	naturally	evolved	viral	population	 is	not	an	optimal	tool	 to	estimate	the	bottleneck	size	from	donor	to	their	recipients	for	influenza	viruses.	However,	by	 introducing	 synonymous	 variants	 into	 the	 challenge	 virus,	 it	 is	 possible	 to	artificially	 increase	 the	 genetic	 diversity	 and	 increase	 the	 power	 to	 detect	multiple	transmission	events	to	a	given	host	and	to	estimate	the	bottleneck	size,	the	effective	population	size	of	viruses	within	 individuals	and	whether	 there	 is	evidence	for	selection.	
5.2	Determinants	of	bottleneck	size/transmission	dose	Several	 factors	 could	 affect	 the	 transmission	 bottleneck	 size.	 Mixed	 infections	of	influenza	virus	in	a	guinea	pig	model	suggest	that	the	size	of	the	bottleneck	is	dependent	 on	 the	 initial	 inoculum	 dose,	 with	 higher	 exposure	 doses	corresponding	 to	 larger	 founding	populations[116].	Ferret	 studies	 suggest	 that	route	 of	 transmission	 can	 affect	 transmission	 bottleneck	 size,	 where	 a	 tighter	bottleneck	 size	 is	 found	 for	 aerosol	 contact	 than	 for	direct	 transmission	 [108].	Work	in	animal	models	of	influenza	virus	suggest	that	populations	in	the	upper	airway	are	the	most	transmissible[117].	Moreover,	the	sampling	method,	sample	
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quality,	 library	 preparation	 and	 sequencing	 methods	 are	 also	 highly	 relevant	when	estimating	an	accurate	bottleneck	size	[100].		A	 stochastic	 pathogen	 dynamic	 in	 transmission	 was	 reported	 for	 influenza	variants	 passage	 from	donor	 to	 their	 recipient[116].	 Some	 studies	have	 shown	that	 transmitted	 viruses	 are	 most	 similar	 to	 those	 present	 early	 in	 the	 donor	infection	 and	 are	 better	 suited	 to	 spread	 between	 hosts	 [118,	 119].	 This	 has	implications	for	outbreak	control	where	early	 intervention	becomes	even	more	important.	 	 Charleston	 et	 al.	 found	 in	 an	 FMD	 study	 that	 control	 needs	 to	 be	implemented	at	or	before	the	onset	of	clinical	signs	[120].	
5.3	Deep	sequencing	to	estimate	transmission	bottleneck	size	The	 availability	 of	 newly	 developed	 next	 generation	 deep	 sequencing	technologies	 (NGS)	 and	 advances	 in	 mathematical	 representation	 of	transmission	could	contribute	to	develop	a	better	understanding	of	transmission	bottlenecking	 [121-123].	 Traditionally,	 the	 viral	 sequence	 was	 detected	 as	 a	single	consensus	sequence	that	represents	the	most	frequent	nucleotide	at	each	genome	position	in	the	public	databases	[124,	125].	However,	each	virus	type	or	progeny	 of	 viral	 infection	 contains	 numerous	 diverse	 variants	 that	 have	relatively	 low	 frequencies	 in	 reality.	These	variants	may	never	reach	dominant	status	 in	 an	 infection	 or	 amplification	 but	 these	 diverse	 variants	 could	 act	 as	subjects	 for	 Darwinian	 selection	 [100].	 The	 development	 of	 next	 generation	sequencing	 allows	 the	 number	 and	 frequency	 of	 each	 variant	 (naturally	generated	 or	 artificially	 introduced)	 to	 be	 quantified	within	 a	 viral	 population	sample.	Whole	genome	sequencing	(WGS)	of	IAV	has	been	reported	to	be	able	to	detect	viral	mutates	above	1-5%	in	the	total	viral	population	[126].	Because	the	genome	 is	 fragmented	 into	 many	 short	 	 (~500bp)	 pieces,	 it	 is	 difficult	 to	demonstrate	 the	 linkage	 among	 the	 detected	 mutations	 [126],	 which	 in	 turn	limits	 the	 ability	 to	 quantify	 the	 diversity	 of	 	 the	 population.	 However,	 other	experimental	designs	can	overcome	this	 technical	 limitation	(Varble	 [108],	and	the	study	in	Chapter	3).		
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5.4	The	challenge	of	deep	sequencing	Determination	of	what	variants	in	a	viral	population	are	genuine	vs	artefacts	by	NGS	 is	 affected	 by	 several	 factors,	 amongst	 which	 viral	 titre	 in	 the	 sample	 is	considered	as	the	most	important	[127,	128].		For	clinical	samples,	viral	genetic	material	 is	 often	 limited,	 therefore	 PCR	 amplification	 is	 needed	 to	 enrich	 the	material	to	a	sequencing	level	[129,	130].	The	extracted	vRNA	is	firstly	converted	to	 cDNA	and	 then	PCR	enriched	 through	20-35	 cycles.	Both	of	 these	 steps	will	introduce	errors.	If	the	titer	of	the	starting	material	is	below	1000	copies/ul,	the	variant	frequencies	can	be	significantly	distorted	after	sample	preparation[127].		Importantly,	 introducing	 biological	 replicates	 in	 the	 assay	 is	 important	 for	 the	determination	of	real	variants	[131].	The	replicates	can	assist	in	setting	variant-calling	thresholds	and	removing	low	confidence	viral	variants	[132].	RT	and	PCR	processes	use	enzymes	with	significant	error	rates,	but	the	chance	for	the	same	error	 to	 occur	 in	 multiple	 replicates	 is	 rare	 (except	 where	 some	 sequence	 or	structural	 feature	 promotes	 this).	 If	 a	 great	 difference	 in	 frequency	 between	replicates	 is	 observed	 in	 a	 high-quality	 sample,	 these	 variants	 should	 be	excluded.	 Therefore,	 it	 is	 essential	 1)	 to	maximize	 the	 amount	 of	 viral	 genetic	material	used	in	each	RNA	extraction,	RT	and	PCR	to	ensure	the	measurement	of	frequency	is	accurate;	and	2)	to	collect	replicate	samples	from	clinical	studies	in	my	research.	More	 recently,	 the	 development	 of	 new	 technology	may	 have	 the	 potential	 to	reduce	 the	 error	 rate	 during	 Next	 generation	 sequencing,	 such	 as	 a	 study	 of	influenza	 virus	 genome	 sequence	 using	 direct	 RNA	 sequencing	 on	 the	 Oxford	Nanopore	MinION	sequencing	platform	[133].	It	could	identify	and	quantify	the	splice	variants	using	 the	virus	RNA	as	 the	 starting	material	but	has	 limitations	for	the	clinical	samples	which	have	fewer	viral	RNA.		
5.5	Evolutionary	consequences	of	transmission	bottlenecks	Influenza	virus	evolution	begins	with	mutations	arising	and	undergoing	selection	within	the	host.		Shedding	duration,	titer	and	bottleneck	size	are	highly	relevant	to	 maintaining	 viral	 diversity.	 Short	 infectious	 periods	 are	 not	 sufficient	 for	
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generating	a	large	number	of	de	novo	mutations.	WGS	studies	support	this	view	and	show	that	most	mutations	are	rare	and	present	in	less	than	10%	of	the	viral	population	in	a	host	[112,	129].	The	infectious	period	of	SIV	is	short	(5-8	days)	for	 a	 typical	 infection	 [94,	 134,	 135].	 Therefore,	 there	 is	 little	 chance	 for	 the	selection	 of	 a	 rare	 variant	 to	 occur	 and	 for	 it	 to	 reach	 higher	 frequencies.	Nevertheless,	 IAV	 does	 display	 extensive	 evolution.	 Adaptive	 mutations	generated	and	selected	very	early	 in	 the	 infection	 	 (possibly	 in	 the	presence	of	relatively	weak	 immunity	 or	 less	 virulent	 virus	 competition),	 would	 allow	 the	virus	to	expand	and	evolve	within	the	animal	over	a	longer	time	[100].	Also,	the	sheer	 number	 of	 influenza	 infections	 every	 year	 may	 impact	 the	 rapid	 global	evolution.	Transmission	 bottlenecks	 determine	 the	 extent	 to	 which	within-host	 diversity	contributes	 to	 evolutionary	 trends	 as	 well.	 Stringent	 transmission	 bottlenecks	reduce	 the	 effective	 population	 size	 of	 transmitted	 viruses	 between	 hosts	 and	decrease	the	efficiency	of	selection	and	variant	establishment	and	fixation	in	the	population,	 posing	 a	 significant	 barrier	 to	 adaptive	 evolution.	 However,	 if	 the	transmission	 bottleneck	 is	 loose,	 transmission	 does	 not	 significantly	 impact	variant	 frequencies	 and	 the	 composition	 of	 the	 founding	 population	 in	 the	recipient	 more	 closely	 matches	 that	 present	 in	 the	 donor	 at	 the	 time	 of	transmission.	 Interestingly,	 a	 coalescent	 model	 was	 applied	 to	 trace	 the	evolution	 origin	 of	 the	 presenting	 viral	 population	 and	 the	 analysis	of	HIV	evolution	suggests	that	most	infections	derive	from	only	a	few	genotypes	[136,	137].		
6.	Thesis	overview		
The	 first	 aim	 of	 this	 project	 was	 to	 build	 up	 a	 large	 number	 of	 the	 influenza	viruses	 that	 contained	 individually	 identifiable	 “barcode	 tags”	 but	 without	altering	 the	primary	sequence	of	 the	viral	proteins.	Secondly,	a	new	method	of	analysing	the	deep	sequencing	data	developed.	The	third	aim	of	this	project	was	to	study	the	replication	and	transmission	dynamics	of	influenza	virus	in	vitro	and	
in	vivo	by	using	these	barcoded	viruses.	
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The	Materials	and	Methods	are	described	in	Chapter	2.	In	 Chapter	 3,	 I	 demonstrate	 the	 principle	 of	 designing	 barcoded	 viruses	 and	discuss	the	process	for	producing	and	testing	the	barcoded	virus	using	a	reverse	genetics	 system	 to	 rescue	 the	 barcoded	 viruses	 based	 on	 A/Puerto	 Rico/8/34	(H1N1)	virus	that	is	a	 lab	standard	influenza	strain	and	relatively	easy	to	work	with.	 Then	 the	 constructed	 barcoded	 system	was	 applied	 to	 generate	 another	tagged	 virus	 population	 based	 on	A/swine/England/1353	 /2009	 (H1N1)	 for	 a	series	of	pig	transmission	studies.	The	barcoded	strains	showed	identical	growth	kinetics	to	their	wild	type	parents,	suggesting	that	the	tags	were	phenotypically	silent	and	didn’t	affect	the	virus	growth	properties.		In	Chapter	4,	five	ULI-tagged	viruses	based	on	APR8	strain	were	used	to	explore	some	fundamental	aspects	of	 infection	dynamics	 in	cell	culture	(such	as	single-	and	multi-hit	dynamics,	virus	aggregates	and	timing	effects	on	co-infection).		In	Chapter	5,	I	describe	the	characterization	and	optimization	of	the	analysis	for	A/swine/England/1353	/2009	(H1N1)	(shortened	as	SIV/1353	in	the	later	text)	barcoded	 viruses	 in	 vitro	 by	 using	 Next	 Generation	 Sequencing	 (NGS).	 Four	aspects	are	included:	analysis	of	NGS	sequencing	data	from	“barcoded	region”	by	introducing	 a	 read	 filter	 to	 reduce	 the	 errors	 and	 estimation	of	 the	number	 of	barcoded	 virus	 in	 each	 viral	 library;	 analysis	 of	 trends	 for	 specific	 barcoded	variant	 populations	 when	 passaging	 in	 vitro;	analysis	 of	 the	 composition	 and	frequency	 of	 each	 viral	 barcoded	 member	 in	 the	 viral	 library;	 whole	 genome	sequencing	to	confirm	the	presence	and	frequency	of	spontaneous	mutations	of	the	 stock	 viruses;	 and	 analysis	 of	 base	 bias	 of	 selected	 substitutions	 in	 the	barcode	region.	In	 Chapter	 6,	 the	 barcoded	 virus	 stock	 based	 on	 SIV/1353	 strain	 was	 further	employed	to	examine	 its	 transmission	dynamics	 in	a	natural	host,	namely	pigs.	Two	pilot	experiments	were	conducted	in	pigs	to	test	the	utility	of	the	barcoded	viruses	 to	 investigate	 viral	 transmission	 dynamics	 between	 the	 donor	 and	contact	 pigs.	 Transmission	 factors	 such	 as	 spatial	 structure,	 transmitted	 dose	between	 animals,	 the	 possibility	 of	 recurrent	 transmission	 events	 (super-
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infection),	anatomical	compartmentalisation	and	virus	shedding	within	a	group	of	pigs	are	described	in	detail.	A	general	discussion	of	the	work	is	presented	in	Chapter	7.	
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1.Materials	
1.1	Cells	HEK	 293T/17	 cells	 (hereafter	 referred	 to	 as	 293T;	 ATCC	 #CRL-11268)	 are	 a	clone	 of	 human	 embryonic	 kidney	 cells	 selected	 for	 their	 high	 transfectability.	The	Madin-Darby	Canine	Kidney	(MDCK)	cell	line	was	derived	from	a	kidney	of	an	 apparently	normal	 adult	 female	 cocker	 spaniel.	 These	 cells	were	purchased	from	ATCC.		
1.2	Media	
MDCK	cell	culture:	Eagle’s	Minimum	Essential	Medium	(EMEM)	supplemented	with	 penicillin	 (100	 U/mL),	 streptomycin	 (50	 μg/mL),	 amphotericin	 (2.6	 μg/	mL),	 L-glutamine	 (10	mM),	 1x	MEM	non-essential	 amino	 acid	 solution	 (Sigma-Aldrich	#M7145)	and	10	%	(v/v)	foetal	bovine	serum	(FBS,	Gibco,	10500064).	
MDCK	cell	infection	medium:		EMEM	supplemented	with	penicillin	(100	U/mL),	streptomycin	 (50	μg/mL),	 amphotericin	 (2.6	μg/	mL),	L-glutamine	 (10mM),	1x	MEM	non-essential	amino	acid	solution	(Sigma-Aldrich	#M7145)	and	0.3	%	(w/v)	bovine	serum	albumin	(BSA).	
293T	 cell	 culture	 medium:	 Dulbecco’s	 Modified	 Eagle	 Medium	 (DMEM)	supplemented	 with	 penicillin	 (100	 U/mL),	 streptomycin	 (50	 μg/mL),	amphotericin	(2.6	μg/	mL),	L-glutamine	(10	mM)	and	10	%	(v/v)	FBS.	
293T	cell	infection	medium:	DMEM	supplemented	with	penicillin	(100	U/mL),	streptomycin	(50	μg/	mL),	amphotericin	(2.6	μg/mL),	L-glutamine	(10	mM)	and	0.3%	(w/v)	BSA.	
1.3	Virus	A/Puerto	 Rico/8/34	 was	 provided	 by	 Dr.	 John	 Lyall	 from	 our	 lab.	A/swine/England/1353	/2009	(H1N1)	(hereafter	called	SIV/1353)	was	used	in	the	 pig	 study,	 provided	 by	 Dr.	 Helen	 Everett	 from	 APHA	 (Animal	 and	 Plant	Health	Agency).	
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2.	Methods	
2.1	Design	and	rescue	of	barcoded	viruses	
2.1.1	The	strategy	of	producing	barcoded	viruses		The	 strategy	 reported	 here	 for	 tagging	 the	 viral	 segments	 exploits	 the	 natural	codon	degeneracy	observed	across	influenza	virus	strains	allowing	the	tags	to	be	embedded	 in	 short	 (~150	 nt)	 regions	 that	 tolerate	 high	 levels	 of	 synonymous	changes.	 The	 “barcode”	 is	 composed	 of	 two	 elements:	 the	 unique	 library	identifier	 (ULI)	 in	 the	 form	of	a	specific	binary	Hamming	code	and	a	 “diversity	region”	(DR)	that	contains	a	random	assortment	of	13	synonymous	codons.	The	ULI	can	be	used	separately	or	in	conjunction	with	the	DR.	Two	sets	of	barcoded	viruses	were	rescued	for	different	research	purposes:	1)	Five	ULI-tagged	viruses	(BCV1-5_APR8)	 each	 containing	 the	 same	 ULI	 code	 in	 segments	 1	 (PB2)	 from	A/Puerto	Rico/8/34	[H1N1]	(APR8),	4	(HA)	and	5	(NP)	virus;	2)	Five	barcoded	virus	populations	based	on	APR8	(DBCV1-5_APR8)	tagged	in	segment	1,	4	and	5	with	the	same	ULI	code	but	in	addition	tagged	in	segment	1	with	the	DR.	
2.1.2	Reverse	genetics	vector	The	virus	rescue	system	used	in	this	work	is	based	on	pRF483	(kindly	provided	by	Prof.	Ron	Fouchier,	Erasmus	Medical	Centre,	Netherlands)	originally	derived	from	the	bi-directional	eight	plasmid	system	developed	by	Hoffmann	et	al.	 [59]	This	plasmid	bears	a	cassette	comprising	two	BsmBI	cloning	sites	to	receive	the	viral	 cDNA,	 located	 between	 the	 Cytomegalovirus	 (CMV)	 immediate-early	promoter	and	a	human	Polymerase	I	(Pol	I)	promoter.	Transfection	of	this	set	of	eight	plasmids	 resulted	 in	 the	production	of	negative-sense	vRNA	(synthesized	from	the	PolI	promoter	and	 terminated	by	a	downstream	PolI	 terminator)	and	mRNA	 (transcribed	 from	 the	 CMV	promoter	 and	 terminated	 by	 a	 downstream	polyadenylation	site)	corresponding	to	all	eight	viral	segments.		The	pRF483	plasmid	was	modified	 to	 produce	pRF483T	 [138]	 by	 inserting	T7	bacteriophage	 early	 terminator	 sequence	 between	 the	 CMV	 promoter	 and	 the	viral	 gene	 segment	 to	 prevent	 cryptic	 transcription	 in	 E.coli.	 This	modification	
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increased	the	stability	of	“problematic”	segments,	such	as	segment	2	which	have	a	tendency	to	be	toxic	in	E.	coli	(Dr.	Tiley’s	unpublished	results).		
2.2	Rescue	of	virus	stocks	BCV1-5_APR8	
2.2.1	Construction	of	plasmids	RF483T_PB2_APR8,	RF483T_HA_APR8	and	
RF483T_NP_APR8	containing	different	ULIs	
Transformation	 of	 stock	 plasmids	 Eight	 stock	 RF483T	 plasmids	 containing	APR8	 influenza	 viral	 segments	 1-8	 were	 provided	 by	 Dr.	 Jon	 Lyall	 from	 our	laboratory.	 Each	 plasmid	 encoding	 one	 full-length	 viral	 segment	 was	transformed	into	DH5α™	Competent	Cells	on	ampicillin	agar	Luria-Bertani	(LB)	plates	 as	 per	manufacturer's	 instructions.	 After	 an	 overnight	 incubation	 of	 the	plates	 at	 37	 °C,	 a	 3	 mL	 liquid	 LB	 broth	 culture	 was	 inoculated	 with	 a	 single	colony	 and	 incubated	 for	 8	 h	 at	 37	 °C	with	 a	 ×225	 rotation	 per	minute	 (rpm)	agitation.	A	150	mL	culture	was	then	inoculated	with	150	μL	of	the	starter	from	3	mL	 culture	 and	 incubated	 overnight	 at	 37	 °C	 with	 a	 ×225	 rpm	 agitation.	 All	cultures	were	done	in	medium	containing	100	μg/mL	of	ampicillin.	The	bacteria	were	 then	pelleted	by	 centrifugation	 and	 the	plasmid	was	harvested	using	 the	GenElute	 Endotoxin-free	 Plasmid	 Maxiprep	 Kit	 (Sigma	 Aldrich)	 as	 per	manufacturer's	instructions.	
Design	 of	 oligonucleotides	 for	 ULIs	 These	 were	 designed	 by	 Dr.	 Laurence	Tiley.	 Locations	 were	 chosen	 by	 examining	 the	 locations	 of	 pairs	 of	 unique	restriction	enzyme	sites	that	were	within	a	suitable	short	distance	(<	50	bp)	of	each	 other	 and	 framed	 a	 region	 that	 had	 a	 sufficient	 number	 of	 naturally	occurring	 synonymous	 variable	 codons	 within	 it.	 This	 region	 was	 excised	 by	restriction	 digest	 of	 the	 plasmids	 and	 replaced	 with	 pairs	 of	 complementary	annealed	 oligos	 with	 the	 appropriate	 overhangs	 at	 each	 end.	 These	 oligo	sequences	 were	 designed	 using	 an	 Excel	 macro	 where	 the	 primary	 coding	sequence	of	the	excised	target	region	could	be	input	(specifying	the	IUPAC	code	at	the	relevant	positions)	plus	the	desired	overhangs	for	cloning.	The	macro	then	varies	the	codons	at	these	positions	in	accordance	with	a	binary	hamming	code	reference	table.	In	total	32	pairs	of	complementary	oligos	were	designed	for	each	of	segment	1,	4	and	5	and	then	synthesised	by	Sigma	Aldrich.	This	provides	the	
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potential	 to	 generate	 up	 to	 32	 individual	 viruses	 tagged	 in	 3	 segments.	 In	 the	event,	only	 five	of	 the	ULIs	were	chosen	 for	 the	reported	studies	and	these	are	listed	in	Tables	2.1-	2.3	
Table	2.	1	Sequence	of	Hamming	codes	in	seg_1_APR8	
Hamming codes   Barcode         Sequence of five barcodes in seg_1 5’-3’ 
Consensus                       TTR ATY ATY GCW GCY AGR AAC ATW GTW AGR  
000000000          BC1          TTG ATC ATC GCT GCC AGG AAC ATT GTT AGG  
                        0   0   0   0   0   0       0   0   0 
000000111          BC2          TTG ATC ATC GCT GCC AGG AAC ATA GTA AGA 
                        0   0   0   0   0   0       1   1   1 
000011001          BC3          TTG ATC ATC GCT GCT AGA AAC ATT GTT AGA  
                        0   0   0   0   1   1       0   0   1      
000011110          BC4          TTG ATC ATC GCT GCT AGA AAC ATA GTA AGG  
                        0   0   0   0   1   1       1   1   0      
000101010          BC5          TTG ATC ATC GCA GCC AGA AAC ATT GTA AGG  
                                  0   0   0   1   0   1       0   1   0                
 
Table	2.	2	Sequence	of	Hamming	codes	in	seg_4_APR8	
Hamming codes    Barcode            Sequence of five barcodes in seg_4 
Consensus                          ACM ATM TGT ATA GGY TAY CAT GCR AAY AAY TCM ACY 
000000000           BC1            ACC ATC TGT ATA GGC TAC CAT GCG AAC AAC TCC ACC 
                                     0   0           0   0       0   0   0   0   0 
000000111           BC2            ACC ATC TGT ATA GGC TAC CAT GCG AAC AAT TCA ACT 
                                     0   0           0   0       0   0   1   1   1 
000011001           BC3            ACC ATC TGT ATA GGC TAC CAT GCA AAT AAC TCC ACT 
                                     0   0           0   0       1   1   0   0   1 
000011110           BC4            ACC ATC TGT ATA GGC TAC CAT GCA AAT AAT TCA ACC 
                                     0   0           0   0       1   1   1   1   0 
000101010           BC5            ACC ATC TGT ATA GGC TAT CAT GCG AAT AAC TCA ACC 
                                     0   0           0   1       0   1   0   1   0                                                                       
	
Table	2.	3	Sequence	of	Hamming	codes	in	seg_5_APR8	
Hamming codes     Barcode              Sequence of five barcodes in seg_5 
Consensus                             CAR GGY TCR ACY CTY CCK AGR AGR TCY 
000000000           BC1               CAG GGC TCG ACC CTC CCT AGG AGG TCC 
                                        0   0   0   0   0   0   0   0   0 
000000111           BC2               CAG GGC TCG ACC CTC CCT AGA AGA TCT 
                                        0   0   0   0   0   0   1   1   1 
000011001           BC3               CAG GGC TCG ACC CTT CCG AGG AGG TCT 
                                        0   0   0   0   1   1   0   0   1 
000011110           BC4               CAG GGC TCG ACC CTT CCG AGA AGA TCC 
                                        0   0   0   0   1   1   1   1   0 
000101010           BC5               CAG GGC TCG ACT CTC CCG AGG AGA TCC 
                                        0   0   0   1   0   1   0   1   0 
Annealing	 of	 oligonucleotides	 for	ULIs	 The	 complementary	 ULI	 oligos	 were	provided	lyophilised	in	a	96	well	plate	by	Sigma	Aldrich.	These	oligonucleotides	were	dissolved	in	60	µL	5	mM	Tris/HCL	(pH	=	8.5)	and	then	each	pair	for	making	each	ULI	was	mixed	in	equimolar	ratios	and	denatured	at	80	°C	for	10	min	then	gradually	cooled	down	to	room	temperature	 to	anneal	 them	 in	preparation	 for	cloning.		
Digestion	 and	 ligation	 of	 plasmids	 and	 ULI	 oligonucleotides	 Plasmids	RF483T_PB2_APR8,	RF483T_HA_APR8	and	RF483T_NP_APR8	were	each	double	digested	with	20	units	of	restriction	enzymes	at	37	°C	overnight	(HindIII	and	PstI	
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for	PB2;	BamHI	and	PstI	 for	NP;	PstI	and	XhoI	 for	HA)	 (New	England	Biolabs).	The	small	excised	fragment	was	eliminated	by	gel	purification	and	50	ng	of	the	purified	large	fragment	was	ligated	with	a	3-fold	molar	excess	of	the	cognate	ULI	annealed	oligonucleotides	in	10	μL	reactions	containing	1	×	ligase	buffer,	and	5	units	of	T4	DNA	ligase	(Invitrogen).	A	no	insert	control	(50	ng	large	fragment,	no	ULI	 oligo)	 was	 included	 to	 assess	 the	 background	 level	 of	 vector	 re-ligation.	Reactions	 were	 incubated	 either	 at	 room	 temperature	 for	 1	 h,	 or	 at	 16	 °C	overnight.	Ligations	were	transformed	into	DH5α	competent	cells	as	above.	The	no	 insert	 control	 showed	 very	 low	 background	 transformation.	 Oligo	 ligation	transformations	 typically	 gave	 20-50	 colonies.	 Four	 well-isolated	 colonies	 for	each	 ligation	were	 then	picked	 and	 grown	overnight	 in	 3	mL	LB	 cultures	with	100	 μg/mL	 of	 ampicillin	 and	 then	 extracted	 by	 QIAprep	 Spin	 Miniprep	 Kit	(Qiagen)	 as	 per	 manufacturer's	 instructions.	 Miniprep	 DNAs	 were	 checked	 by	restriction	digest	 and	 agarose	 gel	 electrophoresis	 and	 those	with	 the	 expected	restriction	 pattern	were	 sent	 for	 Sanger	 sequencing	 using	 primers	 adjacent	 to	the	ULI	regions	(Table	2.4).	The	efficiency	of	oligo	cloning	by	this	method	is	such	that	the	great	majority	of	the	transformants	contain	the	desired	oligo	sequence.		A	correct	clone	for	each	construct	was	maxiprepped	using	a	GenElute	Endotoxin-free	 Plasmid	 Maxi	 prep	 Kit	 (Sigma	 Aldrich).	 The	 full-length	 viral	 genome	 and	flanking	 promoter	 sequences	 were	 verified	 for	 all	 clones	 used	 for	 subsequent	stages.	All	primer	sequences	in	this	report	are	given	from	5'	to	3’.	
Table	2.	4	Primers	used	for	ULI	region	sequencing	
Sequencing	primer	 Barcode	sequencing	primer	PB2seq	 AACTGGTCCGCAAAACGAGA	HAseq	 CGAATCTGGCGCCAAGCTAA	NPseq	 GAAGGCAAACCTACTGGTCCT	
2.2.2	Construction	of	five	RF483T_PB2_APR8	containing	ULI	and	DR	
Annealing	of	DR	oligonucleotides	Annealing	of	the	partial	overlaps	followed	by	extension	and	amplification	with	Taq	DNA	polymerase	was	used	to	generate	the	double-stranded	DNA	product	suitable	for	ligation	adjacent	to	the	ULI	sequences.	In	 details,	 a	 total	 50	 μL	 reaction	 contained	 10	 μL	 5×	 PCR	 Buffer,	 2	 μL	 10	 μM	deoxyribonucleotides	triphosphate	(dNTP),	1	μL	Platinum	Taq	DNA	Polymerase,	33	 μL	 molecular	 biology	 grade	 water	 and	 2	 μL	 of	 each	 forword	 and	 reverse	
		 28	
diversity	 oligonucleotides	 at	 100	 μg/µL.	 DNA	 was	 amplified	 using	 a	 Hybaid	thermal	cycler	with	an	initial	enzyme	activation	step	at	94	°C	for	2	min,	followed	by	10	cycles	of	denaturation	at	94	°C	for	30	s,	annealing	for	30	s,	and	extension	at	72	°C	for	1	min.	After	amplification,	the	121	nt	long	dsDNA	product	was	digested	with	Hind	III	BsrGI	and	purified.	
Ligation	 of	 ULI-tagged	 plasmids	 and	 DR	 oligonucleotides	 The	RF483T_PB2_APR8	 plasmids	 containing	 ULIs	 1-5	 were	 double	 digested	 with	HindIII	and	BsrG	I	(New	England	Biolabs)	overnight	and	gel	purified.	Each	was	then	 ligated	 with	 the	 digested	 diversity	 region	 DNA	 described	 in	 the	 section	above.	Each	ligation	was	transformed	into	Library	Efficiency	DH5αTM	Competent	Cells	 and	 incubated	 on	 ice	 for	 30	mins.	 Cells	 were	 heat-shocked	 for	 45	 s	 in	 a	42	°C	water	bath	and	then	placed	on	ice	for	2	mins.	After	incubating	with	900	µL	S.O.C	Medium	at	37	°C	for	1	h,	the	reaction	was	diluted	1:10,	1:100	and	1:1000	with	S.O.C	Medium.	100	µL	of	each	dilution	was	spread	on	LB	plates	containing	100	µg/mL	ampicillin.	The	rest	of	 the	reaction	products	were	seeded	on	 larger	25	×	25	cm2	agar	plates	overnight	at	37	°C.	Approximately	8000-13,000	colonies	grown	on	the	plate	were	collected	together	in	LB	medium.	The	resulting	mixture	of	 library	plasmids	was	extracted	by	QIAprep	Spin	Midprep	Kit	(Qiagen)	as	per	manufacturer's	instructions.		
2.2.3	Viral	rescue	protocol		The	 rescue	 protocol	 was	 originally	 provided	 by	 Dr	 Helen	 Wise	 from	 Paul	Digard's	 laboratory	(Edinburgh	University)	and	then	was	modified	[139]	by	Dr	Vincent	Bourret,	who	was	a	former	PhD	student	 in	our	 laboratory.	 In	detail,	on	day	0,	1	×	105	293T	cells	were	plated	 in	each	well	of	a	24-well	plate.	On	day	1,	each	well	was	 transfected	with	 total	 0.8	 μg	DNA	 including	 75	 ng	 each	 reverse	genetics	plasmid	and	200	ng	MVV	Env	plasmid	in	100	μL	OptiMEM,	using	3μL	of	FuGene	 (Roche)	 per	 μg	 of	 DNA	 as	 per	manufacturer's	 instructions.	 Cells	 were	incubated	overnight	at	37	°C	and	5%	CO2	in	500	μL	DMEM	culture	medium.	On	day	2,	the	medium	was	removed	and	replaced	by	DMEM	infection	medium	and	incubated	 for	 three	 more	 days.	 TPCK-trypsin	 (Worthington)	 was	 added	 to	 1	μg/mL	on	day	4.	Cell	supernatants	were	harvested	on	day	5	and	transferred	onto	
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MDCK	 cells	 plated	 earlier	 on	 day	 5	 for	 further	 amplification.	 On	 day	 7,	supernatants	from	the	infected	MDCK	were	harvested,	aliquoted	and	frozen	at	-80	 °C.	vRNA	was	extracted	by	 the	QIAprep	Spin	Midprep	Kit	 (Qiagen).	Reverse	transcription	 of	 viral	 RNA	 into	 complementary	 DNA	 (cDNA)	 was	 performed	using	 Thermo	 RevertAid	 reverse	 transcriptase	 as	 per	 manufacturer’s	instructions,	using	a	primer	complementary	to	the	12	bp	conserved	region	at	3’	end	of	 all	 eight	 segments	 (Universal	RT	primer:	AGCGAAAGCAGG).	 Later	 cDNA	was	 amplified	 by	 using	 optimised	 annealing	 temperature	 (TM)	 and	 extension	time	depending	on	 segment	 (Table	2.5).	 The	 sequence	of	 amplified	 cDNA	was	confirmed	by	sequencing	using	the	primers	described	in	the	Table	2.6.	
Table	2.	5	PCR	conditions	specific	for	APR8	and	SIV/1353	virus	gene	segment	
PCR	primers_AP8	 PCR	primers_SIV/1353	 Annealing	temperature	
Extension	
time	PB2F:	AGCGAAAGCAGGTCAATTA	 PB2F:AGCGAAAGCAGGTCAAATATATT	 Touchdown	from	 2.5mins	PB2R:	AGTAGAAACAAGGTCGTTTTTAA	 PB2R:AGTAGAAACAAGGTCGTTTTTAAAC	 65	ºC	to	54	ºC	PB1F:	AGCGAAAGCAGGCAAAC	 PB1F:AGCGAAAGCAGGCAAAC	 Touchdown	from	 2.5mins	PB1R:AGTAGAAACAAGGCATTTTTTCA	 PB1R:AGTAGAAACAAGGCATTTTTTCAT	 67	ºC	to	54	ºC	PAF:	AGCGAAAGCAGGTACTGAT	 PAF:AGCGAAAGCAGGTACTGAT	 Touchdown	from	 2.5mins	PAR:	AGTAGAAACAAGGTACTTTTTTGGA	 PAR:AGTAGAAACAAGGTACTTTTTTGGA	 67	ºC	to	54	ºC	HAIF:	AGCAAAAGCAGGGGAAAA	 HAF:AGCAAAAGCAGGGGAAA	 56ºC	 2mins	HAIR:	AGTAGAAACAAGGGTGTTTTTCC	 HAR:AGTAGAAACAAGGGTGTTTTT	NPF:	AGCAAAAGCAGGGTAGATAATC	 NPF:AGCAAAAGCAGGGTAGATAATC	 53ºC	 2mins	NPR:	AGTAGAAACAAGGGTATTTTTCTTTA	 NPR:AGTAGAAACAAGGGTATTTTTCCT	NAF:AGCGAAAGCAGGAGTTTA	 NAF:AGCAAAAGCAGGAGTTTAA	 52ºC	 2mins	NAR:AGTAGAAACAAGGAGTTTTTTGA	 NAR:AGTAGAAACAAGGAGTTTTTT	MF:AGCGAAAGCAGGTAGATATTGA	 MF:AGCAAAAGCAGGTAGATATTTAAAG	 56ºC	 2mins	MR:AGTAGAAACAAGGTAGTTTTTTACTCC	 MR:AGTAGAAACAAGGTAGTTTTTTACTCTA	NSF:	AGCAAAAGCAGGGTGACA	 NSF:AGCAAAAGCAGGGTGACA	 56ºC	 1.5mins	NSR:	AGTAGAAACAAGGGTGTTTTTTAGTAC	 NSR:AGTAGAAACAAGGGTGTTTTTTATCA	
	
Table	2.	6	Sequencing	primer	for	APR8	and	SIV/1353	virus	gene	segment	
Sequencing	primers_APR8	 Sequencing	primers_SIV/1353	PB2S1:	AGCGAAAGCAGGTCAATTA	 PB2S1:ACCTCTGGCTGTAACATGGTG	PB2S2:AACTGGTCCGCAAAACGAGA	 PB2S2:CAGCACACAGATTGGGGGAG	PB2S3:TTTCGTCAATAGGGCGAATC	 PB2S3:CCCCAAGTACGGAGATGTCG	PB2S4:TGGTCCTGAATCAGTGTTGG	 PB2S4:ATGAAGGCACATCTGGGGTG	PB2S5:	AGTAGAAACAAGGTCGTTTTTAA	 	PB1S1:	AGCGAAAGCAGGCAAAC	 PB1S1:AAATCAACCGGCAGCAACTG	PB1S2:TTCAGAGAAAGAGACGGGTGA	 PB1S2:CCTCGAATGTTCCTGGCGAT	PB1S3:CAAACAAAATGGCGAGACTG	 PB1S3:GCACCAAACCATGAGGGAAT	PB1S4:AGTAGAAACAAGGCATTTTTTCA	 PB1S4:CCCCTGAATCCCTTTGTCAG	PAS1:	AGCGAAAGCAGGTACTGAT	 PAS1:ACAACAGGGGTAGAGAAGCC	PAS2:CTCTGGGATTCCTTTCGTCA	 PAS2:TTCTTGAGGACGACACCACG	PAS3:TGAGAACATGGCACCAGAAA	 PAS3:ACAGCAGAAGTGTCCCACTG	PAS4:	AGTAGAAACAAGGTACTTTTTTGGA	 PAS4:GAGAGCATGATTGAGGCCGA	HAS1:	AGCAAAAGCAGGGGAAAA	 HAS1:CTACATTGTGGAAACATCTAGT	
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HAS2:GGAGAAGGAGGGCTC	 HAS2:CCCAAAGTGAGGGGTCAAGAA	HAS3:	AGTAGAAACAAGGGTGTTTTTCC	 HAS3:CTAACAAAGTAAATTCTGTTAT	NPS1:	AGCAAAAGCAGGGTAGATAATC	 NPS1:TAATCCAGAATAGCATAACA	NPS2:CGAATCTGGCGCCAAGCTAA	 NPS2:ATCCTCAAAGGAAAATTTCA	NPS3:GCACAAAAAGCAATGATGGA	 NPS3:AACCATGGACTCCAATACCC	NPS4:	AGTAGAAACAAGGGTATTTTTCTTTA	 	NAS1:AGCGAAAGCAGGAGTTTA	 NAS1:TTAACATCAGCAACACCAA	NAS2:TCCGTCCCCGTACAA	 NAS2:GCAGTGGCTGTGTTAAAGT	NAS3:AGTAGAAACAAGGAGTTTTTTGA	 NAS3:ATTCAAATACGGAAATGGT	MS1:AGCGAAAGCAGGTAGATATTGA	 MS1:AGGATTTGTGTTCACGCT	MS2:AGTAGAAACAAGGTAGTTTTTTACTCCA	 MS2:CTAGCTCCAGTGCTGGTCT	NS1:	AGCAAAAGCAGGGTGACA	 NS1:ACAATGGATTGGGTGATGC	NS2:	AGTAGAAACAAGGGTGTTTTTTAGTAC	 NS2:ACTTCAGTGTAATCTTTAA	
	
2.2.4	Titration	of	rescued	virus	MDCK	cells	were	grown	in	MEM	culture	medium	and	plated	at	a	density	of	5×105	cells	 per	 well	 in	 6-well	 plates.	 On	 the	 following	 day,	 cells	 were	 washed	 with	phosphate-buffered	saline	(PBS)	3	times	and	inoculated	with	consecutive	10-fold	virus	dilutions	in	infection	medium	for	1	h.	Afterwards,	2	mL	overlay	containing	1	ml	2.4%	Avicel	solution	and	2	μg	trypsin	were	added	and	the	cells	incubated	at	37	 °C	 for	2	days	without	moving.	The	overlay	was	 then	 removed,	 and	cultures	were	 washed	 with	 PBS	 and	 then	 stained	 with	 a	 1%	 crystal	 violet	 solution	containing	10%	formaldehyde.	The	wells	containing	5-50	plaques	were	counted.	The	 viral	 titer	 of	 the	 stock	 sample	 was	 determined	 by	 taking	 the	 number	 of	plaques	 for	 a	 dilution	 and	 the	 inverse	 of	 the	 total	 dilution	 factor.	 Pfu/ml=#	 of	plaques/volume	of	diluted	virus	added	to	the	well	(ml)×	dilution.	As	an	example,	10	plaques	counted	in	the	1×10-6	dilution	using	0.4	ml	 inoculum	(10/10-6	×	0.4)	would	yield	a	titer	of	2.5×107	pfu/ml.	
3.Characterisation	of	DBCV1-5_SIV/1353	virus	stocks	by	NGS	
3.1	Barcode	region	(DR&ULI)	sequencing	and	analysis		
3.1.1	overhang	primer	design	Our	barcoded	virus	contains	two	signature	sequences,	one	is	called	the	DR	which	contains	13	wobble	positions	 (highlighted	 in	yellow),	and	 the	other	one	 is	ULI,	which	 for	 the	 5	 ULIs	 used	 in	 this	 study,	 contains	 six	 wobble	 positions	 in	 the	
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sequence	 (highlighted	 in	green).	We	generated	5	barcode	 libraries	each	with	a	single	ULI	 and	a	varying	 complement	of	13	 silent	mutations	within	 the	DR.	To	determine	 the	 diversity	 of	 these	 libraries,	 vRNA	 of	 each	 stock	 was	 firstly	extracted	and	then	synthesized	to	cDNA	using	primer: AGCGAAAGCAGGTCAAATATATT.	Two	specific	primers	with	5’	overhang	adaptor	sequences	attached	were	used	to	amplify	cDNA,	shown	in	Table	2.7.	The	amplicon	sequence	for	NGS	including	the	ULI	 (bases	 chosen	 are	 highlighted	 in	 green)	 and	 DR	 (bases	 are	 highlighted	 in	yellow)	is	shown	as	below.	
GCGGAACAGGCAGTGTGTACATTGARGTDTTRCATTTGACYCAAGGRACVTGYTGGG
AACARATGTATACTCCAGGHGGRGAAGTGAGRAATGAYGATGTTGAYCAAAGCTTGA
TCATCGCWGCYAGRAACATWGTWAGRAGAGCTGCAGTGTCAGCAGATCC(R=A/G 
Y=C/T H=A/C/T V=A/C/G D=A/G/T) (163bp)	
Table	2.	7	Primers	with	overhang	adaptor	
											PCR	primer		 																				Primer	Sequence			Forward_overhang				 TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGgcggaacaggcagtgtgtacattg			Reverse_overhang					 GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGggatctgctgacactgcagctct				
Note:	the	sequence	of	specific	primer	binding	sites	in	segment	1	are	highlighted	in	red.	The	bold	sequence	corresponds	 to	 the	 index	 primer	 binding	 sites	 for	 the	 16s	Metagenomic	 Sequencing	 Library	 Preparation	protocol	(https://web.uri.edu/gsc/files/16s-metagenomic-library-prep-guide-15044223-b.pdf).	
3.1.2	Sample	preparation	for	Next	generation	sequencing	(NGS)	The	 cDNA	 amplicon	 was	 then	 prepared	 following	 the	 protocol	 for	 16S	Metagenomic	 Sequencing	 Library	 Preparation.	 Briefly,	 1)	 two	 specific	 primers	with	 the	 overhang	 adaptor	 attached	 were	 used	 to	 amplify	 cDNA	 using	 the	NEBNext	kit	(M0543S)	for	20-30	cycles;	2)	the	products	were	cleaned	up	using	AMPureXP	beads;	3)	the	purified	products	were	then	amplified	using	the	Nextera	XT	Index	Kit	for	8	cycles	to	attach	dual	indices	and	Illumina	sequencing	adapters;	4)	 after	 purification	 of	 the	 indexed	 products,	 a	 final	 sequencing	 library	containing	 equalised	 amounts	 of	 each	 (confirmed	 by	 Qubit	 and	NEB	 quant	 kit	(E7630S))	was	loaded	on	an	Illumina	Miseq	at	4nM	including	5%	Phix	based	on	the	MiSeq	Reagent	Mirco	Kit	v2,	300cycles	(MS-103-1002).	
3.1.3	Preprocessing	the	raw	NGS	data		After	MiSeq	runs	were	completed,	 the	quality	of	 reads	was	assessed	by	FastQC	on	BaseSpace	(Illumina)	and	then	visualized	by	the	DADA2	pipeline	which	is	the	
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R	package	 inferring	exact	sequence	variants	 from	amplicon	data.	The	sequence	that	embraces	the	entire	DR	and	ULI	was	aligned,	filtered	and	merged	against	the	reference	 sequence	 (the	 degenerate	 BC/DR	 sequence)	 to	 produce	 a	 consensus	sequence	by	using	Samtool,	Trimmomatic	(Phred	score	>	33,	read	length	>	130	bp)	and	Fast	length	Adjustment	of	Short	reads	(setting	the	minimal	overlap	to	60	bp	 and	 maximal	 to	 151	 bp).	 Then	 a	 customized	 script	 written	 in	 Perl	 (see	Appendix)	was	applied	to	estimate	the	number	of	rescued	barcoded	variants	in	each	 viral	 stock	 (Chapter	 5	 section	 1.1).	 Then,	 the	 barcoded	 variants	 were	extracted	and	aggregated	by	searching	for	13	wobble	positions	in	the	“diversity	region”	and	6	wobble	positions	in	the	“unique	region”.	
3.1.4	Bioinformatics	analysis	and	plotting	of	NGS	data	Correlation	 analysis	 between	 replicates	 and	 samples	 was	 performed	 using	Python	 to	 display	 correlation	 plots,	 statistics	 and	 confidence	 intervals	 (Figure	
5.2	 and	 5.4	 in	 Chapter	 5).	 Analysis	 of	 substitution	 frequency	 distributions	(Figure	 5.6	 in	 Chapter	 5)	 was	 performed	 using	 Weblogo	(https://weblogo.berkeley.edu/logo.cgi).	 All	 other	 analysis	 in	 chapter	 5	 was	carried	out	using	R.	
3.2	Whole	genome	sequencing	and	analysis	
3.2.1.	Sample	preparation	for	WGS	Viral	RNA	of	each	stock	was	extracted	as	described	above.		cDNA	was	generated	with	the	Superscript	IV	and	universal	influenza	virus	primers,	and	then	the	cDNA	was	 amplified	 by	 the	 common	 universal	 primers.	 (Primer	 1:	 common_uni12F:	
5’GCCGGAGCTCTGCAGATATCAGCRAAAGCAGG3’,	 Primer	 2:	 common_uni13R:	
5’GCCGGAGCTCTGCAGATATCAGTAGAAACAAGG3’).	 50	 μL	 reaction	 mixtures,	including	 10	 μL	 of	 the	 first-strand	 cDNA,	 25	 μL	 of	 Q5	High-Fidelity	 2×	Master	Mix,	5	μL	of	primer	mix	1	and	10	μL	of	the	Nuclease-Free	water.	The	first	cycle	of	the	amplification	program	consisted	of	a	30	s	period	at	98	°C	and	was	followed	by	10	cycles	with	the	following	conditions:	98	°C	for	10	sec,	48	->	68	°C	at	slow	ramp	 (1	 °C/sec)	 and	 72	 °C	 for	 3	 mins.	 The	 third	 high	 annealing	 temperature	cycling	(20	cycles)	containing:	98	°C	for	10	sec,	68	°C	for	30	sec	and	72	°C	for	3	
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mins.	 The	 program	ended	with	 one	 cycle	 at	 72	 °C	 for	 2	min.	 The	mixture	was	amplified	 for	 30	 cycles	 and	 then	 run	 on	 a	 gel	 to	 check	 the	 success	 of	 the	amplification	of	 the	expected	segments.	The	products	were	sent	to	Department	of	Biochemistry,	University	of	Cambridge	for	sequencing.		
3.2.2.	Bioinformatics	analysis	of	the	whole	genome	segments	of	five	
plasmids	and	P3	stocks	Sequence	 reads	 were	 analysed	 by	 the	 pipeline	 written	 by	 Dr.	 Lajos	 Kalmer	(Department	 of	 Veterinary	 Medicine,	 University	 of	 Cambridge).	 The	 raw	 data	were	 processed	 according	 to	 the	 steps	 as	 follows:	 (1)	 Pair-end	 reads	 were	mapped	with	 the	 reference	 genome	 by	 using	 Burrows-Wheeler	 Aligner	 (BWA,	mem	and	number	of	 threads	 (-t,	4)	was	used)	and	 the	sequences	with	a	Phred	quality	score	<	30	were	then	eliminated;	(2)	PCR	duplicates	within	the	sequence	were	 removed	 by	 Picard;	 (3)	 sequence	was	 then	 locally	 realigned	 by	 Genome	Analysis	Toolkit	(GATK);	and	(4)	The	frequency	at	each	position	was	calculated	in	 R	 and	 visualized	 by	 Integrative	 Genomics	 Viewer	 (IGV).	 	 The	 results	 were	plotted	in	R.	
4.	 Studies	 of	 single-hit	 and	 asynchronous	 infection	 in	 vitro	 by	
using	barcoded	virus	
4.1	Isolation	of	single	plaque	to	identify	the	number	of	ULI	MDCK	cells	were	grown	in	MEM	culture	medium	and	plated	at	a	density	of	5	×	105	 cells	 per	well	 in	 6-well	 plates.	 On	 the	 following	 day,	 cells	were	 inoculated	with	consecutive	10-fold	dilutions	of	different	mixtures	of	ULI1-5	tagged	viruses	by	different	purposes.	The	MDCK	cells	were	covered	by	mixed	2%	agar,	2×	MEM	medium	and	2	μg	 trypsin.	After	 three	or	 four	days	 incubating	 at	 37	 °C,	 visible	individual	plaques	were	firstly	marked	and	then	picked	by	glass	pipette	for	vRNA	extraction	 according	 to	 a	 commercial	 protocol.	 Well-separated	 plaques	 were	collected	from	the	wells	containing	1-20	plaques.	vRNA	was	extracted	followed	by	 RT-PCR.	 15	 plaques	 were	 collected	 from	 3	 wells,	 of	 which	 10	 of	 them	amplified	 to	 produce	 the	 correct	 band	 size	 observed	 by	 agarose	 gel	
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electrophoresis.	These	were	sent	for	sequencing	using	the	BC_identifer	primers	(Table	2.8)	
Table	2.	8	Sequence	of	PCR	primers	
Sequencing	primer	 Primer	sequence	PB2_ideBC	 ACATCGGAATCGCAACTAACG	HA_ideBC	 GAAGGCAAACCTACTGGTCCT	NP_ideBC	 																																			CGAATCTGGCGCCAAGCTAA	
4.2	Asynchronous	infection	in	vitro		DBCV1_APR8	was	used	to	infect	MDCK	cells	for	15	mins	at	MOI	=	3,	after	that,	the	cells	 were	 washed	 by	 PBS	 and	 then	 incubated	 for	 5	 mins	 with	 citric	 acid.	Depending	 on	different	 experimental	 purpose	 (see	 the	 diagram	 in	Chapter	4),	the	 second	 virus	 was	 inoculated	 at	 different	 time	 post	 infection.	 The	 same	inactivation	 wash	 was	 applied	 after	 15	 mins	 absorption,	 then	 140	 μL	 viral	supernatant	 were	 collected	 from	 one	 well	 of	 a	 12-well-plate.	 Three	 replicates	were	 carried	 out	 for	 each	 experiment.	 Then,	 Quantitative	 PCR	 (qPCR)	 was	performed	 for	 each	 sample	 using	 SensiMix™	 SYBR®	 No-ROX	 kit.	 The	oligonucleotide	primer	sequences	used	for	qPCR	are	shown	below	(Table	2.9).		
Table	2.	9	BC	1	and	3	specific	primers	
Primer	 Sequence	BC1-PB2F	 CATGTTGGAGAGAGAACTGGT	BC3-PB2F	 GTTGCATTTGACTCAAGGAACA	BC1-PB2R	 AGCTCTCCTAACAATGTTCCTG	BC3-PB2R	 GCAGCTCTTCTAACAATGTTTCTA	
4.3	Flow	Cytometric	to	analysis	of	cell	receptors	The	 HA’s	 present	 on	 human	 influenza	 A	 viruses	 preferentially	 bind	 to	 cell	receptors	 containing	 α2,	 6-sialic	 acid,	 whereas	 avian	 influenza	 viruses	preferentially	 bind	 to	 α2,	 3-sialic	 acid.	 APR8	 has	 undergone	 adaption	 to	 the	allantoic	membrane	of	embryonated	chicken	eggs	and	now	preferentially	binds	α2-3	 sialic	 acid	 receptors.	 It	 plaques	 on	 MDCK	 cells	 because	 these	 cells	predominantly	 express	 α2,3-sialic	 acid	 receptors.	 Expression	 of	 the	 viral	neuraminidase	 is	expected	 to	 reduce	 the	 level	of	 sialic	acid	on	 the	cell	 surface.	This	 can	 be	 quantified	 by	 specific	 lectin	 staining.	 Briefly,	 MDCK	 cells	 were	infected,	then	at	different	time	post	infection	were	washed	with	PBS	and	scraped	
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together	for	10	mins	at	37	°C.	To	determine	lectin	staining,	cells	were	collected	and	centrifuged	at	220×	g	for	5	mins	and	re-suspended	in	PBS.	Surface	α2,3-sialic	receptor	 expression	 was	 determined	 by	 primary	 staining	 with	 20	 µg/mL	biotinylated	Maackia	amurensis	lectin-II	 (MAA-II)	 (B-1265,	Vector	 Laboratories,	Burlingame,	 CA).	 Secondary	 staining	 was	 performed	 with	 APC-conjugated	streptavidin	(BD,	Mountain	View,	CA)	diluted	in	PBS	for	1	hour	on	ice.	Cells	were	then	fixed	with	2%	formaldehyde	for	30	mins	on	ice	and	washed	with	flow	buffer	(1%	 BSA,	 0.1%	 NaN3	 in	 PBS).	 Cells	 were	 acquired	 using	 an	 Accuri	 C6	 flow	cytometer	 (BD	 Biosciences,	 CA)	 and	 expression	 of	 cell	 markers	 was	 analysed	using	the	Accuri	C6	software.		
5.	Investigation	of	influenza	transmission	dynamics	by	barcoded	
viruses	
5.1	Animal	experiment	1	The	pilot	animal	work	was	carried	out	by	our	collaborators	at	Animal	and	Plant	Health	 Agency	 (APHA)	 (Figure	2.1).	 Briefly,	 three	 “donor”	 pigs	 (DP1.1-DP1.3)	were	 intranasally	 infected	with	a	deliberate	mixture	of	 the	 five-barcoded	virus	populations	at	5×106	TCID50	in	2	ml	(1	ml	of	mixed	 inoculum	was	administered	to	each	nostril).	Three	uninfected	“contact”	pigs	(CP1.1-CP1.3)	were	added	to	the	group	48	hrs	later.	Donor	and	contact	pigs	were	co-housed	together	for	14	days	during	which	nasal	swabs	were	collected	once	daily.	Four	replicate	swabs	were	taken	each	time	(two	per	nostril)	to	allow	the	reproducibility	of	sampling	to	be	assessed.	 One	 swab	 was	 selected	 at	 random	 and	 placed	 in	 virus	 transport	medium	for	determining	viable	virus	shedding	titres.	The	three	remaining	swabs	from	each	 infected	and	contact	pig	were	 frozen	and	 later	processed	 to	harvest	viral	RNA	using	the	QIAamp	viral	RNA	kit	by	the	APHA.		
5.1.1	Bioinformatics	analysis	of	the	NGS	data	in	pilot	1	Viral	RNA	from	the	first	pilot	study	was	extracted	without	carrier	RNA	using	the	QIAamp	viral	RNA	kit.	 Some	of	 extracted	vRNA	sample	was	amplified	with	 the	overhang	 primer	 (Table	2.7)	 for	 32	 cycles	 to	 reach	 the	 Earlham	 Institute	 (EI)	required	sequencing	amount	and	sent	to	sequence	to	test	the	method.	The	data	
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was	 analysed	 by	 Pattern	match	 and	DADA2	which	 is	 an	 open-source	 software	package	for	modelling	and	correcting	Illumina-sequenced	amplicon	errors[140].	The	 software	 could	 identify	 variants	 as	 little	 as	1	nucleotide	different.	 Shadow	variants	could	be	observed	from	Pattern	match	but	not	DADA2.	However,	these	spurious	 variants	 were	 not	 observed	 when	 vRNA	 extracted	 from	 viral	 stocks	whose	start	 copies	were	10-100	 times	more	 than	 the	clinical	 samples	and	was	undergone	 25	 cycles	 for	 enrichment.	 As	 shadow	 variants	 were	 observed	surrounded	by	dominant	variants,	a	custom	script	written	by	Dr.	Lajos	Kalmer	to	remove	 the	 variants,	 which	 had	 1	 nucleotide	 genetic	 distance	 to	 the	 top	 5	variants.	 By	 analysing	 the	 same	 samples,	 DADA2	 found	 a	 similar	 number	 of	variants	that	was	analysed	by	Pattern	match,	especially	for	the	highly	abundant	variants,	shown	in	Table	2.10.	In	this	section,	carrier	RNA	was	used	during	in	the	cDNA	synthesis	to	improve	recovery.	The	cDNA	amplification	was	reduced	to	25	cycles.	DADA2	was	applied	to	analyse	the	data	of	the	viral	inoculum	and	swab	samples.		Three	 swabs	 collected	 from	 different	 nostrils	 but	 the	 same	 pig.	 The	 non-parametric	method,	Spearman	correlation	coefficient,	was	applied	to	analyse	the	paired	variants	among	 the	 three	swabs.	 (In	 theory,	 the	value	of	 the	correlation	coefficient	 varies	 from	 -1	 to	 1.	 A	 positive	 value	 means	 that	 the	 two	 variables	under	consideration	have	a	positive	linear	relationship	and	vice	versa.	The	closer	the	 value	 is	 to	 -1	 or	 +1,	 the	 stronger	 the	 degree	 of	 linear	 dependence.)	Comparing	 correlation	 coefficients	 was	 conducted	 by	 Fisher’s	 r	 to	 z	transformation.	 The	 z	 scores	 can	 be	 compared	 and	 analysed	 for	 statistical	significance	by	determining	the	observed	z	test	statistic.	The	super-infection	data	was	sorted	from	high	to	low	in	abundance	from	5	d.p.c	to	1	d.p.c	in	spread	sheet	and	 then	 plotted	 the	 data	 in	 MATLAB.	 The	 network	 analysis	 of	 transmission	source	portability	was	analysed	with	igraph	in	R.	
Table	2.	10	Analysis	comparison	between	pattern	match	and	DADA2	
Sample	ID	
Variants	
detected	by	
DADA2	
Variants	
detected	by	
Pattern	match	
No.	of	
common	
variants	
Unique	
variants	
detected	by	
DADA2	
Unique	
variants	
detected	by	
PM	CP1.3	4day_1	 37	 41	 36	 1(=23reads)	 5	(<70reads)	CP1.3	4day_2	 86	 93	 84	 2(<10reads)	 9	(<33reads)	CP1.3	4day_3	 60	 65	 59	 1(=66reads)	 6	(<36reads)	
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5.2	Animal	experiment	2	This	animal	study	was	carried	out	by	our	collaborator	at	the	Pirbright	Institute	(Figure	2.1).	Three	pigs	(DP2.1-2.3)	were	intranasally	infected	with	the	mixture	of	five-barcoded	virus	at	5×106	pfu/ml	(not	TCID50	as	in	Exp	1).	Four	nasal	swabs	were	 collected	 (two	 from	 each	 nostril)	 daily	 until	 4	 d.p.i.	 The	 swabs	 were	individually	 labelled	 to	 indicate	 sampling	 order	 and	 left/right	 nostril.	 Viral	samples	from	the	deep	part	of	the	nostril,	upper	trachea,	lower	trachea,	lung	and	BALF	(Bronchoalveolar	Lavage	Fluid)	were	collected	post-mortem	on	4	d.p.i.	The	swab	 samples	were	processed	 to	extract	 viral	RNA	using	TRIzol	 and	 the	vRNA	was	purified	through	the	column	provided	by	the	QIAamp	viral	RNA	kit.		
	 					
Figure	2.1.	Graphical	description	of	two	pilot	studies	In	order	to	increase	the	reliability	of	data	analysis,	the	sample	preparation	was	optimized	in	two	ways.	One	was	increasing	the	amount	of	vRNA	extracted	from	swab	 samples	 and	 the	 other	 one	 was	 introduction	 of	 Unique	 Molecular	Identifiers	(UMIs)[141].		
5.2.1	Optimization	of	vRNA	extraction		Nasal	 swabs	were	 collected	 from	each	pig	and	 then	 transferred	 into	 individual	tubes	 prefilled	 with	 1	 ml	 Trizol,	 all	 swabs	 were	 stored	 at	 -80°C	 until	 further	processing	 and	 RNA	 isolation.	 For	 RNA	 extraction/precipitation,	 1)	 0.2	 mL	 of	chloroform	was	add	per	nasal	swab	(in	1	ml	Trizol)	incubating	for	2-3	mins;	2)	
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the	 aqueous	 phase	 containing	 the	 RNA	 was	 transferred	 to	 a	 new	 tube	 after	centrifuging	the	sample	for	15	mins	at	12,000	×	g	at	4	°C;	3)	5–10	µg	of	RNase-free	 glycogen	 as	 a	 carrier	 was	 added	 into	 the	 aqueous	 phase;	 4)	 3M	 Sodium	acetate	(pH	5.2)	was	added	1/10	and	then	2.5	Volumes	100%	ethanol	was	added	to	 the	aqueous	phase;	5)	vRNA	was	 centrifuged	 to	 form	a	gel-like	at	pellet	not	more	than	12,000	×	g	at	4	°C;	6)	after	removing	the	supernatant,	the	pellet	was	washed	 by	 1	ml	 75%	 ethanol	 twice;	 7)	 the	 RNA	 pellet	 was	 air-dried	 for	 5-10	mins	and	then	dissolved	DEPC-treated	water.	
5.2.2	Design	of	cDNA	primer	identifier	Unique	molecular	 identifiers	 (UMIs)	 are	 random	oligonucleotide	 barcodes	 that	are	 increasingly	used	 in	high-throughput	sequencing	experiments.	The	random	Ns	provide	a	unique	tag	to	each	of	the	cDNA	generated.	It	allows	the	“true”	copy	number	of	each	individual	variant	to	be	estimated	by	eliminating	the	duplicates	resulting	 from	 the	 PCR	 stages.	 The	workflow	 of	 sample	 preparation	with	 UMI	identifiers	 was	 shown	 in	 the	 Figure	 2.2.	 The	 UMI	 primer	 was	 designed	 to	include	 three	 parts:	 a	 fraction	 of	 arbitrary	 sequence	 that	 does	 not	match	with	PB2_SIV/1353,	 10	 random	Ns	 that	 generate	 1048,576	 different	 identifiers	 and	specific	binding	sequence	on	vRNA	of	the	PB2_SIV/1353	segment.	UMIs	primer:	CTCGGCGGTCTGCCAAAGTNNNNNNNNNNCAGGCAGTGTGTACATTG.	 The	 sequence	highlighted	 in	red	 background	 is	 the	 binding	 site	 of	 local	 specific	 primers.	 The	 sequence	highlighted	in	grey	is	the	introduced	arbitrary	sequence	that	does	not	match	any	sequence	 in	 the	 flu	genome.	Reverse	 transcription	of	 viral	RNA	 into	 cDNA	was	carried	 out	 using	 Thermofisher	 RevertAid	 H-	 reverse	 transcriptase	 as	 per	manufacturer’s	 instructions	 with	 a	 RT	 UMI	 primer	 in	 20µL	 reaction	 including	10µL	cDNA.	Before	inactivating	the	transcriptase	stage,	the	residual	UMIs	primer	was	inactivated	by	introducing	a	UMI	blocker	primer	(20	pmol)	for	15mins.	After	that,	 the	 RT	 was	 inactivated	 for	 15	 min	 at	 75°C.	 The	 UMI	 blocker	 primer	 is:	TAGCTAGCTAGCTCAATATAAACACTGCCTG	 (ddc)	 (2',3'-dideoxycytidine	 (ddC)	 at	 3’end).	 The	 cDNA	amplicon	 was	 then	 prepared	 as	 following	 the	 protocol	 for	 16S	 Metagenomic	Sequencing	Library	Preparation.	
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Figure	2.	2	The	workflow	of	sample	preparation	using	UMI	primer		
5.2.3	Bioinformatics	analysis	of	the	NGS	data	in	pilot2	The	sequence	data	was	analysis	by	custom	script	written	by	Dr.	Lajos.	Kalmer.	Briefly,	 the	 sequences	 were	 first	 aligned	 with	 the	 reference	 sequence.	 	 Those	variants	that	exceeded	the	threshold	read	frequency	(≥	5)	were	included	in	the	next	 step.	Variants	with	 identical	barcodes	and	highly	 similar	UMIs	 (<	2/10	nt	difference)	were	classed	as	amplification	artefacts	and	all	but	the	most	abundant	of	these	were	excluded.		Likewise,	for	those	with	highly	similar	barcode	regions	(<	2/19	nt)	and	identical	UMI	all	but	the	most	abundant	were	excluded;	The	final	most	stringent	filter	removed	the	variants	that	differed	by	<	2	nt	in	the	barcode	and	 <	 2	 nt	 in	 the	 UMI.	 This	 results	 in	 a	 conservative	 lower	 estimate	 of	 the	number	of	variants	present	and	the	abundance	of	each.					
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Chapter	3		
Design	and	rescue	of	barcoded	viruses		
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	In	this	chapter,	I	will	describe	how	to	establish	a	system	of	generating	“barcoded	viruses”.		
1.	Principle	of	designing	“barcoded	virus”	
Codons	are	nucleotide	triplets	that	specify	the	incorporation	of	a	specific	amino	acid	during	mRNA	translation.	The	four	naturally	occurring	nucleotides	provide	64	 different	 codons.	 Three	 of	 these	 are	 usually	 used	 as	 stop	 codons.	 The	remaining	ones	are	used	to	specify	particular	amino-acids	through	base-pairing	with	the	anticodon	loop	of	amino-acyl	tRNAs.	Typically	20	different	amino	acids	are	specified	 in	 this	way	and	the	code	 is	said	 to	possess	“redundancy”	as	some	amino	acids	are	specified	by	between	1	and	6	different	codons	(e.g.	tryptophan	and	arginine	respectively).	In	most	cases,	this	redundancy	is	located	at	position	3	of	the	codon	(the	“wobble	position”).	Such	codons	are	said	to	be	“synonymous”).		This	 redundancy	 can	 be	 exploited	 in	 nature	 to	 enable	 the	 use	 of	 overlapping	reading	 frames	 or	 to	 embed	 other	 signals	 within	 the	 RNA	 sequence	 without	being	 entirely	 constrained	 by	 the	 consequences	 on	 primary	 amino	 acid	sequence.	 Analysing	 mRNA	 sequences	 for	 regions	 of	 lower	 than	 expected	redundancy	is	a	powerful	tool	for	 identifying	regions	of	mRNAs	and	viral	RNAs	that	 are	 doing	more	 than	 just	 coding	 for	 a	 single	 protein.	 Gog	 et	 al.	 [142]	 by	comparing	 naturally	 existing	 influenza	 virus	 sequences,	 produced	 a	 consensus	sequence	for	each	segment	and	identified	the	codons	where	the	observed	codon	redundancy	 was	 significantly	 lower	 than	 the	 expected	 frequency,	 suggesting	these	 bases	 were	 constrained	 by	 something	 other	 than	 the	 amino	 acid	 they	encoded.	 	 Alternatively,	 this	 data	 set	 can	 be	 analysed	 to	 identify	 regions	 that	tolerate	 multiple	 synonymous	 changes	 implying	 that	 such	 regions	 are	 simply	encoding	 a	 primary	 amino	 acid	 sequence.	 This	 enables	 silent	 mutations	 to	 be	introduced	 that	 should	have	negligible	 consequences	on	virus	 function	but	 can	be	used	as	markers	to	identify	and	track	these	viruses.	
2.	Results	
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2.1	Criteria	of	choosing	region	on	viral	segment	to	make	barcodes	The	criteria	of	choosing	the	region	to	carry	the	barcode	were	that	there	should	be	 a	 suitable	 density	 of	 naturally	 occurring	 synonymous	 variation	 so	 that	 the	barcodes	 could	 be	 easily	 introduced	 using	 synthetic	 oligonucleotides	 and	 that	the	region	could	be	sequenced	in	both	orientations	by	NGS.		Firstly,	 choosing	 such	 an	 appropriate	 region	 to	 carry	 the	 barcode	 that	 ideally	would	 have	minimal	 bias	 against	 any	 particular	 codon	 at	 each	 position,	 it	was	therefore	 deemed	 acceptable	 if	 there	 were	 a	 minimum	 of	 two	 commonly	occurring	synonymous	options	that	showed	similar	frequencies	in	the	database	analysed	 by	Gog	 et	al	 [142].To	 illustrate	 this	 idea,	Table	3.1	 shows	 the	 codon	frequency	for	amino	acids	262	and	264	of	segment	1	in	the	natural	existing	virus	population.	Alanine	is	potentially	coded	for	by	codon	GCN	but	only	GCT	and	GCA	are	 abundant	 at	 this	 position	 in	 the	 natural	 existing	 influenza	 viruses.	Synonymous	 changes	 could	 therefore	be	 introduced	as	GCW	(W	 is	 IUPAC	code	for	T	or	A)	and	likewise	with	AGR	for	arginine	264.		
Table	3.	1	Example	of	selected	codons	for	designing	barcodes	associated	with	invariant	alanine	(A)	
and	arginine	(R)	amino	acid	(AA)	
Codon	 AA	 Obs1	 Codon	 AA	 Obs1	Position	 262	 	 Position	264	 R	 0	gct	 A	 190	 cgt	 R	 0	gcc	 A	 2	 cgc	 R	 0	gca	 A	 175	 cga	 R	 0	gcg	 A	 2	 cgg	 R	 5		 	 	 aga	 R	 131		 	 	 agg	 R	 233	
Note:	1	Observed	frequency	of	codon	at	specified	position		Secondly,	 the	 regions	 for	 editing	with	 barcodes	 should	 be	 short	 enough	 to	 be	sequenced	from	both	pair	ends	by	NGS	(i.e.	<	150	nt	 long)	 in	order	to	 increase	the	 throughput	 and	 accuracy	 but	 reduce	 the	 costs	 and	 efforts	 in	 the	 following	experiments.		Based	on	these	two	criteria,	a	fraction	sequence	of	segment	1	(seg_1)	was	chosen	to	generation	a	region	of	“unique	library	identifier	(ULI)”	and	a	“diversity	region”	(DR),	 as	 the	 fortuitous	 location	of	unique	 restriction	 sites	 spanning	 this	 region	with	sufficient	tolerance	for	the	synonymous	changes	(Figure	3.1).		
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	Figure	3.	1	Section	of	conserved	sequence	of	seg_1	generated	by	Gog	et	al	[142].		The	region	chosen	for	introducing	ULIs	is	highlighted	in	grey.	An	adjacent	area	to	the	ULIs	region	that	was	selected	for	the	DR	is	highlighted	in	blue.		*	is	the	wobble	position	of	each	amino	acid	code.	Within	the	DR,	13	mutations	match	with	 the	 first	 criteria.	 	The	restriction	enzyme	sites	 (BsrGI,	HindIII	and	PstI	ordered	from	left	to	right)	used	for	inserting	synthetic	ULIs	and	DR	oligos	are	underlined	in	red	line.		The	strategy	reported	here	for	the	“barcode	region”	comprised	two	elements:	the	ULI	composed	of	a	binary	error-correcting	Hamming	code	(5	codes	are	used	 in	this	 study)	 and	 the	 DR	 where	 a	 random	 combination	 of	 synonymous	 codon	exchanges	at	multiple	different	nucleotide	positions	efficiently	generate	27,648	distinct	variants,	shown	in	Figure	3.2.	The	process	of	generating	and	optimizing	“barcoded	virus	system”	firstly	used	a	reverse	genetics	system	to	rescue	viruses	based	 on	 A/Puerto	 Rico/8/34	 [H1N1]	 (APR8)	 virus,	 which	 is	 a	 standard	influenza	and	an	easy-handled	strain	in	the	lab.		
	
Figure	3.	2	Consensus	sequence	of	tag	region	within	Seg_1	(PB2).		ULI	is	highlighted	in	grey.	An	adjacent	area	containing	13	silent	mutations	(DR)	is	highlighted	in	blue.	There	are	 10	 wobble	 positions	 with	 2	 substitutions	 each	 and	 3	 wobble	 positions	 contain	 3	 substitutes	 each.	Theoretically,	27,648	distinct	variants	can	be	generated	from	DR.	Five	out	of	32	prepared	ULIS	were	firstly	selected	to	generate	the	five	barcoded	viruses	containing	individual	ULI	and	DR.			Two	 groups	 of	 barcoded	 viruses	were	 aimed	 to	 rescued	 for	 different	 research	purposes	in	my	PhD	project.	Firstly,	five	ULI-tagged	viruses	(BCV1-5_APR8)	were	rescued	containing	ULIs	individually	in	seg_1,	4	and	5	to	carry	out	fundamental	virology	studies,	shown	in	Figure	3.3a.	Each	ULI	was	provided	with	a	Hamming	code,	 also	 visible	 from	 the	 Tables	 2.1-2.3,	 each	 sequence	 of	 five	 barcodes	
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corresponds	 with	 the	 given	 Hamming	 Code	 and	 most	 notably	 the	 Hamming	codes	are	the	same	across	the	three	segments.		These	random	combinations	of	13	wobble	positions	can	theoretically	construct	27,648	different	 variants	 for	 some	 studies	 like	 bottleneck	 analysis	 and	 longer-term	 tracking	 of	 transmission	 chains	 where	 a	 larger	 number	 of	 variants	 are	preferable.	Five	barcoded	viruses	(DBCV1-5_APR8)	including	(ULI	&	DR)-tagged	seg_1	and	ULI-tagged	seg_4	and	seg_5	were	also	rescued,	shown	in	Figure	3.3b.		
		
	
Figure	3.	3	Design	of	two	groups	of	barcoded	viruses.		(a)	Schematic	depicting	wild	type	segments	of	APR8	strain,	which	encoded	known	identifiers	in	seg_1,	4	and	5.	(b)	The	ULI-tagged	seg_1	was	further	modified	by	inserting	the	DR	next	to	ULI	and	was	rescued	with	ULI-tagged	seg_4	and	5	as	well	as	 the	rest	 five	wild	 type	segments	 to	generate	DBCV_APR8.	Barcoded	virus	1	(BCV1_APR8	or	DBCV1_APR8)	contained	ULI-1	in	seg_1,	4	and	5,	i.e	the	same	embedded	Hamming	code	in	each	case,	but	in	the	segment	specific	context.	Likewise	for	ULI-2	to	5	in	Barcoded	virus	1	-5	etc.	
(a)		
(b)		
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2.2	Rescue	of	virus	stocks	BCV1-5_APR8	Eight	stock	RF483T	plasmids	containing	APR8	influenza	viral	segments	1-8	were	provided	by	Dr.	Jon	Lyall	in	our	laboratory.	The	plasmids	containing	segments		1,	4	and	5	 	were	digested	with	HindIII	 (798)/PstI	 (836),	PstI	 (73)	/XhoI	(141)	or		BamHI	 (522)/PstI	 (585)	 respectively	 (the	 coordinates	 of	 the	 restriction	 sites	shown	 in	parentheses,	with	numbering	starting	 from	the	 first	adenosine	of	 the	cRNA	segment)	and	ligated	with	cognate	synthesized	ULIs,	and	then	these	three	modified	plasmids	 transfected	with	 the	other	 five	segments	 in	 rescue	plasmids	into	293T	cells	to	generate	five	barcoded	virus	stocks	(BCV1-5_APR8).	Barcoded	virus	1	(BCV1_APR8)	contained	ULI-1	in	seg_1,	4	and	5.	(i.e.	the	same	embedded	Hamming	 code	 in	 each	 case,	 but	 in	 the	 segment	 specific	 context.)	 Likewise	 for	ULI-2	to	5	in	BCV2_APR8	etc.	The	details	for	virus	rescue	are	summarized	in	the	Chapter	 2	 as	 this	 is	 considered	 a	 routine	 process	 and	 will	 not	 be	 discussed	further.		Post-rescue,	the	viral	RNA	was	extracted	and	synthetized	into	cDNA.	The	identity	and	purity	of	each	barcode	within	segments	1,	4	and	5	were	confirmed	by	Sanger	sequencing	 (Figure	 3.4	 (seg_1)	 and	 Supplementary	 Figure	 S3.1a-b).	 The	results	indicated	that	all	BCV1-5_APR8	were	successfully	rescued.									 		
 						 		(a).ULI-1AGCTTGATCATCGCTGCCAGGAACATTGTTAGGAGA	(Hamming	code	000000000)	(b).ULI-2	AGCTTGATCATCGCTGCCAGGAACATAGTAAGAAGA	(Hamming	code	000000111)	(c).ULI-3	AGCTTGATCATCGCTGCTAGAAACATTGTTAGAAGA	(Hamming	code	000011001)	(d).ULI-4	AGCTTGATCATCGCTGCTAGAAACATAGTAAGGAGA	(Hamming	code	000011110)	(e).ULI-5	AGCTTGATCATCGCAGCCAGAAACATTGTAAGGAGA	(Hamming	code	000101010)	
		 		 		 		 		 					 	 	 	
		 	 	 		 	 	 	 	 	 	
	 	 	 	 	 	
(a)	 (b)	
(c)	 (d)	
(e)	
Figure	3.	4	Section	of	a	chromatogram	from	viral	segment	1	barcode	area,	showing	ULI	region	
for	ULI1-5	
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2.3	Rescue	of	diversity	region-tagged	virus	stocks	DBCV1-5_APR8	
2.3.1	Two	strategies	for	generating	oligos	for	the	DR	library	Two	strategies	were	adopted	to	make	the	DR	oligos.	The	first	one	was	that	two	overlapping	 oligos	 63	 and	 53	 bp	 long	with	 a	 23	 bp	 overlap	were	 designed	 to	ensure	that	two	templates	were	bound	to	each	other	and	these	annealed	oligos	were	 then	 extended	 and	 amplified	 to	produce	 a	121	bp	product	 containing	14	synonymous	variant	codons,	shown	in	Table	3.2.	This	product	was	digested	with	BsRGI	and	HindIII	and	cloned	into	pRF483T_Seg1_ULI1.	Initially	the	entire	pool	of	 transformants	 was	 harvested	 and	 sequenced.	 Then	 individual	 clones	 were	picked	at	random	and	sequenced	to	trouble-shoot	the	process.	This	strategy	was	assumed	to	be	straightforward	but	resulted	in	an	unexpectedly	high	frequency	of	synthesis	 errors	 (Tables	 S3.1.1-3.1.4	 in	 supplementary	 data).	 This	 became	immediately	 apparent	 from	 the	 sequencing	 of	 the	 pooled	 library	 of	transformants	 that	 produced	 high	 quality	 sequence	 in	 the	 constant	 regions	adjoining	the	diversity	region	but	also	unreadable	sequence	across	the	“diversity	region”	itself	(Figure	3.5).	Mixed	peaks	in	the	wobble	positions	were	expected,	but	 the	 unreadable	 mess	 resulted	 from	 multiple	 random	 errors	 particularly	indels	that	disrupted	the	register	of	the	sequence.	Highly	accurate	synthesis	of	an	oligonucleotide	 >60	 bp	 (with	 a	 substantial	 number	 of	 mixed	 base	 wobble	positions)	is	a	clearly	technical	challenge.	The	supplier	(Sigma	Aldrich)	offered	to	re-synthesize	 the	 oligos	 but	 failed	 because	 3	 out	 of	 six	 individual	 clones	 that	were	sequenced	had	a	48	nt	deletion.	This	could	be	explained	by	the	fact	one	of	the	 wobble	 positions	 inadvertently	 generated	 a	 BsrGI	 site,	 resulting	 in	 the	deletion.	 It	 became	 clear	 that	 the	 error	 frequency	 from	 other	 clones	 was	 still	unacceptably	high,	though	two	out	of	the	remaining	3	clones	were	correct.	These	oligos	 were	 therefore	 redesigned	 to	 eliminate	 the	 unwanted	 BsrGI	 site	 (and	hence	 now	 with	 only	 13	 synonymous	 variant	 codons).	 Another	 two	 attempts	with	were	also	unsuccessful.				
		 47	
		 	A	 second	 strategy	 was	 attempted	 which	 used	 the	 ligation	 of	 three	 splinted	phosphorylated	 template	 oligos	 of	 length	 less	 than	 50	 bp	 (Thermofisher	Scientific),	as	shown	in	Table	3.3.	 	The	oligos	were	annealed	with	their	splints,	ligated	 and	 then	 amplified	 to	 produce	 the	 full	 121bp	 diversity	 region.	 This	resulted	in	two	out	of	five	individually	sequenced	clones	having	single	nucleotide	deletions	in	the	region	derived	from	the	48	bp	long	central	oligo	(Table	S3.1.5	
in	supplementary	data).		A	satisfactory	product	(based	on	strategy	1),	as	shown	in	Figure	3.6	and	Table	
S3.1.6	in	supplementary	data,	was	eventually	provided	by	Sigma	Aldrich	after	their	Technical	Services	team	further	optimized	QC,	HPLC	and	PAGE	purification.		
Figure	3.	5	The	mixed	messy	chromatogram	of	diversity	region. 
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Table	3.	2	Double-Randomer	strategy	
Annealed oligos 	
GT GTG TAC ATT GAR GTD TTR CAT TTG ACY CAA GGR ACV TGY TGG GAA CAR ATG TAy ACT CCA GG	
                                                       ACC CTT GTY TAC ATr TGA GGT CCD CCY CTT CAC TCY TTA CTR CTA CAA CTR GTT TCG AAC TAA TAA CGA CG	
Note:	The	nucleotides	highlighted	in	pink	was	a	synonymous	change	introduced	that	could	form	BsrGI	site	if	the	substation	is	C.	Later,	this	synonymous	change	was	removed	and	edited	as	“T”.	BsrGI	and	HindIII	cloning	sites	are	indicated	in	bold.			
 
Table	3.	3	Clamped	oligo	strategy	
Annealed oligos                             	
GA ACA AGC AGT GTG TAC ATT GAR GTD TTR CAT TpTG ACY CAA GGR ACV TGY TGG GAA CAR ATG TAT ACT CCA GGH GGR GAA GpTG AGR AAT GAY GAT GTT GAY CAA AGC TTG ATT ATT GCT GC 	
                   ATG TAA CTY CAH AAY GTA A AC TGR GTT CCY TGB ACR ACC             ATA TGA GGT CCD CCY CTT C AC TCY TTA CTR CTA CAA CTR GTT 5’                         		
	
	
	
Figure	3.	6	Sequencing	across	the	barcode	region	for	a	mixture	of	~13,000	cloned	plasmids	generated	from	DR	regions	of	APR8	strain.		The	wobble	position	mixed	base	 incorporations	are	highlighted	in	green.	The	insertion	(-)	at	position	37	is	an	artefact	of	 the	partially	overlapping	G	and	A	peaks	for	this	wobble	position	(R).	The	T	highlighted	in	red	at	position	73	is	where	the	oligo	was	altered	to	eliminate	the	creation	of	the	unwanted	BsrGI	site.		
		 		 		 		 		 		 		 		 		 		 		 		 		T	
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2.3.2	Rescue	barcoded	viruses	contain	ULI	and	DR	based	on	APR8	strain	Once	 a	 high-quality	 DR	 region	 was	 confirmed,	 the	 ligation	 was	 repeated	 for	pRF483T-Seg1-ULI1,	 pRF483T-Seg1-ULI2,	 pRF483T-Seg1-ULI3,	 etc.	Transformations	 were	 scaled	 up	 to	 generate	 five	 pooled	 plasmid	 libraries	containing	approximately	13,000	clones	corresponding	to	a	random	assortment	of	 diversity	 regions.	 The	 pRF483T_Seg1_ULI1_DR	 library	 was	 then	 combined	with	its	cognate	ULI-tagged	segment	4	&	5	plasmids	and	finally	transfected	along	with	 five	 rescue	plasmids	 for	 the	other	 segments	 to	 rescue	 the	barcoded	virus	population	 designated	 “DBCV1_APR8”.	 Likewise	 each	 of	 other	 Seg1_ULI_DR	libraries	was	 used	 to	 generate	 4	more	 viruses	 designated	DBCV2-5_APR8.	 The	specific	ULI	could	help	to	trace	the	source	of	the	virus	in	the	transmission	in	vitro	or	in	vivo	and	the	number	of	different	DR	allowed	the	quantification	of	how	many	of	 these	 viruses	 were	 to	 be	 transmitted.	 Viral	 RNA	 was	 extracted	 and	 then	synthetized	into	cDNA	for	Sanger	sequencing.	The	virus	sequence	matched	with	the	 expected	 sequence,	 indicating	 that	 all	 DBCV1-5_APR8	 were	 successfully	rescued.		
2.3.3	Comparison	of	the	multi-cycle	growth	properties	of	the	barcoded	
viruses.	To	determine	if	the	introduction	of	variable	ULIs	and	DR	into	three	segments	had	growth	impact	on	virus	fitness	in	culture,	they	were	compared	with	the	wild	type	APR8	which	were	rescued	and	propagated	 in	parallel.	As	shown	 in	Figure	3.7,	the	 DBCV1-5_APR8	 had	 very	 similar	 end	 yields	 and	 growth	 kinetics	 on	MDCK	cells.		
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Figure	 3.	 7	 Comparison	 of	 the	 growth	 kinetics	 of	 rescued	 DBCV1-5_APR8	 and	 wild	 type_APR8	 in	
MDCK	cells.		Cells	were	infected	at	a	MOI=	0.01	in	the	presence	of	trypsin,	and	viral	titer	was	determined	at	12	h,	24	h	and	48	h	post	infection	and	processed	by	plaque	assay.	Y-axis	log10	pfu/ml.	
2.4	Barcoded	viruses	rescue	based	on	the	SIV/1353	strain	
2.4.1	Modification	on	Seg_1	of		SIV/1353	to	prepare	for	barcode	
introduction	A	primary	objective	of	this	study	was	to	use	barcoded	viruses	to	study	influenza	replication	dynamics	 in	vivo,	particularly	 in	pigs.	After	 the	process	was	worked	out	 and	optimized	using	APR8,	 it	was	 therefore	necessary	 to	 reproduce	 it	 in	 a	field-strain	 of	 swine	 influenza.	An	 established	 collaboration	 funded	by	 a	 sLoLa	project	 with	 APHA	 and	 Pirbright	 led	 to	 the	 decision	 to	 use	A/Swine/England/1353	 H1N1	 (SIV/1353	 strain).	 The	 ULI	 region	 and	 DR	 of	seg_1	are	100%	conserved	at	the	amino	acid	level	between	APR8	and	SIV/1353,	so	it	 is	possible	to	adopt	exactly	the	same	strategy	and	use	the	same	optimized	oligos	 produced	 for	 APR8.	 [Note:	 In	 addition	 to	 the	 13	 synonymous	 codons	described	above,	there	were	3	additional	synonymous	differences	between	APR8	and	SIV/1353	within	DR,	highlighted	in	blue	in	Figure	S3.2	a-e.		Eight	 gene	 segment	 coding	 sequences	 for	 SIV/1353	were	obtained	 from	APHA	and	 used	 to	 design	 a	 reverse	 genetics	 system	 for	 this	 strain.	 Sequences	 from	APHA	 were	 initially	 “repaired”	 at	 their	 termini	 using	 the	 sequence	 from	A/England/195	as	the	reference	and	then	BLASTed	against	the	NCBI	database	of	
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swine	influenza	sequences.	Missing	sequences	from	the	termini	that	were	added	from	 A/England/195	 were	 adjusted	 to	 match	 the	 nearest	 swine	 influenza	relative	(checking	for	consistency	in	other	related	isolates).	The	added	terminal	sequences	were	appended	with	the	Type	IIS	restriction	enzyme	sites	introduced	to	 each	 segment	 to	 enable	 cloning	 into	 two	 BsmBI	 sites	 of	 the	 rescue	 vector	pRF483T7e.	The	introduced	sites	are	shown	in	Table	3.4.	The	example	of	adding	two	BsmBI	sites	is	demonstrated	in	the	supplementary	data.	
Table	3.	4	Introduction	of	enzyme	site	in	to	SIV/1353	strain	
Segments	 Cloning	enzyme	site	 Sequences	to	be	added	on	
Start	(5’-3’)	 End	(5’-3’)	2,4,	6,7and	8	 BsmBI	 CGTCTCA’GGGG	 ’AATATGAGACG	1	 BsaI	 GGTCTCA’GGGG	 ’AATATGAGACC	3	and	5	 BtgZI	 GCGATGATCACTACTA’GGGG	 ’AATAATCACTACTACATCGC	The	 only	 modifications	 to	 the	 segment	 sequences	 required	 were	 to	 engineer	seg_1	 to	 generate	 the	 three	 required	 sites	 for	 oligo	 cloning	which	were	 absent	(HindIII,	 PstI	 and	BsrGI).	 Five	mutations	were	 introduced,	 as	 shown	 in	Figure	
3.8a.	Then	eight	plasmids	containing	viral	genes	plus	the	added	sequence	were	ordered	 from	 Life	 Technologies	 Co.	 Each	 plasmid	 was	 digested	 with	 the	appropriate	Type	IIS	restriction	enzyme	and	then	ligated	with	RF483T7e	vector.	The	same	five	ULI	used	in	APR8	were	introduced	into	SIV/1353	Seg_1.	Then	the	DR	region	that	contains	13	silent	mutations	was	inserted	as	before	and	used	to	generate	 5	 plasmid	 libraries	 for	 segment	 1	 with	 ~8000	 clones	 in	 each.	 These	were	 checked	 by	 Sanger	 sequencing	 across	 the	 region	 of	 the	 mixed	 library	plasmid	DNA	and	the	quality	demonstrated	that	the	problem	of	oligo	fidelity	had	not	recurred.	
	
a	
b	
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Figure	3.	8	Restrictions	enzyme	sites	edited	for	generating	barcodes	a)	Segment	1	was	engineered	(all	changes	are	silent)	to	have	the	same	3	restriction	sites	necessary	for	ULI	and	DR	oligo	 cloning.	The	nucleotides	highlighted	 in	 green	 indicate	 the	wobble	positions	 in	DR	and	blue	indicate	wobble	positions	 in	ULI	 region	of	APR8	strain.	The	nucleotides	highlighted	 in	 red	 indicate	 silent	mutations	 introduced	 to	 construct	 or	 remove	 restriction	 sites	 into	 the	 SIV/1353	 strain.	 (b)	 Schematic	depicts	wild	type	seg_1	of	SIV/1353	strain	where	was	encoded	known	identifiers	ULI	and	the	DR.	Note,	ULIs	were	not	introduced	into	Seg_4	and	Seg_5,	so	these	stocks	are	not	suitable	for	studying	reassortment.	
2.4.2	Rescue	the	five	SIV/1353	stocks	containing	ULI	and	DR	Each	 of	 the	 seg_1	 barcoded	 libraries	 was	 transfected	 into	 293T	 cells	 with	 the	plasmids	delivering	 the	other	7	viral	 segments.	The	 identity	and	purity	of	each	ULI	and	DR	within	seg_1	viral	RNA	was	confirmed	by	Sanger	sequencing	of	the	RT-PCR	 amplified	 barcode	 region	 (Supplementary	 Figure	 S3.2	 a-e).	 The	sequencing	 results	 indicate	 that	 all	 DBCV1-5_1353	 were	 successfully	 rescued	and	 varied	 proportionately	 at	 the	 expected	 synonymous	 codons.	 	 The	 other	 3	synonymous	 codons	mentioned	 above	 which	 differed	 between	 APR8	 and	 SIV-1353	 did	 not	 revert	 back	 from	 the	 APR8	 sequence	 specified	 by	 the	 diversity	region	oligo	to	that	of	the	wild	type_1353.	
2.4.3	Titration	of	rescued	viruses	The	 titers	 of	 the	 five	 rescued	 viruses	 (DBCV1-5_1353)	 were	 3.5×104	 pfu/mL,	2.2×104	 pfu/mL,	 1×105	 pfu/mL,	 3.5×105	 pfu/mL	 and	 1.7×105	 pfu/mL,	respectively	(primary	293T	rescue	titres	“P0”	stocks).		
2.4.4	DBCV1-5_1353	fitness	comparison	in	vitro	and	in	vivo	Viral	 yields	 in	 the	 cell	 culture	 supernatant	 were	 titrated	 by	 plaque	 formation	assay	on	MDCK	cells.	Each	generated	isogenic	virus	was	infected	on	MDCK	cells	at	low	multiplicity	(moi	=	0.01)	to	examine	multi-cycle	replication.	As	shown	in	
Figure	 3.9,	 the	 synonymous	 mutation	 tags	 (ULI	 and	 DR)	 introduced	 did	 not	affect	 the	 viral	 replication	 in	vitro.	 In	 a	 multi-cycle	 replication	 assay	 in	 MDCK	cells,	 there	was	no	obvious	difference	in	viral	 titer	at	each	time	point	 following	the	 infection	 with	 wild	 type	 SIV/1353,	 although	 a	 slightly	 lower	 titer	 of	DBCV5_1353	was	observed	at	24	h.p.i.	(hour	after	post	infection).			
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Figure	3.9.	Comparison	of	the	growth	kinetics	of	five	rescued	viruses	and	wild	type	SIV/1353	in	MDCK	cells.	Cells	were	infected	at	a	MOI=	0.01	in	the	presence	of	trypsin,	and	viral	titer	was	determined	at	12	h,	24	h	and	48	h	post	infection	and	processed	by	plaque	assay.		Meanwhile,	 the	viral	geonome	copies	were	detemined	by	qRT-PCR	when	the	 in	supernatant	 was	 harvested	 at	 48h	 to	 study	 the	 correlation	 between	 genome	copies	 vs	 viral	 titer.	 The	 ratio	 of	 viral	 copies/titer	 was	 observed	 to	 be	 454:1	(±102)	at	48h.p.i,	shown	in	Table	3.5.	
Table	3.	5	The	ratio	of	viral	copies/pfu	titer	at	different	post	infection	hours			 12h.p.i	 24h.p.i	 48h.p.i	DBCV1_1353	 308.69	 322.48	 376.20	DBCV2_1353	 322.35	 380.15	 324.00	DBCV3_1353	 180.14	 406.17	 560.07	DBCV4_1353	 598.34	 303.07	 538.75	DBCV5_1353	 294.98	 176.69	 468.57	STDEV	 154.60	 89.23	 101.98	Average	 340.90	 317.71	 453.52	More	 sensitive	 assessment	 of	 virus	 fitness	 by	 analysing	 competition	 in	 mixed	cultures	was	done	by	comparing	deep-sequencing	read	frequencies.	Five	rescued	barcoded	 virus	 stocks	were	mixed	 equivalently	 in	 plaque	 titer	 as	 inoculum	 to	infect	 three	 pigs	 (DP2.1-DP2.3	 section	 1.2	 of	 Chapter	 6).	 Four	 swabs	 were	collected	from	each	pig	on	1-4	d.p.i.	The	proportion	of	each	DBCV_1353	present	in	the	inoculum	and	four	swabs	were	analysed	by	Next	generation	Illumina	deep	sequencing	(NGS).	As	shown	in	Figure	3.10,	the	proportion	of	each	DBCV	in	the	inoculum	 was	 close	 to	 the	 expected	 20%.	 The	 highest	 proportion	 (23%)	 was	present	 in	DBCV3	and	DBCV4	in	contrast	to	the	 lowest	one	(DBCV2,	14%).	The	proportion	of	each	barcoded	viruses	showed	the	same	trend	with	copies/titer	of	
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each	barcoded	virus	(Table	3.5).	As	the	inoculum	was	mixed	by	the	same	plaque	titer,	 different	 viral	 copies/titer	 of	 the	 5	 DBCVs	 could	 have	 contributed	 to	 the	inequality	 in	 the	 inoculum.	 Unexpectedly,	 an	 increase	 of	 DBCV5	 (from	21%	 to	29%	±	4%)	and	a	decrease	of	DBCV3	(from	23%	to	15%	±1%)	were	observed	in	proportion	from	inoculum	to	all	donor	pigs.	However,	the	portion	of	each	DBCV	was	found	to	be	stable	from	1	to	4	d.p.i.	for	all	three	pigs,	indicating	that	different	ULI	 did	 not	 affect	 virus	 growth	 across	 4	 d.p.i.	 once	 the	 mixed	 inoculum	established	in	the	pigs.	
	
Figure	3.	10	Fitness	comparison	in	a	mixture	of	DBCV1-5	in	pigs.		Each	plot	 describes	how	 the	 change	of	 the	proportion	of	 each	DBDV	presented	within	 the	 inoculum	and	three	pooled	swabs	at	different	sequential	post	infection	days	in	the	individual	donor	pig.			
3.	Discussion		
Tagged	bacteria	and	virus	 can	be	 traced	and	 therefore	provide	a	useful	 tool	 to	study	transmission	dynamics	[143,	144].	Wild-type	isogenically	tagged	bacteria	have	been	used	to	investigate	the	transmission	dynamics	in	salmonella	[145]	and	campylobacter	 [146].	 The	 method	 for	 generating	 phenotypically	 identical	bacterial	 strains	 involves	 using	 unique	40-bp	DNA	 tags	 inserted	 into	 the	 same	noncoding	region	of	the	bacterial	chromosome.	However,	inserting	such	tags	into	the	 noncoding	 regions	 located	 at	 the	 3’	 and	 5’	 ends	 of	 IAV	 cannot	 be	 done	neutrally,	 as	 these	 regions	 contain	 essential	 transcriptional	 control	 and	packaging	 signals.	As	 for	 generating	 tagged	 influenza	 viruses,	 Frise	et	al.	 [116]	have	reported	a	method	to	introduce	one	or	two	silent	mutations	into	seg_1	for	generating	two	isogenic	influenza	viruses.	Other	method	described	by	Varble	et	
al.	 [108]	 used	 genetic	 barcode	 tags	 inserted	 into	 a	 pseudo-intronic	 noncoding	site	introduced	between	NS1	and	NS2	to	generate	100	distinct	influenza	viruses.	
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Here,	 a	 method	 was	 reported	 for	 generating	 thousands	 of	 barcoded	 influenza	viruses	in	a	single	round	by	inserting	silent	mutations	within	the	coding	regions	of	 influenza	 virus.	 The	 key	 to	 generating	 numerous	 variants	 is	 to	 identify	 and	synthesize	a	 short	 region	 that	 contains	a	high	density	of	natural	existing	 silent	mutations	 and	 can	 be	 also	 digested	 by	 existing	 restriction	 enzyme	 sites.	Therefore,	 there	 is	no	need	 to	be	 limited	 to	using	pre-existing	 restriction	sites,	like	we	did	for	APR8	though	gene	synthesis	methods	are	now	routine.	The	most	critical	 step	 is	 the	 synthesis	 of	 a	 high	 quality,	 long	 (e.g.	 >	 60	 nt)	 oligo	 with	multiple	mixed	base	 incorporations.	Two	strategies	were	used	 in	 five	attempts	involving	two	commercial	companies	to	obtain	the	ideal	oligos	containing	2	or	3	substitutions	 at	 each	 wobble	 position.	 The	 essential	 attribute	 is	 low	 INDEL	frequency.	 This	was	 apparently	 technically	 challenging	 as	 reflected	 by	 the	 fact	that	 even	 relatively	 short	 48nt	 oligos	 used	 in	 the	 second	 strategy	 did	 not	improve	the	synthetic	accuracy	sufficiently.	For	most	cloning	and	PCR	purposes	the	 standard	 synthesis	 quality	 is	 adequate,	 but	 only	 when	 extreme	 care	 was	taken	was	the	synthesis	quality	satisfactory	for	the	specific	purpose	of	diversity	region	library	generation.		Virus	rescue	is	a	powerful	tool	for	the	investigation	of	influenza	virus	[147-149].	Our	lab	has	reported	that	293T	cell	 fusion	mediated	by	combining	Maedi-Visna	virus	envelope	protein	can	improve	the	primary	rescue	efficiency	to	104PFU/ml	per	well	of	a	24-well	plate	[138],	which	allows	a	large	amount	of	viral	particles	to	be	rescued	at	a	single	round.	In	this	study,	each	uniquely	tagged	plasmid	library	used	 for	 transfection	 contained	 approximately	 8000	 plasmid	 clones	 of	 strain	SIV/1353	and	104-105	PFU/ml	of	primary	progeny	from	20	pooled	wells	of	a	24-well	 plate	 format.	 This	 suggests	 that	 there	 are	 up	 to	 8000	 out	 of	 a	 theoretical	27,000	possible	different	barcoded	variants	in	every	DBCV1-5_1353	virus	library	(detailed	 characterization	 of	 this	 is	 provided	 in	 Chapter	 5).	 	 The	 system	 can	efficiently	 generate	 2-3	 orders	 of	magnitude	 greater	 diversity	 than	 the	 library	approach	used	by	Varble	and	more	importantly	this	can	be	achieved	in	a	single	transfection	step	(compared	to	100	individual	rescues).		The	following	chapters	will	 describe	 the	 characterization	 and	 use	 of	 these	 libraries	 to	 study	transmission	dynamics	in	pigs.	
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As	 existing	 natural	 synonymous	 change	 is	 employed	 for	 generating	 influenza	virus,	 the	 rescued	 barcoded	 viruses	 DBCVs1-5_APR8	 and	 DBCVs1-5_1353	 are	expected	 to	 have	 approximately	 equivalent	 growth	 ability.	 If	 any	 unfit	 ULI	regions	 were	 found,	 it	 could	 be	 then	 replaced	 by	 a	 fit	 one	 since	 32	 different	barcodes	have	been	designed	for	the	purpose	of	the	study.	Likewise	significantly	unfit	 variants	 in	 the	 DR	 could	 be	 probably	 eliminated	 during	 the	 rescue	 stage	and	would	not	detrimentally	impact	on	the	use	of	the	library.	 	The	introduction	of	five	ULIs	was	tested	for	fitness.	From	Figure	3.7	and	3.9,	the	ULI	tags	did	not	affect	the	multi-cycle	growth	properties,	compared	to	the	wild	type	viruses.	As	to	whether	the	ULIs	compete	against	each	other,	five-mixed	ULI-tagged	DBCV_1353	were	infected	into	donor	pigs.	No	particular	ULIs	altered	in	frequency/presence	across	4	days	in	donor	pigs,	as	shown	in	Figure	3.10,	suggesting	that	ULIs	were	a	neutral	introduction.	
4.	Conclusion	
Here	a	reverse	genetics	system	that	can	generate	numerous	barcoded	influenza	viruses	 is	 reported.	 The	 tag	 introduced	 into	 APR8	 and	 SIV/1353	 strains	 have	shown	 similar	 growth	 kinetics	 to	 their	 wild	 types.	 This	 barcoding	 system	 is	thought	to	be	generally	applicable	to	any	virus	where	sufficient	sequencing	data	and	an	efficient	rescue	system	is	available.		
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Studies	 of	 single-hit	 and	 asynchronous	 infection	 in	 vitro	 using	
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Five	ULI-tagged	viruses	based	on	the	APR8	strain	(BCV1-5_APR8)	were	rescued	and	the	introduced	ULI	tag	was	confirmed	to	be	a	neutral	modification	that	did	not	 change	 the	 viral	 growth	property	 on	MDCK	when	 compared	with	 the	wild	type	viruses	in	Chapter	3.	In	this	chapter,	BCVs1-5_APR8	(termed	BCVs1-5	below)	will	be	employed	to	study	two	fundamental	questions	regarding:	
1. Single-	or	multiple-hit	kinetics	within	one	infectious	event;	and	
2. temporal	effects	on	mixed	infection	dynamics	in	cell	culture.	
1.	Background	
Influenza	 virus	 usually	 produces	 considerably	 more	 physical	 particles	 than	“infectious	 units”	 (exemplified	 in	 the	 particle	 to	 plaque-forming	 unit	 ratio)	 in	plaque	 assay	 experiments	 [54,	 150-153].	 For	 example,	 1000	 individual	 virus	particles	may	 typically	 only	 produce	 10-100	 plaques.	 Three	 explanations	 have	been	proposed.	The	 first,	 often	 expressed	but	poorly	 supported,	 explanation	 is	that	most	RNA	virus	particles	are	defective	and	 thus	 fail	 to	cause	an	 infectious	event	[150].	The	second	and	more	plausible	explanation	proposes	that	for	each	“successful”	infection	event,	several	critical	steps	involved	in	the	virus	infection	cycle	 have	 to	 be	 successfully	 negotiated.	 If	 the	 probability	 of	 a	 segment	succeeding	at	each	step	is	less	than	1,	the	overall	success	rate	would	reflect	the	product	of	these	probabilities	and	even	when	every	particle	in	the	population	is	initially	viable,	the	infectivity	ratio	could	be	substantially	lower	than	1.	The	final	hypothesis	is	that	in	order	to	initiate	a	successful	infection,	cells	may	need	to	be	“hit”	 by	 more	 than	 one	 virus	 particle	 to	 ensure	 viral	 replication	 in	 the	 cell.		Examples	 for	 “two-hit”	 (plants	 virus	 and	 fungi	 [154,	 155])	 and	 “three-hit”	 (a	mosquito-borne	 virus)	 [156]	 models	 have	 been	 reported.	 Obligatory	 multi-hit	strategies	result	in	characteristic,	non-linear	infectivity	titration	curves,	which	is	not	 the	 case	 for	 influenza,	 but	 this	 does	 not	 mean	 that	 multi-hit	 events	 are	unimportant	 for	 influenza	 virus.	 These	 three	 explanations	 are	 not	 mutually	exclusive.	 A	 virus	 with	 many	 defective	 particles	 can	 rescue	 itself	 by	complementation	and	reassortment	if	>1	virus	particles	enter	the	cell.	Likewise	for	 an	 infection	 event	 where	 one	 segment	 fails	 to	 traverse	 a	 particular	
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intracellular	 hurdle,	 a	 second	 infection	 event	 may	 provide	 the	 missing	component.		Intuitively	 it	 seems	 inevitable	 that	 virus	 infection	 events	 are	 rarely	 caused	 by	single-particles.	 Multi-particle	 infection	 is	 probably	 the	 norm.	 This	 is	 due	 to	several	straightforward	reasons.	Firstly,	the	release	of	particles	from	an	infected	cell	will	produce	such	a	high	local	concentration	of	virus	that	neighbouring	cells	[157]	 are	 likely	 to	 be	 infected	 by	 more	 than	 one	 particle	 especially	 for	 local	transmission	within	a	 tissue.	Single	particle	 infection	 is	perhaps	more	common	during	 aerosol	 transmission	 bottlenecking.	 However,	 field-isolates	 of	 viruses	have	a	tendency	to	clump/aggregate	[158,	159].	So	even	when	an	infection	is	a	single	synchronous	event,	more	than	one	set	of	genomes	may	be	delivered	to	the	cell.	Also	even	when	a	cell	has	been	infected	by	a	single	virus	particle	from	one	source,	 it	 will	 not	 immediately	 become	 refractory	 to	 super-infection	 and	therefore	 may	 be	 asynchronously	 infected	 by	 another	 particle.	 Therefore,	 is	there	a	timing	effect	that	influences	the	outcome	of	asynchronous	infection	and	if	so,	what	might	be	the	mechanism?		In	cell	culture	and	in	vivo	these	mixed	infection	events	are	likely	to	predominate	(at	least	after	the	first	round	of	infection).	A	full	understanding	of	virus	infection	dynamics	should	take	these	possibilities	into	consideration.	The	barcoded	virus	system	 can	 be	 used	 as	 a	 tool	 for	 studying	 these	 dynamics.	 Therefore,	 the	genetically	distinguishable	but	phenotypically	 identical	barcoded	variants	were	applied	to	explore	the	effects	on	mixed,	asynchronous	and	multi-hit	infection.		
2.	Results	
2.1	Estimating	the	incidence	of	single	or	multiple	infections	in	plaque	
assays		The	ULI-tagged	viruses	were	used	to	investigate	the	nature	of	a	plaque-forming	unit	 (e.g.	 whether	 it	 represented	 a	 single	 infection	 event	 with	 a	 single	 viral	particle,	 shown	 in	 Figure	 4.1).	 A	 mixture	 of	 the	 BCV1-5	 viruses	 stocks	 was	prepared	by	combining	equivalent	numbers	of	pfu	and	this	mixed	stock	was	then	serially	diluted	for	plaque	assay.	10	well-separated	plaques	were	picked	and	the	
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PCR	 amplification	 product	 of	 the	 expected	 size	was	 sent	 for	 sequencing	 of	 the	Segment	1	barcode	ULI.	Nine	of	these	plaques	produced	legible	chromatograms,	and	 one	 unreadable	 chromatograph	 (rather	 than	 mixed	 plaque).	 As	 shown	 in	
Table	4.1,	 each	 plaque	 contained	 a	 single	 barcode	 and	 all	 five	 barcodes	were	represented	in	this	small	sample	of	picked	plaques.	This	is	a	control	experiment	in	order	to	confirm	that	at	low	MOI,	the	frequency	of	multiple	infection	events	is	low	as	indicated	by	only	one	ULI	being	present	in	each	plaque.		
	
Figure	4.	1	Diagram	of	detected	hit/multiple	hit	in	single	plaque.	The	mixture	of	equivalent	titer	BCV1-5	was	serially	diluted	to	infect	MDCK	cells.	Then	the	individual	plaques	were	picked	for	sequencing	the	ULI	region	to	understand	how	many	viruses	(ULI)	were	present	in	a	signal	plaque	to	form	an	infectious	event.		
Table	4.	1	Barcodes	in	single	picked	plaques	scanned	by	diluted	DBCV1-5	infection	
Picked	plaque		 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	Barcodes	in	PB2	 BC1	 BC2	 BC5	 BC5	 BC5	 BC2	 BC4	 BC3	 BC4	 -	However,	this	does	not	necessarily	mean	that	the	infection	event	was	caused	by	a	single	particle,	 as	 infection	by	 two	or	more	particles	with	 identical	ULIs	 (e.g.	 if	the	particles	were	clumped)	would	generate	the	same	result.	Virus	particles	are	likely	to	clump	(particularly	in	field	isolates	of	influenza	virus	which	 typically	 form	 filamentous	 aggregating	 particles)	 [160].	 To	 determine	whether	the	ULI-tagged	viruses	could	be	used	to	address	this	question,	a	mixture	containing	equal	proportions	of	BCV1-5_APR8	was	used	to	infect	MDCK	cells	at	MOI	=	5	 (MOI=1	 for	each	virus)	 in	 total	 to	ensure	 that	more	 than	99%	of	 cells	were	infected	(with	a	94%	chance	that	each	was	infected	by	2	or	more	different	ULI-tagged	viruses).	After	24	hours,	the	progeny	of	BCV1-5	were	harvested	and	diluted	 for	 plaque	 purification	 (Figure	 4.2).	 If	 virus	 tends	 to	 clump	 together	during	 particle	 release,	 the	 majority	 of	 the	 clumps	 should	 be	 a	 mixture	 of	different	ULI-tagged	viruses.	The	percentage	 increases	 from	71%	through	86%	
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to	 90%	 with	 the	 increasing	 clump	 size	 from	 2,	 3,	 to	 4	 according	 to	 Poisson	distribution.	
	
Figure	4.	2	Diagram	of	the	possibility	of	clumped	virus	in	single	plaque	Five	barcoded	viruses	were	mixed	at	high	MOI=5	(5pfu/cell)	to	infect	MDCK	to	generate	clumped	progeny.	Then	 the	 diluted	 progeny	 was	 applied	 to	 form	 individual	 plaques.	 If	 multiple	 ULIs	 were	 observed,	 it	demonstrated	that	multiple	particles	contributed	to	the	infection.		Consequently,	 the	 chance	 of	 failing	 to	 observe	 an	 infection	 event	 due	 to	 a	clumped	 virus	was	 low	 even	 if	 the	 clump	 size	was	 only	 2	 (Table	 4.2).	 All	 10	plaques	produced	legible	chromatograms	for	the	segment	1	barcode	area.	Eight	plaques	contained	a	single	barcode	and	two	(#7	and	#9)	had	two	ULIs	for	one	or	more	 of	 their	 segments,	 indicating	 that	 20%	 of	 the	 plaques	 were	 initiated	 by	multiple	infection	events.		The	comparison	of	ULIs	present	in	segments	1,	4	and	5	showed	that	none	of	the	10	plaques	had	all	the	same	cognate	barcodes	for	these	segments.	This	was	expected	because	the	initial	mixed	infection	had	undergone	free	reassortment	and	hence	shuffled	the	ULIs	on	each	of	the	3	segments.		
Table	4.	2	Barcode	from	single	picked	plaque	by	the	progeny	of	mixed	DBCV1-5		
Single	plaque	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	PB2	 BCV5	 BCV4	 BCV3	 BCV1	 BCV3	 BCV3	 BCV1&2	 BCV1	 BCV2	 BCV4	HA	 BCV1	 BCV3	 BCV5	 BCV4	 BCV2	 BCV4	 Mix	 BCV3	 BCV4&1	 BCV2	NP	 BCV5	 BCV4	 BCV4	 BCV5	 BCV2	 BCV1	 BCV2&3	 BCV1	 BCV2&1	 BCV5	Note:	mix	denotes	the	combination	of	ULI	was	too	complex	to	identify	the	specific	contributors	its	clump	size	was	>2.	
2.2	Temporal	effects	on	mixed	infection	dynamics	in	cell	culture	
2.2.1	Design	and	examination	of	sequence-specific	primer	to	distinguish	
two	ULIs	The	goal	of	 this	experiment	was	to	determine	the	effect	of	 the	timing	of	super-infection	on	the	yields	of	primary	and	secondary	infecting	viruses	by	using	two	
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isogenic	variants.	To	achieve	this,	it	was	necessary	to	develop	an	assay	that	could	differentially	 quantify	 two	 synonymous/isogenic	 variants	 in	 a	 population.	 PCR	with	 barcode-specific	 primers	 offers	 a	 simple	 method	 for	 distinguishing	 two	different	barcoded	regions,	as	the	primers	can	be	designed	to	have	mismatches	at	their	3’	end	with	the	template	DNA	that	is	refractory	to	amplification.	A	pair	of	ULI-specific	 primers	 were	 designed	 and	 used	 for	 distinguishing	 DBCV1	 and	DBCV3	viruses.		As	 shown	 in	Figure	4.3,	 the	 annealing	 temperature	was	 varied	 from	 58	 °C	 to	70	 °C	 in	2	 °C	 steps	 to	determine	an	optimized	Tm	 for	distinguishing	 two	ULIs.	The	 BC3	 plasmid	 was	 distinguished	 from	 the	 BC1	 plasmid	 at	 annealing	temperatures	of	68	°C	and	70	°C	by	the	specific	BC1-primer	(product	at	200bp	and	 the	 absence	 of	 the	 shorter	 unidentified	 120bp	 product	 from	 the	 BC3	template).	Further	optimization	of	the	annealing	temperature	was	carried	out	by	qPCR.	
					 											 	 	
Figure	4.	3	Optimization	of	different	annealing	temperatures.		Lanes	M	 are	DNA	 ladders.	 Odd	 lane	 numbers	 are	 the	 PCR	 products	 of	 BC1	 plasmid	 template	which	was	amplified	 by	 BC	 1	 primer.	 Even	 lane	 numbers	 are	 the	 PCR	 product	 of	 BC3	 templates	 and	 BC1	 primer.	Annealing	 temperature	 of	 1	 and	 2	 was	 58°C;	 annealing	 temperature	 of	 3	 and	 4	 was	 60°C;	 annealing	temperature	of	5	and	6	was	62°C;	annealing	temperature	of	7	and	8	was	64°C;	annealing	temperature	of	9	and	10	was	66°C;	annealing	temperature	of	11	and	12	was	68°C;	annealing	temperature	of	13	and	14	was	70°C.	Based	 on	 the	 optimization	 of	 annealing	 temperature	 by	 PCR	 shown	 above,	differential	qPCR	was	optimized	over	the	temperature	range	from	66	°C	to	70	°C	(data	 not	 shown).	 The	 best	 signal	 to	 noise	 differential	 between	 two	 templates	was	observed	at	68°C.	As	shown	in	Table	4.3,	qPCR	calculated	copy	numbers	for	the	matched	 template	 and	 primer	 combinations	 correlated	 very	 closely	 over	 a	wide	 range	 of	 template	 concentrations,	 whereas	 the	 mis-matched	 primer	
200	bp	100	bp	 M		1				2				3				4					5				6				7				8					
Template											1					3				1				3				1					3				1				3	Temperature      58°C    60°C   62°C    64°C 
M						9						10				11				12					13				14		
1						3							1						3							1						3	66°C      68°C        70°C 
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template	 combinations	 resulted	 in	 very	 low	 signals,	 e.g.	 on	 template	 BC3	(1.00E+07	copies),	and		BC1	primer	reaction	reported	only	eight	copies	by	qPCR.	Similarly,	on	BC1	template	(1.00E+07	copies),	the	BC3	primer	reaction	reported	only	246	copies.	This	is	a	strong	signal	to	noise	ratio.	
Table	4.	3	The	qPCR	copies	number	of	BC1	and	BC3	amplified	by	BC1	and	BC3	primer	respectively	
Template		
(Given	copies)	
qPCR	amplify	by		BC	3	primer	
(Ct	calculated	copies)	
qPCR	amplify	by		BC	1	primer	
(Ct	calculated	copies)	BC1	1.00E+07	 2.46E+02	±	1.89E+02	 9.60E+06	±	1.09E+06	BC1	1.00E+06	 8.17E+01	±	2.35E+01	 1.33E+06	±	2.33E+05	BC1	1.00E+05	 2.48E+01	±	1.22E+01	 1.23E+05	±	2.25E+04	BC1	1.00E+04	 1.57E+01	±	8.65E+00	 1.46E+04	±	2.12E+03	BC1	1.00E+03	 6.56E+00	±	9.76E-01	 1.45E+03	±	3.46E+02	BC3	1.00E+07	 9.09E+06	±	5.38E+05	 7.82E+00	±	2.45E+00	BC3	1.00E+06	 1.33E+06	±	1.83E+05	 9.96E-01		±	4.64E-01	BC3	1.00E+05	 1.08E+05	±	1.64E+04	 7.83E-01		±	8.92E-01	BC3	1.00E+04	 9.66E+03	±	5.52E+02	 1.33E+00	±	6.40E-01	BC3	1.00E+03	 1.15E+03	±	1.26E+02												 7.91E-01		±	1.02E-01		After	confirming	the	cycle	conditions	that	could	distinguished	two	templates,	the	ability	to	quantify	a	specific	barcode	within	a	mixture	of	two	different	barcodes	was	assessed	in	order	to	further	mimic	the	real	experimental	circumstances.	The	amount	 of	 BC1	 template	was	 kept	 constant	 (at	 107	 copies	 per	 PCR),	while	 the	proportion	of	the	BC3	template	was	varied	from	1	%	to	99	%.	From	Table	4.4,	it	is	 clear	 that	 the	 number	 of	 copies	 of	 BC1	 determined	 by	 the	 q-PCR	 remained	accurate	throughout	the	range	of	BC3	proportion	in	the	sample.	Even	when	the	mismatched	template	(BC3)	was	a	hundred	times	more	abundant	than	BC1,	the	specific	primer	BC1	still	quantified	it	accurately.		The	 reciprocal	 experiment	 using	 a	 fixed	 concentration	 of	 BC3	 template	 and	varying	 the	 proportion	 of	 BC1	 template	 produced	 very	 similar	 results	 (Table	
4.4).	 This	 provides	 a	 useful	 accurate	 and	 sensitive	 tool	 for	 quantifying	 the	amount	of	each	barcode	in	a	mixed	population	and	has	been	used	here	to	study	the	temporal	dynamics	of	mixed	infections	in	cell	culture.			
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Table	4.	4	The	accurate	differentiation	of	different	percentage	of	BC1	
%BC1	in	total	template	
conc		(Given	copies)	
Total	template	conc	
(Given	copies	of	
BC1+BC3)	
BC	 1	 conc	 in	 template	
(given	copies)	
BC	1	conc	in	template	
(Ct	calculated	copies)	99%	 1.00E+07	 1.00E+07	 9.94E+06	±	9.19E+04	90%	 1.11E+07	 1.00E+07	 8.92E+06	±	1.48E+05	70%	 1.43E+07	 1.00E+07	 9.78E+06	±	1.34E+04	50%	 2.00E+07	 1.00E+07	 9.87E+06	±	3.32E+05	30%	 4.33E+07	 1.00E+07	 9.82E+06	±	1.34E+05	10%	 1.10E+08	 1.00E+07	 1.01E+07	±	1.48E+05	1%	 1.01E+09	 1.00E+07	 1.03E+07	±	1.41E+05	
2.2.2	Asynchronous	infection	in	vitro	1)	 Time-dependent	 interactions	 between	 primary	 and	 secondary	 infecting	viruses.	The	experimental	design	is	 illustrated	in	the	schematic	at	the	top	of	Figure	5.5.	Each	experimental	 condition	was	performed	 in	 triplicate	 in	 separate	wells	of	a	24	well	 plate	 so	 that	 each	 sample	 could	 be	 harvested	 at	 the	 appropriate	 time	point.	The	cells	were	firstly	infected	with	BCV1	at	moi	=	3	at	T0	and	then	super-infected	using	a	second	virus	(BCV3,	moi=3)	at	different	times	post-infection	(i.e.	v2_1hpi,	v2_3hpi,	v2_4hpi,	v2_5hpi,	v2_6hpi	and	v2_7hpi).	Inocula	were	removed	and	the	cells	were	washed	briefly	with	low	pH	buffer	15mins	post-adsorption	to	ensure	 synchronous	 infection.	 The	 yields	 of	 the	 primary	 and	 super-infecting	viruses	were	then	determined	at	24	h.p.i	(T24hr)	using	the	q-PCR	assay	described	above.	 As	 shown	 in	Figure	 4.4,	 the	 final	 T24hr	 viral	 yield	 of	 the	 primary	 virus	single	 infection	 was	 7.44	 log10	 genome	 copies/ml.	 Where	 super-infection	occurred	 at	 T1hr	 there	was	 a	 small	 decrease	 in	 final	 yield	 of	 the	 primary	 virus	(7.18	 log10	 genome	 copies/ml).	The	 super-infecting	virus	had	exactly	 the	 same	titre,	consistent	with	two	viruses	essentially	sharing	the	final	yield	equally	(7.18	Log10	_+	7.18	Log10	=	7.48	Log10	genome	copies/ml).	This	sharing	is	apparent	at	T2hr	and	T3hr	but	 from	T4hr	onwards	 it	 is	also	apparent	that	the	final	yield	of	 the	super-infecting	 virus	 was	 progressively	 diminished	 (significantly	 from	 T6hr	onwards).	A	slight	decline	in	the	primary	virus	final	yield	is	apparent	(e.g.	Log10	7.09	at	T8hr)	but	this	 is	 likely	to	be	caused	by	the	loss	of	the	primary	virus	that	has	 been	 released	 by	 that	 time	 but	 then	 eliminated	 due	 to	 wash	 steps	 of	 the	super-infection.	This	suggests	that	there	is	a	time	window	of	approximately	4-5	hours	during	which	secondary	infection	can	occur	without	detriment	to	the	final	
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yield	 of	 the	 super-infecting	 virus.	 After	 this	 time	 period,	 the	 primary	 virus	suppressed	the	replication	of	the	super-infecting	virus	(an	8-hour	delay	resulted	in	 >	 1.5	 log10	 decrease	 in	 yield	 down	 to	 5.66	 log10	 genome	 copies).	 This	 is	probably	a	conservative	estimate.		At	MOI	=	3,	5%	of	cells	could	be	uninfected	at	T0hr	 and	 therefore	 could	 potentially	 be	 infected	 only	 by	 the	 second	 virus	(although	 it	 was	 assumed	 that	 the	 conditions	 still	 allowed	 this	 –	 e.g.	 the	induction	 of	 IFNR	 genes	 was	 not	 induced	 and	 the	 factor	 in	 the	 MOI	 was	substantially	higher	in	terms	of	genome	copies).		
	
Figure	4.	4	The	comparison	of	the	final	(T24hr)	yields	of	primary	and	super-infecting	viruses.		Mean	yield	±	 standard	deviation	of	 3	 replicates	 is	 shown	at	 each	 time	point.	 The	 statistical	 analysis	was	performed	using	Two-sample	 t-test.	The	 significant	differences	between	 two	groups	 are	 indicated.	 Single	stars	denote	0.01<p<0.05,	double	stars	0.001<p<0.01,	triple	stars	p<0.001.	2)	Accelerated	replication	of	super-infecting	virus.		It	was	observed	that	the	super-infecting	virus	final	(T24hr)	yields	were	similar	to	the	 primary	 virus	 when	 the	 superinfection	 occurred	 within	 the	 first	 4-5	 hr	implying	 that	 the	 super-infecting	 virus	was	 able	 to	 catch-up	with	 the	 primary	infection,	 i.e.	 its	 replication	was	 accelerated.	 To	 demonstrate	 this	 directly,	 it	 is	necessary	to	determine	the	yields	at	earlier	time	points.	The	experimental	design	
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is	 shown	 in	 the	 schematic	 (Figure	5.6a).	MDCK	cells	were	 infected	at	T0hr	with	BC1-tagged	 virus	 (MOI=3)	 as	 before.	 At	 0,	 1,	 3,	 4,	 5,	 6	 or	 7	 h.p.i.,	 cells	 were	superinfected	with	BC3-tagged	virus	(v1+v2,	v2_1hpi,	v2_3hpi,	v2_4hpi,	v2_5hpi,	v2_6hpi	and	v2_7hpi,	respectively).	Supernatants	were	harvested	and	the	yield	of	BCV3	was	determined	at	hours	of	secondary	post	infection	(h.s.p.i)	at	0,	1,	3	5,	7	and	9	(Figure	4.5a).	As	shown	in	Figure	4.5b,	the	infection	by	BCV3	on	its	own	(MOI	=	6)	showed	a	typical	one-step	growth	curve.	The	genomes	detected	at	T1hr	represent	 the	 residual	 inoculum	 after	 the	 wash	 step	 (acid	 washing	 eliminates	infectivity	 but	 not	 detectable	 genome	 copies).	 The	 yield	 increased	 abruptly	between	T3hr	and	T4hr	but	plateaued	by	T5hr.		Simultaneous	infection	of	BCV1	and	BCV3	(MOI	=	3	of	each)	resulted	in	the	same	replication	kinetics	(turquoise	line)	but	 a	 lower	 plateau	 yield	 of	 BCV3	 (presumably	 due	 to	 the	 “yield	 sharing”	observed	in	Figure	4.5).	Delaying	super-infection	by	1-3	hr	(red	and	blue	lines)	had	little	discernible	impact.	A	four-hour	delay	also	had	no	impact	on	the	plateau	level	but	a	clear	increase	in	BCV3	yield	at	T3hr	(grey	line)	was	seen.	Thus	a	virus	entering	 an	 already	 infected	 cell	 at	 a	 stage	 when	 the	 first	 virus	 had	 started	replication	 3-4	 hr	 before	 resulted	 in	 an	 accelerated	 progression	 for	 the	 super-infecting	virus.	However,	 a	delay	 for	>=	5	hr	negated	 this	 enhancement	 (green	line).		The	experiment	was	repeated	focusing	on	the	critical	time	period	between	0	–	4	hr	post-primary	infection	(Figure	4.5c).	As	shown	in	Figure	4.5d,	a	comparison	of	 the	 yield	 of	 BCV3	 from	 the	 simultaneous	 infection	 (green	 bar)	 with	 those	where	superinfection	was	delayed	for	3	or	4	hr	(red	and	blue	bars)	resulted	in	a	small	but	statistically	significant	 increase	 in	 the	yield	over	 the	subsequent	2	hr	time	period	(a	4-fold	yield	boost	was	observed	for	v2_3hpi	at	4	h.s.p.i.	(p	<0.05)	and	v2_4hpi	at	3	and	4	h.s.p.i.	(p	<0.01).	This	effect	was	no	longer	apparent	by	5	h.s.p.i.	Delaying	superinfection	by	5	hr	(grey	bar)	resulted	 in	statistically	 lower	yields	achieved	at	4	hr	and	5hpsi	as	observed	earlier.	Thus	the	initially	enhanced	environment	for	superinfecting	virus	replication	became	refractory	after	5	hr.			
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Figure	4.	5	The	temporal	effects	on	mixed	infection	dynamics	in	cell	culture	(a)	the	schematic	diagram	of	experiment	design	of	the	2nd	infecting	virus	with	different	post	infection	hours	at	1,	3,	5	,7and	9	h.s.p.i;	(b)	The	yield	of	2nd	infecting	virus	with	different	post	infection	hours	at	1,	3	5,	7	and	9	 h.s.p.i.;	 (c)	 the	 schematic	 diagram	 of	 experiment	 design	 of	 the	 2nd	 infecting	 virus	 with	 different	 post	infection	hours	at	2,	3,	4	and	5	h.s.p.i;	 (d)	 the	yield	of	 the	2nd	 infecting	virus	with	different	post	 infection	hours	at	2,	3,	4	and	5	h.s.p.i.	Mean	yield	±	standard	deviation	of	3	replicates	was	shown	at	each	time	point.	The	statistical	analysis	was	performed	using	Two	samples	 t-test.	The	significant	differences	between	 two	groups	were	indicated.	Single	stars	denote	0.01<p<0.05,	double	stars	0.001<	p	<0.01,	triple	stars	p	<0.001.	
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This	transition	between	4-5	hr	coincides	with	the	time	period	when	the	infected	cells	 start	 releasing	 the	 viral	 progeny	 of	 the	 primary	 infecting	 virus.	 Thus	 the	environment	 of	 the	 infected	 cell	 may	 have	 changed	 to	 a	 state	 that	 no	 longer	allows	 efficient	 entry	 and/or	 replication	 of	 the	 second	 virus.	 One	 explanation	might	be	the	reduction	of	virus	receptor	expression	due	to	the	action	of	the	viral	NA.	If	this	were	the	case,	the	level	of	sialic	acid	receptor	on	the	cell	surface	would	be	predicted	to	have	decreased	at	this	time.	Although	A/PR/8/34	is	originally	from	humans,	 its	 adaptation	 to	 embryonated	 hens	 eggs	 implies	 that	 it	 now	preferentially	 binds	 alpha-2-3	 linked	 sialic	 acid	 receptors.	MDCK	 cells	 staining	for	α2,3-sialic	was	therefore	determined	by	flow	cytometry	analysis	of	the	cells	using	biotinylated	Maackia	amurensis	lectin-II	 (MAA-II).	Receptor	expression	on	infected	cells	decreased	gradually	over	time	to	statistically	significant	levels	by	8	hr	post	infection	(p<	0.05)	(Figure	4.6).		
	
Figure	4.	6	Binding	of	the	specific	biotinylated	Maackia	amurensis	lectin-II	(MAA-II)	to	the	MDCK	cell	
surface	receptor	The	cells	were	infected	for	5,	6	and	8	hours	compared	to	the	non-infected	MDCK	with	MOI=3.	(*p<0.05)	
3.	Discussion		
It	is	now	clear	for	influenza	virus	that	one	infectious	viral	particle	can	cause	an	infection	event.	However,	multiple	infection	events	are	more	likely	to	represent	the	normal	situation.	Even	at	extremely	low	MOIs,	cells	may	still	be	infected	by	more	 than	 one	 particles	 at	 a	 higher	 frequency	 than	 predicted	 by	 Poission	
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distribution	[161].	The	plaque	assay	is	a	 fundamental	method	to	determine	the	virus	concentration	and	is	based	on	the	principle	that	each	plaque	represents	a	single	infectious	unit.	But	what	this	truly	represents	is	not	at	all	clear.		The	ratio	of	 1:10	 -	 1000	plaque-to-genome	 copies	 for	 influenza	A	 virus	was	 shown	by	 a	number	of	previous	studies	[162,	163].	A	moderate/low	MOI	infection	in	terms	of	pfu	may	equate	to	a	high	MOI	infection	in	terms	of	particles/genome	copies	if	there	 is	 a	 large	 discrepancy	 between	 particle/genome	 copy	 number	 and	infectivity	such	as	might	be	the	case	if	there	are	abundant	defective	particles	(e.g.	DIs	 and	 “partially	 infectious”	 particles)	 or	 if	 the	 virus	 is	 prone	 to	 aggregation	(either	intrinsically	such	as	for	filamentous	strains	or	due	to	antibody	binding	or	receptor-mediated	 e.g.	 if	 treated	 with	 neuraminidase	 inhibitors).	 Multiple	infection	 is	a	very	 important	aspect	of	 influenza	biology,	which	 fundamental	 to	reassortment	 and	 complementation.	 The	 former	 is	 an	 obvious	 contributor	 to	virus	evolution	and	pandemic	threat.	The	latter	is	a	neglected	area	of	study	but	likely	to	be	important	in	the	survival	and	propagation	of	mutant	viruses.	This	chapter	sought	to	demonstrate	that	the	barcoded	virus	system	developed	in	Chapter	3	could	be	used	to	investigate	mixed	infection	events	and	shed	light	on	some	of	these	processes.	
Table	4.2	show	that	when	using	viral	progeny	from	a	mixed	infection	at	a	high	moi,	 2	 out	 of	 10	 plaques	 contained	 2	 or	more	 ULIs,	 demonstrating	 that	 these	plaques	were	initiated	by	>1	particle.	Plaque	#3	was	likely	to	be	caused	by	two	infecting	particles	and	plaque	#7	by	>	2	particles.	More	precise	definition	of	the	clump	 size	would	 require	 a	much	 larger	 scale	 experiment	with	more	ULIs	 and	statistical	 analysis	 of	 the	 frequency,	 each	 of	which	 is	 observed	 in	 combination	with	 the	 others.	 However,	 the	 small	 scale	 experiment	 described	 here	 has	provided	convincing	evidence	that	a	substantial	percentage	(~20%)	of	infection	events	in	cell	culture	may	be	initiated	by	more	than	one	particle.	This	is	adequate	as	a	proof	of	principle,	but	it	would	be	prudent	to	repeat	this	experiment	to	get	a	more	accurate	estimate	 for	 this	 frequency	and	 to	 study	how	 this	 is	 affected	by	culture	conditions	(e.g.	virus	strain,	NA	inhibitors	and	antibodies).	A	recent	study	[164]	 on	 polioviruses	 has	 demonstrated	 that	 4.9%	 plaques	 (6	 out	 of	 123)	contained	more	than	one	virus.		
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The	opportunity	for	multiple	infections	is	not	limited	to	simultaneous	infection.	Asynchronous	 infection	 could	 occur	 up	 to	 4-5	 hr	 post	 primary	 infection	 with	little	 disadvantage	over	 the	 super-infecting	 virus.	 Indeed	 it	was	 found	 that	 the	super-infecting	 virus	 could	piggy-back	on	 the	 first	 one,	 rapidly	 catch	 it	 up	 and	share	50:50	of	the	final	yield.	The	situation	described	above	provided	an	optimal	scenario	for	efficient	complementation.	Infected	cells	became	refractory	to	super-infection	after	4-5	hours	(nearing	the	end	of	the	replication	cycle).	There	are	several	possible	explanations	for	this:		1. Loss	of	sialic	acid	receptor	due	to	NA	activity,	2. Switch	over	to	a	late	temporal	phase	of	the	replication	cycle,	and	3. Exhaustion	of	cellular	resources.	The	small	reduction	in	cell-surface	staining	for	alpha-2-3	sialic	acid	observed	at	5	hr	 might	 contribute	 to	 the	 refractory	 of	 cells	 to	 infection	 at	 this	 point.	 	 Virus	particles	are	able	to	release	themselves	by	this	time	point	and	the	NA	is	active	by	then.	 However,	 the	 high	 local	 concentration	 and	 the	 focus	 of	 virus	 particle	associated	 with	 NA	 might	 be	 more	 effective	 at	 allowing	 release	 compared	 to	preventing	 super-infecting	 virus	 binding.	 	 It	 is	 likely	 that	 other	 factors	 make	more	 substantial	 contribution.	 A	 direct	 assay	 for	 virus	 binding	 and	 entry	 is	required	for	a	definitive	answer	to	this.	Influenza	shows	marked	temporal	phases	in	its	life	cycle.	In	early	infection	RNPs	are	 actively	 transported	 to	 the	 nucleus	 and	 transcribed.	 Then	 they	 switch	 to	replication	and	ultimately	to	nuclear	export	and	packaging.	Super-infecting	virus	could	benefit	from	skipping	the	early	phase	and	go	on	directly	to	the	replication	phase.	However,	once	the	RNP	export	phase	has	begun,	it	is	unlikely	to	establish	itself	successfully.	The	 early	 boost	 observed	 in	 Figure	 4.6	 is	 consistent	 with	 this	 scenario,	suggesting	that	the	secondary	infecting	virus	could	take	advantage	of	the	already	initiated	replication	machinery.	Previous	studies	have	reported	the	order	of	viral	gene	expression.	For	example,	NP	and	NS1	proteins	are	synthesized	in	the	early	stages	of	infection	[165,	166],	whereas	the	HA,	NA	and	M1	proteins	occur	during	
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the	later	stages	[167,	168].	M1	was	shown	to	export	the	RNPs	from	the	nucleus	and	played	a	vital	role	in	recruiting	the	viral	components	to	the	site	of	assembly	at	 the	plasma	membrane	 [169].	After	1-2	hr,	 the	2nd	 virus	 yield	boost	was	not	observed	because	its	vRNA	replication	and	nuclear	export	were	not	completed	at	this	time	point.	However,	the	2nd	virus	didn’t	need	to	synthesize	its	own	proteins	and	the	production	and	export	of	RNPs	from	the	nucleus	to	cytoplasm	requires	3-4	h.p.i.	[170].	This	could	explain	the	fact	that	the	viral	particles	containing	the	2nd	barcode	 increased	at	3	and	4	h.s.p.i.	However,	 this	advantage	didn’t	remain	when	the	secondary	virus	infection	was	at	5	h.s.p.i.	because	the	replication	cycle	had	already	transitioned	to	the	RNP	nuclear	export	phase.	
4.	Conclusion		
Barcoded	 viruses	 provide	 a	 useful	 tool	 for	 investigating	 two	 fundamental	virology	 questions	 regarding	 (1)	 single	 or	 multiple	 hits	 kinetic	 within	 one	infectious	 event;	 and	 (2)	 temporal	 effects	 on	mixed	 infection	 dynamics	 in	 cell	culture.	One	virus	could	cause	infectious	events	and	more	than	one	viral	particle	could	be	observed	from	single	plaque.	In	asynchronous	infection,	the	yield	of	2nd	infecting	 virus	was	 boosted	when	 cells	were	 infected	 before	 the	 time	 point	 of	primary	 virus	 release,	 but	 the	 yield	 decreased	when	 the	 cell	 started	 releasing	virus.	The	decreased	NA	receptors	could	be	one	of	the	major	reasons	behind	this	decrease.
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Chapter	5		
Characterization	of	rescued	barcoded	variants		
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	The	rescue	of	five	barcoded	virus	libraries	each	of	which	has	a	single	unique	ULI	and	~8000	DR	variants	was	described	 in	Chapter	3.	This	chapter	will	 focus	on	the	characterization	of	rescued	barcoded	virus	(all	DBCV1-5	in	this	chapter	were	the	 barcoded	 virus	 rescued	 based	 on	 SIV/1353	 strain)	 in	 vitro	by	 using	 Next	Generation	Sequencing	(NGS).	Four	aspects	of	the	analysis	are	listed	below:	1. analysis	 of	 NGS	 sequencing	 data	 from	 the	 “barcoded	 region”	 and	 read	filter	 optimization	 to	 reduce/eliminate	 low	 confidence/erroneous	 reads	and	 estimation	 of	 the	 abundance	 and	 population	 complexity	 of	 the	barcoded	viruses	in	each	viral	library,	2. analysis	 of	 the	 compositions	 and	 frequency	 of	 each	 viral	 barcoded	member	in	the	viral	library,		3. analysis	of	obvious	 trends	 in	specific	barcoded	 frequency	changes	when	passaging	in	vitro,	and	4. whole	 genome	 sequencing	 to	 determine	 the	 frequency	 of	 “backbone”	mutations	 of	 the	 stock	 viruses	 and	 to	 study	 the	 base	 bias	 of	 selected	substitutions	at	the	13	DR	wobble	positions.	
1.	Methods	
1.1.	Bioinformatics	analysis	of	the	“barcoded	region”	NGS	data		After	 MiSeq	 runs	 were	 completed,	 the	 quality	 of	 the	 reads	 was	 assessed	 by	FastQC	 on	 BaseSpace	 (Illumina)	 and	 then	 visualized	 by	 the	 DADA2	 pipeline	which	 is	 the	 R	 package	 inferring	 exact	 sequence	 variants	 from	 amplicon	 data.	Only	 the	 sequence	 that	 covers	 the	 entire	 “barcode	 region”	 (Phred	 scorce	>	33,	read	length	>	140	bp)	was	retained	and	merged	against	the	reference	sequence	to	produce	a	consensus	sequence	by	using	Trimmomatic	and	SAM	tool	packages.	Then	a	customised	script	(see	Appendix)	written	in	Perl	was	applied	to	estimate	the	 number	 of	 rescued	 barcoded	 variants	 in	 each	 viral	 stock.	 Briefly,	 all	 reads	shown	below	were	aligned	with	the	consensus	for	the	barcoded	region.		
[AG]GT[AGT]TT[AG]CATTTGAC[CT]CAAGG[AG]AC[ACG]TG[CT]TGGGAACA[AG]ATGTATACTCCAGG[ACT]GG[GA]GAAGTGAG[AG]AATGA[CT]GATGTTGA[CT]CAA
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AGCTTGATCATCGC[AT]GC[CT]AG[AG]AACAT[AT]GT[AT]AG[AG].	 (Where	 the	greyed	 sequence	 corresponds	 to	 the	 ULI	 and	 the	 square	 brackets	 indicate	 the	[variant	nucleotide]	options	at	each	position	of	the	ULI	and	DR	elements)	The	 barcoded	 variants	 were	 extracted	 and	 aggregated	 by	 searching	 for	 13	wobble	positions	in	the	“diversity	region”	and	6	wobble	positions	in	the	“unique	region”.	
2.	Results	
2.1	Optimizing	variant	calling	and	discriminating	signal	from	noise	
2.1.1	Threshold	setting	Sequencing	the	barcode	regions	of	the	viral	RNA	libraries	produced	a	very	large	number	 of	 sequence	 reads	 corresponding	 to	 the	 expected	 barcode	 consensus.	Within	 these	 reads,	 the	 abundance	 of	 any	 individual	 variant	 differed	 over	 a	broad	 range	 from	 1	 to	 ~30	 (the	 term	 “variant”	 was	 used	 synonymously	 with	“allele”,	 indicating	 a	 specific	 constellation	 of	 ULI	 and	 DR	 sequences).	 Low	abundance	 variants	 might	 be	 genuinely	 present	 in	 the	 sample	 but	 might	 also	originate	from	processing	and	sequencing	errors.	To	address	the	reproducibility	of	sampling,	sequencing	and	data	processing	procedures,	two	aliquots	from	the	same	 viral	 supernatant	 for	 each	 of	 five	 P2	 virus	 stocks	 (P2DBCV1-5)	 were	extracted	for	RNA,	reverse	transcribed,	amplified,	tagged,	sequenced,	filtered	and	analysed	 in	 parallel	 using	 the	 established	 protocol.	 The	 frequency	 of	 common	variants	(fc)	in	five	pairs	of	replicates	was	calculated	as	the	number	of	common	variants/the	 total	 number	 of	 the	 variants	 detected	 in	 both	 replicates	 for	abundance	 threshold	 n,	 i.e.	 	 f	n=	 [(P2ÇP3)/ (P2ÈP3)]n.	 Figure	 5.1	 shows	 that	this	value	changed	as	the	read	count	threshold	for	inclusion	was	varied	between	1	and	20.Also	the	increase	in	the	abundance	threshold	from	1	to	4	resulted	in	a	sharp	 increase	 in	 fc	 from	 ~	 35%	 to	 90%,	 summarised	 in	Table	 5.1.	 With	 the	continuous	 increase	 in	 the	 abundance	 threshold,	 fc	hit	 100%	 when	 the	 reads	presented	 in	 range	 of	 11-19	 in	 its	 corresponding	 DBCV1-5	 viral	 stock	 library.	Due	to	the	 insistency	observed	from	5	stocks,	here	the	reads	threshold	was	set	firstly	as	4	(fc		>	90%	)	to	extract	the	variants.		
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Figure	5.	1	The	frequency	of	common	variants	(fc)	in	five	pair	of	P2	replicates	with	reads	setting	
from	1-20.	Dash	line	highlighted	the	read	threshold	set	at	4.	
	
Table	5.	1	Concordance	between	replicates	Sample	ID	 fc	(Reads≥1)	 	fc		(Reads≥4)		 Highest	discordant	frequency	(Reads≥4)	DBCV1_Replicates1		 25.53%	 92.70%	 0.02%	DBCV1_Replicates2	 	 	 0.02%	DBCV2_Replicates1	 33.07%	 90.60%	 0.03%	DBCV2_Replicates2	 	 	 0.02%	DBCV3_Replicates1	 41.65%	 94.50%	 0.04%	DBCV3_Replicates2	 	 	 0.02%	DBCV4_Replicates1	 38.39%	 93.00%	 0.03%	DBCV4_Replicates2	 	 	 0.02%	DBCV5_Replicates1	 37.46%	 93.40%	 0.06%	DBCV5_Replicates2	 		 		 0.02%	MEAN±	STDV	 35.22%±6.22%	 92.80%±1.40%	 0.03%±0.01%	The	 scatter	 plots	 in	 Figure	 5.2	 compare	 the	 frequencies	 of	 each	 variant	occurring	 between	 replicates,	 relative	 to	 the	 total	 number	 of	 variants.	 The	relationship	between	each	pair	of	replicates	is	highly	correlated.		The	majority	of	data	points	 fit	within	 the	boundaries	predicted	 for	sampling	error	due	to	 finite	coverage	 (±	 (f/D)0.5,	 where	 f	 is	 frequency,	 and	 D	 is	 input	 viral	 copies).	 The	variants	 falling	 outside	 the	 predicted	 error	 boundaries	 are	 referred	 to	 as	“discordant”.	There	are	two	classes	of	these	variants,	numerically	discordant	(i.e.	higher	 vs.	 lower	 frequency)	 and	 absolute	 discordance	 (present	 vs.	 absent	 –	which	are	the	points	clustering	parallel	 to	the	X	or	Y	axis).	As	shown	in	Figure	
5.2	 and	 summarised	 in	 Table	 5.2,	 no	 discordant	 variants	 were	 present	with	>0.06%	frequency	in	any	samples.		
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Figure	5.	2	Scatter	plots	showing	the	correlation	between	replicate	samples	for	each	of	the	five	
P2DBCV	stocks.	Each	circle	represents	a	single	variant	with	its	coordinates	indicating	its	relative	frequency	(i.e.	variant	read	count/total	number	of	reads	for	all	variants	plotted	on	a	log10scale)	in	the	two	replicates.	The	error	boundaries	(dotted	lines)	indicate	the	predicted	spread	of	sampling	error	at	the	different	abundance	levels.	
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The	 used	 passaging	 methodology	 should	 ensure	 that	 even	 low	 abundance	variants	 could	 be	 transferred	 to	 the	 subsequent	 culture	 passage	 and	 the	sampling	size	is	sufficient	to	ensure	substantial	over-sampling	of	the	population	present.	Therefore	“genuine	variants”	are	likely	to	be	observed	in	two	sequential	passages	 (P2,	 P3).	 In	 order	 to	 remove	 the	 sequencing	 noise	 and	 confine	subsequent	analyses	 to	genuine	viral	 variants,	P2	 and	P3	stocks	of	 five	 libraries	were	 sequenced	 and	 analysed	 for	 the	 distribution	 of	 common	 variants	 (i.e.	“common”	 in	 the	 sense	 of	 being	 detected	 in	 P2	 and	 P3	 for	 each	 library).	 For	abundance	 thresholds	 between	 1	 and	 30,	 f	n	was	 calculated	 to	 understand	 the	concordance	between	the	two	passages.	As	shown	in	Figure	5.3,	there	is	also	a	sharp	break-point	at	abundance	levels	<	4	reads.	This	pattern	was	observed	in	all	five	stocks	viruses.	Variants	in	P2	or	P3	with	≥	4	reads	had	a	high	probability	(p	=~0.9)	 of	 present	 in	 the	 other	 passaged	 stock.	 This	 probability	 dropped	 for	thresholds	<	4,	reaching	~	0.5	for	the	single-read	variants.	This	analysis	confirms	that	 the	 threshold	 value	 of	 ≥	 4	 is	 appropriate	 for	 analysing	 the	 viral	 library	stocks.	The	numbers	of	barcoded	variants	in	each	stock	(applying	this	threshold)	are	summarized	in	Table	5.2.		
Table	5.	2	Number	of	the	variants	in	P2	and	P3	
									Sample	ID	 Sequencing	depth	
Number	of 
Variants	≥4 Common	variants	P2DBCV1	 70,280	 1061	 962	P3DBCV1	 74,981	 1086	 	P2DBCV2	 93,820	 1284	 1173	P3DBCV2	 87,089	 1314	 	P2DBCV3	 87,477	 1966	 1831	P3DBCV3	 77,562	 2208	 	P2DBCV4	 97,835	 1678	 1511	P3DBCV4	 75,479	 1702	 	P2DBCV5	 88,319	 1161	 1051	P3DBCV5	 87,437	 1228	 	
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Figure	5.	3	The	frequency	of	common	variants	(fc)	in	five	pairs	of	passage	comparisons.	Reads	setting	from1-30.	Dash	line	highlights	the	reads	threshold	set	at	4.	
2.2	Propagation	in	Vitro	
2.2.1	Changes	in	variant	distribution	during	MDKC	cell	passaging.	Having	determined	an	appropriate	preliminary	threshold	setting	for	identifying	and	 estimating	 the	 number	 of	 genuine	 variants	 in	 the	 sample	 populations,	 I	analysed	 how	 the	 variant	 distributions	 altered	 over	 the	 primary	 rescue	 and	passaging	 phases	 of	 preparing	 the	 virus	 stocks.	 Comparing	 the	 relative	abundance	 of	 each	 variant	 in	 the	 primary	 MDCK-passage	 (P1)	 of	 the	 viruses	rescued	 in	293T	cells	(P0)	 to	 that	of	 the	subsequent	MDCK-passaged	stocks	(P2	and	 P3),	 it	 is	 obvious	 that	 there	 is	 a	 substantial	 discordance.	 Some	 variants	present	at	relatively	high	levels	in	P1	are	absent	or	present	at	much	lower	levels	in	 P2,	 and	 vice	 versa	 (Figure	 5.4	 a1-5).	 However,	 this	 discordance	 decreased	markedly	between	P2	and	P3	(Figure	5.4	b1-5).	Plotting	P1-P3	data	sequentially	against	each	variant	coloured	and	ranked	by	its	abundance	in	P3	(Figure	5.4	c1-
5)	allowed	the	 individual	variant	 to	be	 tracked	across	all	3	passages.	 It	 reveals	the	numerous	abundances	shifts	between	P1	and	P2	and	the	subsequent	stability	of	the	P2/P3	stocks.	No	single	barcoded	variant	exceeded	a	relative	abundance	of	0.05	 (i.e,	5%)	 in	any	of	 the	viral	 libraries.	This	 frequency	distribution	 suggests	that	the	rescued	variants	were	relatively	evenly	mixed.		
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Figure	5.	4	Propagation	in	Vitro	Scatter	plots	(a1-5)	showing	the	correlation	between	each	of	the	five	P1DBCV	and	P2DBCV	variants,	while	the	correlation	between	each	of	the	five	P2DBCV	and	P3DBCV	variants	frequency	is	shown	in	Scatter	plots	(b1-5).	Each	circle	represents	a	single	variant	with	its	coordinates	indicating	its	relative	abundance	(i.e.	variant	read	count/total	number	of	reads	for	all	variants	plotted	on	a	 log10scale).	The	error	boundaries	 (dotted	 lines)	 indicate	 the	predicted	spread	of	sampling	error	at	 the	different	abundance	 levels.	 	Line	graph	(c1-5)	indicates	the	change	in	the	frequency	of	specific	variant	across	3	passages.	
		
a4	 b4	 c4	
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2.3	Detailed	characterisation	of	the	P3	viral	library	Stocks	 P2	 and	 P3	 were	 more	 stable	 than	 P1.	 For	 P3	 stocks,	 there	 were	 1086	variants	 in	 DBCV1,	 1314	 variants	 in	 DBCV2,	 2208	 variants	 in	 DBCV3,	 1702	variants	in	DBCV4,	and	1228	variants	in	DBCV5,	respectively	(Table	5.3).	Based	on	these	results,	it	was	decided	to	characterize	the	P3	libraries	in	preparation	for	their	use	as	the	inoculum	for	the	planned	in	vivo	studies	in	pigs	(Chapter	5).	All	the	 variants	 (>30	 reads)	 in	 each	 viral	 library	 are	 shown	 in	 the	 supplement	
Figure	S5.1.	a-e.		
2.3.1	Frequency	distribution	and	composition	of	the	P3	barcoded	libraries	The	majority	 of	 the	 variants	 (around	87%)	present	within	 the	 library	had	 less	than	 100	 reads,	 while	 only	 a	 few	 variants	 with	 one	 magnitude	 higher	 were	detected	in	each	viral	stock.	The	details	of	variant	frequency	are	shown	in	Table	
5.3,	 the	majority	 of	 the	 barcode	 variants	were	 present	 at	 0.01%-0.1%,	with	 a	mean	 ±	 STDV	 of	 60.2%	 ±	 4.6%	 and	 only	 0.3%	 ±	 0.1%	 of	 the	 variants	 were	present	 at	more	 than	 1%.	 This	 again	 suggests	 that	 the	 rescued	 libraries	 were	relatively	mixed	evenly,	though	there	were	a	few	variants	overrepresented.		
Table	5.	3	Composition	of	the	variants	in	their	library	
Frequency	 DBCV1	 DBCV2	 DBCV3	 DBCV4	 DBCV5	 Average±SD	
<0.01%	 18.32%	 18.19%	 27.45%	 19.69%	 22.67%	 21.3%±3.9%	
0.01%-0.1%	 56.54%	 61.34%	 63.27%	 65.37%	 54.27%	 60.2%±4.6%	
0.1%-1%	 24.68%	 20.17%	 9.10%	 14.87%	 22.75%	 18.3±%6.3%	
>1%	 0.46%	 0.30%	 0.18%	 0.12%	 0.31%	 0.30%±0.1%	
	2.3.2.	Variants	independence	on	pigs	inoculation	
	In	 order	 to	 determine	 whether	 the	 >1%	 barcode	 variants	 in	 the	 stock	 also	remained	genetically	dominant	 in	 infected	pigs,	 the	 frequency	of	 those	variants	based	on	abundance	and	rank	in	the	donor	pigs	was	analysed	and	summarized	in	
Table	 5.4.	 The	 rank	 of	 variants	 varied	 from	 1	 to	 886	 and	 did	 not	 show	 any	advantage	in	pig	infection.		
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Table	5.	4	The	frequency	and	rank	of	the	dominant	variant	(>1%	in	viral	stock)	in	donor	pigs		
		 		 Animal	experiment	1	 Animal	experiment	2	
Variants	ID	 Stock	 DP1.1	 Rank	 DP1.2	 Rank	 DP1.3	 Rank	 DP2.1	 Rank	 DP2.2	 Rank	 DP2.3	 Rank	GTGTGGTGCAACC-BC3	 4.87%	 NA	 NA	 NA	 NA	 NA	 NA	 0.30%	 16	 0.25%	 41	 0.51%	 9	GGGTGGTGTAGCC-BC3	 3.36%	 NA	 NA	 0.95%	 12	 0.20%	 105	 0.30%	 15	 0.25%	 39	 0.70%	 2	AGGCAGTATGATT-BC5	 2.84%	 NA	 NA	 0.16%	 116	 NA	 NA	 0.64%	 3	 1.52%	 6	 0.72%	 1	ATATACTACGACC-BC1	 2.63%	 2.71%	 10	 0.04%	 561	 NA	 NA	 0.22%	 34	 0.17%	 56	 0.15%	 106	GGGTGGTGTGGTC-BC2	 2.43%	 NA	 NA	 0.17%	 104	 0.23%	 84	 0.09%	 227	 0.06%	 273	 0.09%	 199	AAACAACAAGACC-BC1	 1.88%	 NA	 NA	 0.13%	 159	 NA	 NA	 0.28%	 19	 0.11%	 103	 0.23%	 66	AAACACCAAAACC-BC2	 1.83%	 NA	 NA	 0.19%	 94	 0.10%	 190	 0.09%	 219	 0.08%	 187	 0.16%	 98	ATGTGGCACAATC-BC1	 1.60%	 NA	 NA	 0.02%	 775	 0.03%	 516	 0.32%	 11	 0.06%	 284	 0.19%	 77	AAGCGCCATAGCT-BC1	 1.58%	 NA	 NA	 1.75%	 5	 0.45%	 36	 0.27%	 20	 0.27%	 37	 0.06%	 373	GTGTGGTGTGGTC-BC3	 1.51%	 NA	 NA	 NA	 NA	 NA	 NA	 0.12%	 108	 0.04%	 395	 0.09%	 202	ATACGCTAAGACC-BC5	 1.43%	 NA	 NA	 0.08%	 285	 NA	 NA	 0.22%	 33	 0.31%	 35	 0.25%	 61	GGATGGTGCAATC-BC3	 1.37%	 NA	 NA	 0.02%	 722	 0.05%	 354	 0.08%	 262	 0.02%	 886	 0.03%	 727	GGGTAGTGTGGCC-BC5	 1.28%	 NA	 NA	 NA	 NA	 NA	 NA	 0.33%	 10	 0.57%	 30	 0.17%	 89	GGGTGGTGAAGCT-BC2	 1.28%	 NA	 NA	 0.07%	 313	 0.07%	 256	 0.13%	 94	 NA	 NA	 0.03%	 834	AAACAACAAAACC-BC4	 1.27%	 NA	 NA	 0.18%	 99	 NA	 NA	 0.18%	 54	 0.12%	 98	 0.28%	 47	GTGTGGTGCAACC-BC2	 1.27%	 NA	 NA	 NA	 NA	 NA	 NA	 0.09%	 187	 0.06%	 259	 0.10%	 162	GGGTGGTGCAGCT-BC4	 1.27%	 NA	 NA	 1.03%	 10	 NA	 NA	 0.17%	 61	 0.09%	 152	 0.17%	 86	GGGCAGTACAACC-BC5	 1.18%	 NA	 NA	 NA	 NA	 NA	 NA	 0.18%	 52	 0.25%	 40	 0.18%	 82	GGGTAGCGTGATC-BC1	 1.14%	 NA	 NA	 0.58%	 27	 0.26%	 72	 0.30%	 14	 0.06%	 244	 0.04%	 500	
Note:	Pigs	were	 infected	with	barcoded	 inoculum	 in	 two	pilot	 studies.	DP	denotes	donor	pigs.	The	proportion	of	 listed	variants	 from	1d.p.i	 (day	post	 infection)	 in	donor	pigs	 is	reported.	 The	 ranking	 order	 from	 top	 to	 bottom	 is	 based	 on	 the	 frequency	 of	 the	 variants	 present	 in	 the	 viral	 stock.	 The	 corresponding	 frequency	 of	 each	dominate	 variant	 in	different	 donor	 pigs	 from	 different	 animal	 experiments	 is	 listed.	 The	 value	 of	 frequency	 from	 high	 to	 low	 is	 highlighted	 based	 on	 a	 three-colour-scale	 (red-yellow-green).
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2.3.3	Analysis	of	variant	population	changes	during	the	rescue	and	
passaging	processes.	This	 section	 examines	 whether	 the	 rescue	 and	 passaging	 process	 altered	 the	relative	 distribution	 of	 the	 diversity	 region	wobble	 positions	 compared	 to	 the	starting	plasmid	library	used	in	the	rescue.		Two	questions	were	addressed	here:	1. Does	 rescue	 and	 amplification	 in	 cell	 culture	 result	 in	 a	 reproducible	change	 in	 the	 nucleotide	 bias	 at	 any	 of	 the	 diversity	 region	 nucleotide	positions	at	the	population	level?	2. Is	 there	 anything	 unusual	 about	 the	 variants	 that	 become	 predominant	over	 the	 course	 of	 passages	 1,	 2	 and	 3	 (i.e.	 indicative	 of	 variations	 in	replicative	fitness)?	The	 frequency	 of	 each	 synonymous	 substitution	 was	 plotted	 for	 the	 plasmid	libraries	 and	 the	 P3	 stocks,	 as	 shown	 in	 Figure	 5.5	 a-e.	 Comparing	 P3	 virus	stocks	with	 their	 cognate	plasmid	 libraries	 shows	 that	 there	were	 some	minor	changes	(up	and	down)	in	base	distribution,	but	there	was	no	consistent	pattern	at	 any	 particular	 nucleotide	 position	 across	 all	 5	 of	 stock	 populations.	 The	distribution	 did	 not	 differ	 significantly	 at	 any	 positions	 between	 the	 plasmid	libraries	 and	 their	 corresponding	P3	 viral	 library	 (p	 >	 0.05,	 paired	 t-test).	 This	indicates	 that	 at	 the	 population	 level,	 there	 was	 no	 obvious	 selection	 for,	 or	against,	a	particular	nucleotide	at	any	of	the	13	wobble	positions	of	the	diversity	region	 that	 occurred	 during	 the	 transition	 from	 the	 plasmid	 library	 to	 the	 P3	stock	preparation.		
Figure	 5.6	 is	 the	 logo	 plot	 summarising	 the	 base	 distribution	 for	 all	 of	 the	sequences	present	in	five	plasmid	libraries	(Figure	5.6a)	compared	with	that	for	all	the	variants	in	P3	virus	stocks	(Figure	5.6b).	The	comparison	with	only	those	variants	that	were	common	for	the	five	P3	stocks	(Figure	5.6d	cf.	5.6c)	appears	to	show	a	change	in	distribution	(nts	1,	3,	4,	5,	6,	7,	8).	However,	this	was	largely	(but	possibly	not	entirely)	accounted	for	when	compared	with	the	distribution	of	
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the	sequences	that	were	found	in	common	in	5	plasmid	libraries	(Figure	5.6c).	These	 nt	 positions	were	 then	 compared	with	 those	 of	 A/swine/England	 1353	(indicated	 below	 the	 logos)	 in	 order	 to	 determine	 whether	 this	 reflected	 a	reversion	 towards	 the	WT	 sequence.	 Four	 positions	 (nt	 3,	 5,	 6	 and	 8)	 tended	towards	the	wild	type	at	these	positions	(Figure	5.6d),	whereas	the	others	(nt	1,	4	and	7)	did	not.	Thus,	there	was	no	convincing	evidence	that	the	barcode	region	was	 undergoing	 significant	 change	 towards	 the	 wt	 sequence	 or	 any	 other	sequence	at	the	population	level.	
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Figure	5.	5	Comparison	of	the	substitution	distributions	of	the	diversity	regions	wobble	bases	for	the	
five	plasmid	libraries	and	resultant	P3	virus	stocks	The	left	column	of	each	pair	corresponds	to	the	plasmid	libraries	while	the	right	to	the	P3	viral	libraries.	(a-e)	DBCV1-5.	
d	
e	
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c	
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Figure	 5.	 6	 Analysis	 of	 the	 substitution	 distribution	 of	 all	 pooled	 detected	 variants	 and	 common	
variants	in	five	libraries	in	their	plasmid	library	and	P3	stock	library.	The	 logo	 font	 height	 represents	 the	 frequency	 (ranked	 top	 to	 bottom)	 of	 the	 base	 substitutions	 at	 the	indicated	nucleotide	positions	in	the	chosen	population.	
2.4.	Whole	genome	sequencing	of	the	P3	libraries	The	 rescue	 and	passaging	procedures	were	 expected	 to	 produce	 some	 level	 of	sequence	 variation	 in	 the	 backbone	 due	 to	 spontaneous	 mutations	 occurring	during	 replication	 due	 to	 the	 error-prone	 influenza	 viral	 polymerase,	 although	the	 original	 virus	 stocks	 were	 generated	 from	 plasmids	 that	 presumably	provided	 a	 constant	 cloned	 backbone.	 It	 is	 therefore	 important	 to	 assess	 this	variation	in	the	stocks	by	determining	the	whole	viral	genomic	sequence.	
	2.4.1.	Mutation	detection	All	eight	segments	were	sequenced	completely,	from	which	100%	coverage	was	obtained	 for	 each	 influenza	 genome	 of	 this	 study.	For	 each	 viral	 segment,	polymorphisms	occurring	at	≥	5%	were	examined.		As	shown	in	Table	5.5,	four	mutations	in	different	genome	segments	were	detected.	A	deletion	in	PB1_pos30	was	present	at	14%	in	the	DBC4V	stock	but	absent	(i.e.	<	5%)	from	other	stocks.	Likewise,	 a	 K136N	 mutation	 in	 HA	 was	 observed	 at	 5.8%	 only	 in	 the	 DBC3V	stock.	 However,	 three	 mutations	 were	 observed	 consistently	 in	 all	 5	 stocks:	W406R	(segment	3,	PA),	D72A	and	S486A	(segment	5,	NP).	
Table	5.	5	Mutation	detection	in	each	library	
Segment	 aa_Pos	 wt	 Mutation	 DBCV1	 DBCV2	 DBCV3	 DBCV4	 DBCV5	2	 30	 	 deletion	 	 	 	 14%	 	3	 406	 T(W)	 A(R)	 6.5%	 12.0%	 13.6%	 4.2%	 7.9%	4	 136	 G(K)	 T(N)	 	 	 5.8%	 	 	5	 72	 A(D)	 C(A)	 7.7%	 15.1%	 11.6%	 8.3%	 11.2%	5	 486	 T(S)	 G(A)	 7.7%	 7.2%	 6.5%	 6.9%	 4.4%	
a	 b	
c	 d	
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3.	Discussion	
3.1	Spurious	variants	and	abundance	threshold	setting.	Next	generation	sequencing	(NGS)	provides	a	rapid	and	cost-effective	approach	to	 investigate	 viral	 evolutionary	 events	 such	 as	 bottleneck	 size	 and	 selection	[171].	However,	the	errors	generated	during	sample	preparation	or	sequencing	contribute	 to	 the	difficulty	 in	distinguishing	 the	genuine	barcode	variants	 from	the	errors[172].	It	is	well-known	that	there	are	at	least	four	stages	where	errors	can	 be	 introduced:	 replication	 errors	 made	 by	 the	 influenza	 viral	 polymerase	itself	 (unexpected	 but	 nevertheless	 “genuine”	 viral	 sequences),	 reverse	transcription	(RT)	errors	during	cDNA	synthesis,	Taq	polymerase	errors	during	polymerase	 chain	 reaction	 (PCR)	 amplification	 steps,	 and	 nucleotide	 miscall	from	the	sequencing	platform.	The	RT	and	PCR	stages	are	error	prone,	which	is	more	 dependent	 on	 the	 fidelity	 of	 the	 enzyme	 and	 the	 number	 of	 cycles.	 PCR	error	 is	 a	 cumulative	 process,	 as	 a	 mutation	 introduced	 into	 one	 template	 is	passed	 on	 to	 its	 progeny	 that	 becomes	 the	 new	 templates	 in	 later	 cycles.	Therefore,	the	number	of	errors	increases	with	increasing	the	number	of	cycles.	In	 terms	 of	 the	 errors	 introduced	 by	 the	 Illumina	 platform,	 there	 is	 a	measurement	 of	 quality	 score	 assigned	 to	 every	 sequencing	 base.	 A	 “Phred	score”	of	30	was	applied	as	quality	control	in	this	study,	which	means	that	there	is	a	1	in	1,000	probability	of	the	base	being	called	incorrectly	[173].	Furthermore,	it	has	been	reported	that	certain	motifs	(e.g.	GGC	or	GGX)	shown	more	common	base	 miscall	 errors	 on	 the	 Illumina	 platform	 and	 there	 are	 other	 less	 well	understood	template	features	associated	with	increased	sequencing	errors	[174].		The	 technical	 replicates	 of	 the	 stock	 viruses	 are	 essential	 to	 identify	 the	threshold	 accuracy	 of	 the	 errors	 mentioned	 above.	 Firstly,	 samples	 had	undergone	 PCR	 cycles	 (enrichment	 stage	 ×	 25	 cycles	 and	 another	 10	 cycles	 of	tagging	 the	 Illumina	 adapters).	 The	 RT	 and	 PCR	 process	 is	 error	 prone	 (error	rate:	 approximately	1	 in	17,000-30,000	 for	RT	and	1	 in	5.3	×	10−7	 for	Q5	DNA	polymerase)	[175,	176],	and	thus	there	was	a	rare	chance	to	get	the	same	early	
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RT	 and	 PCR	 errors	 in	 both	 technical	 replicates.	 If	 great	 differences	 in	 the	frequency	 of	 barcoded	 variants	 between	 two	 replicates	 were	 observed,	 one	barcoded	 variant	 would	 presumably	 have	 had	 the	 error	 introduced	 at	 RNA	synthesis	or	at	an	early	stage	of	PCR	amplification.	As	shown	 in	Figure	5.1,	no	discordant	variant	with	high	frequency	was	observed	in	a	replicate	of	any	of	the	five	 viral	 stocks.	 The	 errors	 caused	by	 late	 stage	PCR	and/or	 sequencing	were	more	 abundant	 but	 the	 spurious	 sequences	 generated	 by	 late	 stage	 PCR	 and	sequencing	without	enormous	amplification	should	have	relatively	few	reads.	In	this	case,	it	is	feasible	to	set	a	read	threshold	to	remove	the	erroneous	variants.	As	shown	 in	Table	5.1,	 the	concordance	of	 common	variants	observed	 in	both	replicate	 samples	 increased	 to	around	90%	with	 increasing	abundance	up	 to	a	threshold	of	4	reads.	This	pattern	match	method	with	relatively	higher	threshold	should	be	sufficient	for	estimating	the	variants	size	but	cannot	distinguish	all	the	genius	or	spurious	variants.		In	Figure	5.4,	the	similar	frequency	of	each	barcoded	virus	presents	in	P2	and	P3	suggests	that	no	obvious	strong	selection	was	observed	during	the	amplification	of	five	stocks	on	MDCK	cells.	This	finding	is	well	aligned	with	a	previous	study	by	Varble	 et	 al.	 [108].	 A	 relative	 inconsistency	 was	 observed	 between	 P1	 and	 P2	stocks.	It	is	possible	that	these	changes	were	not	causally	related	to	the	barcode	sequence,	but	were	instead	merely	passengers,	linked	to	other	changes	occurring	elsewhere.	 For	 instance,	 a	 particular	 barcode	 variant	 present	 in	 a	 virus	with	 a	spontaneous	 beneficial	 mutation	 in	 HA	 might	 well	 be	 expected	 to	 increase	 in	frequency.	 The	 opposite	 would	 be	 the	 case	 if	 the	 spontaneous	 mutation	 was	detrimental.	 Another	 reason	 behind	 the	 inconsistency	 could	 be	 a	 technical	artefact.	 In	 particular,	 some	 residual	 plasmid	 DNA	 used	 in	 the	 rescue	 could	remained	at	detectable	 levels	 in	P1	and	was	amplified	by	PCR,	 (although	every	effort	 was	 made	 to	 minimize	 or	 remove	 this	 by	 washing	 post-transfection,	filtering/pelleting	of	the	293T	cells	and	subsequent	dilution	in	culture	medium,	and	DNA	treatment	of	the	RNA	during	the	extraction).	With	further	dilution	with	increasing	passage,	the	plasmid	DNA	would	be	out	of	the	detection	in	PCR.		It	was	 found	 that	 the	distribution	of	 synonymous	bases	at	each	position	of	 the	barcode	region	 in	 the	viral	population	was	 inherent	 to	 the	base	distribution	 in	
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the	plasmid	library,	and	also	there	was	no	significant	selective	advantage	for	any	synonymous	 base	 in	 the	 rescued	 virus	 population,	 after	 the	 stock	 virus	 was	grown	on	MDCK	cells	for	three	passages.	The	sequences	present	in	the	plasmid	library	did	not	show	the	exact	1:2	or	1:3	ratio	at	each	position	expected	from	the	mixed	 base	 synthesis,	 e.g.	 there	 was	 a	 consistent	 under-representation	 of	adenines	at	DR	locus	2.	This	bias	was	probably	caused	by	DR	oligos	synthesis.	The	NGS	analysis	of	each	DBCV_1353	found	that	the	majority	of	barcoded	viruses	were	 present	 at	 0.01-0.1%	 and	 2-4	 members	 at	 1%-5%.	 This	 could	 be	 a	reflection	of	virus	fitness	differences	either	due	to	the	barcode	itself,	or	through	its	linkage	to	other	adaptive	mutations.	Alternatively,	it	could	be	due	to	variation	in	cell-to-cell	yield	during	the	virus	rescue	process	without	any	consequences	on	virus	fitness.	Recent	reports	suggest	that	even	in	apparently	uniform	cell	culture	situations,	 there	 is	remarkable	heterogeneity	 in	 terms	of	virus	gene	expression	(and	presumably	yield).	This	~500-fold	variation	also	raises	 the	concern	about	how	the	presence	of	dominant	variants	might	produce	a	significantly	unbalanced	viral	 distribution	 on	 the	 donor	 pigs,	 which	 might	 complicate	 interpreting	 the	data	for	transmission	dynamics.	The	frequency	and	rank	were	tracked	for	all	the	variants	>	1%	within	the	stocks,	showing	that	the	dominant	variants	in	the	stock	did	not	show	obvious	advantage	when	they	infected	donor	pigs.	
3.6	Mutations	detected	from	P3	stock	by	whole	genomic	sequencing	The	barcoded	 virus	 stocks	were	 generated	by	 transfecting	 plasmid	 libraries	 of	8000	variants,	but	only	a	subset	(~2000)	of	the	potential	variants	were	rescued	(it	was	 anticipated	 theoretically	 that	 this	 number	 should	 be	 close	 to	 the	 8000	maximum).	 It	 is	 therefore	 necessary	 to	 confirm	 whether	 these	 variants	represented	a	sub-population	of	more	readily	rescued	sequences	or	a	bottleneck	of	 some	 sort.	 	 The	 analysis	 reveals	 no	 specific	 enrichment	 at	 any	 particular	position	within	 the	barcode	and	 the	abundance	of	each	of	 the	rescued	variants	was	 relatively	 evenly	 distributed	 in	 the	 population.	 WGS	 was	 therefore	performed	 to	 look	 for	 the	 evidence	 of	 mutation	 selection	 elsewhere	 in	 the	genome.	
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Previous	studies	have	suggested	0.5-5%	[177,	178]	as	a	threshold	to	confidently	determine	the	actual	presence	of	a	variant.	Therefore	it	was	concentrated	on	the	threshold	≥	5%.	Each	of	 the	mutations	observed	at	>	5%	was	 the	one	 that	has	been	observed	before	and	shown	to	have	a	phenotypic	effect	on	the	virus.	Seg4	K136N	 (A/CA/7/09)	 derived	 from	 Brandt’s	 voles	 showed	 a	 reduced	 viral	replication	on	MDCK	cells	compared	with	the	wild	type	strain	[179].	In	contrast,	Hailong	 et	 al.	 reported	 that	 the	 three	 mutations	 (K136N,	 S200P,	 and	D239G)	were	 found	after	 a	 single	passage	 in	 the	A/CA/04/09	strain	 (reference	FJ966082.1)	 in	 embryonated	 eggs	 and	 the	 K136N	mutation	 showed	 increased	virus	 growth	 in	 eggs	 and	 MDCK	 cells	 [180,	 181]	 which	 may	 explain	 why	 this	mutant	was	detected	at	around	5%	in	one	of	the	P3	virus	populations	(P3DBCV3).	The	 seg5	 S486A	 mutant	 has	 shown	 a	 defect	 in	 polymerase	 activity,	 RNP	formation	 and	 viral	 replication[170].	 Amino-acid	 A72	 on	 NP	 is	 located	 in	 the	RNA-binding	groove	and	is	involved	in	the	packaging	of	vRNA	segment	into	virus	[182].	The	D72A	mutation	has	been	shown	to	cause	viral	growth	defects	with	no	apparent	 effect	 on	 genome	 replication	 and	 transcription,	 and	 also	 affect	 the	efficient	 incorporation	 of	 multiple	 viral-RNA	 (vRNA)	 segments	 into	 progeny	virions	 [183].	 Besides	 the	 contentious	 phenotype	 associated	 with	 the	 K136N	mutation	 in	 HA,	 other	 two	mutations	 were	 expected	 to	 cause	 defects	 in	 virus	propagation	in	MDCK	cells.	So	the	appearance	of	these	two	mutations	in	all	five	of	 the	 P3	 stocks	 here	 was	 unexpected.	 One	 possibility	 is	 that	 they	 were	preferentially	selected	in	293T	cells	at	the	time	of	rescue	and	were	not	selected	in	MDCK	cells	at	all	(indeed	they	might	be	 in	decline	–	sequencing	of	P1	and	P2	stocks	could	be	helpful	in	resolving	this).	Alternatively	they	could	be	maintained	stably	in	the	population	despite	their	predicted	defects.	The	presence	of	a	frame-shift	 mutation	 in	 PB1	 at	 a	 frequency	 of	 14%	 in	 P3DBCV4	 was	 even	 more	surprising	 as	 this	 should	 be	 completely	 defective	 for	 virus	 replication.	 This	suggests	 that	 under	 the	 culture	 conditions	 used	 for	 preparing	 the	 stocks,	sufficient	 co-infection	 occurred	 to	 allow	 the	 complementation	 of	 unfit	 or	 even	completely	defective	variants.	It	is	possible	that	these	mutations	were	relevant	to	the	small	number	of	relatively	high	frequency	variants	identified	in	the	barcode	analysis	(those	present	at	1	~5%).	It	was	expected	that	a	spontaneous	backbone	mutation	 conferring	 a	 selective	 advantage	 at	 any	 stage	 would	 initially	 be	
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associated	(i.e.	by	indirect	genetic	linkage)	with	a	particular	barcode	present	in	the	 same	 virus	 particle/infected	 cell.	 This	 linkage	would	 deteriorate	 rapidly	 if	the	mutation	and	the	barcodes	were	on	different	segments	and	would	be	rapidly	dispersed	 in	 subsequent	 co-infections	with	 other	 variants	 and	 backbones.	 The	relatively	small	number	and	overall	 frequency	of	 these	variants	are	unlikely	 to	affect	 the	utility	of	 the	barcode	 library	 for	monitoring	 transmission	chains,	but	they	 could	 reduce	 the	 accuracy	 of	 bottleneck	 calculations.	 In	 addition,	 the	presence	 of	 a	 small	 but	 significant	 number	 of	 potentially	 low-fitness	 variants	could	 result	 in	 an	 unexpected	 bottleneck	 if	 they	 were	 non-viable	 or	 rapidly	eliminated	when	inoculated	into	donor	pigs	in	vivo.	Therefore	it	is	also	of	interest	to	determine	whether	these	mutations	remain	in	the	infected	donor	pigs,	which	will	be	discussed	in	the	next	chapter.	
4.	Conclusion	
In	 this	chapter,	 the	characterization	of	viral	stocks	DBCV1-5	was	performed	by	NGS.	The	number	of	variants	in	each	stock	virus	was	estimated	by	setting	a	read	threshold	at	4	and	around	2000	variants	were	obtained	from	each	barcoded	viral	library.	 High	 correlation	 between	 P2	 and	 P3	 stocks	 suggests	 that	 the	 initial	rescued	 viruses	 stabilised	 after	 amplification	 on	MDCK	 cells.	 Therefore,	 the	 P3	virus	was	chosen	as	stock	for	 further	characterisation	and	use.	A	few	barcoded	members	 of	 the	 virus	 were	 >1%	 within	 the	 stock	 but	 those	 variants	 did	 not	display	 an	 advantage	 when	 infected	 into	 donor	 pigs.	 The	 assessment	 of	substitutions	 at	 each	 wobble	 positions	 in	 P3	 stock	 demonstrates	 that	 rescued	virus	relied	on	the	compositions	of	plasmid	rather	than	selection	during	rescue	or	replication	on	MDCK	cells.	WGS	of	stock	virus	shows	that	a	significant	number	of	spontaneous	(potentially	unfit)	mutations	were	maintained	in	the	cell	cultured	stocks.	These	 could	potentially	have	an	effect	on	experimental	 infection	 in	vivo	(i.e.	in	pigs).				
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The	rapid	global	evolution	of	influenza	virus	begins	with	the	mutations	that	arise	during	 individual	 infection.	 Analysing	 within-host	 and	 between-host	transmission	 can	 contribute	 to	 our	 understanding	 of	 the	 evolutionary	 and	epidemiological	factors	that	shape	the	global	evolution	of	influenza	virus.	It	has	been	 demonstrated	 in	 Chapter	 5	 that	 sequential	 passaging	 in	vitro	 (a	 form	 of	artificial	 transmission)	 can	 result	 in	 stable	 populations	 without	 substantial	bottlenecking	 or	 other	 confounding	 artefacts	 occurring.	 In	 this	 chapter	 the	barcoded	virus	was	further	employed	to	examine	its	transmission	dynamics	in	a	natural	host,	namely	pigs.	Two	pilot	experiments	were	conducted	in	pigs	to	test	the	 utility	 of	 the	 barcoded	 viruses	 to	 investigate	 viral	 transmission	 dynamics	between	 the	 donor	 and	 contact	 pigs.	 Transmission	 factors	 such	 as	 timing,	transmitted	 dose	 between	 animals,	 the	 possibility	 of	 recurrent	 transmission	events	 (super-infection),	 anatomical	 compartmentalisation	 and	 virus	 shedding	within	a	group	of	pigs	will	be	described	in	detail.	
1.	Results	
1.1	Comparison	of	RT	efficiency	by	using	different	reverse-transcriptase	
enzymes	and	different	amounts	of	carrier	RNA	In	order	to	optimise	the	efficiency	of	cDNA	synthesis	 for	detecting	very	 limited	amounts	 of	 vRNA	 extracted	 from	 swabs,	 the	 influence	 of	 the	 amount	 of	background	 RNA	 (poly-A	 carrier	 RNA)	 and	 different	 kinds	 of	 commercial	enzymes	were	 tested	with	 their	 corresponding	 reverse	 transcription	 system.	A	previous	study	[184]	 	reported	that	 	SuperScript	II	showed	the	best	capacity	to	transcribe	 higher	 levels	 of	 cDNA	 copies	 in	 a	 comparison	 with	 Sensiscript,	Omniscript,	SuperScript	III,	and	PowerScript,	when	the	target	gene	copy	number	was	low	(2.6	x103	copies/RT	reaction).	Therefore,	SuperScript	II,	SuperScript	IV,	RevertAid	 and	 RevertAid	 H	 minus	 (-)	 were	 used	 for	 testing	 the	 RT	 reaction	efficiency	 to	extend	 this	 comparison.	Figure	6.1b	demonstrates	 the	number	of	detectable	 cDNA	 copies	 of	 segment	 7	 (M	 gene)	 from	 the	 same	 quantity	 and	source	 of	 vRNA	 template,	 measured	 by	 five	 commercial	 RTase.	 These	 five	 RT	systems,	 all	 used	 a	 fixed	 background	 of	 1	 μg	 carrier	 RNA	 and	 2	 pmol	 gene	
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specific	 primer,	 but	 showed	 different	 performance	 to	 transcribe	 the	 same	template,	 varying	 from	 2.45×104	 to	 4.67×104	 copies.	 There	 is	 no	 statistical	difference	in	yield	by	using	the	commercial	transcriptase	(p>0.05,	two	sample	t-test)	 (Figure	 6.1b).	 However,	 RevertAid	 H-	 transcribed	 low	 copies	 of	 cDNA	better	than	other	systems	and	so	was	chosen	for	all	future	experiments.	The	original	SOP	 for	RNA	extraction	 from	virus	samples	used	by	APHA	did	not	routinely	include	carrier	RNA	as	it	was	believed	that	it	could	potentially	interfere	with	 subsequent	 sequencing	 analysis.	 This	 works	 satisfactorily	 for	 sequencing	high	 titre	 samples.	To	determine	 its	 impact	on	 the	efficiency	of	 recovering	 low	amounts	 of	 viral	 RNA	 from	 swab	 samples,	 a	 range	 of	 carrier	 RNA	 levels	were	tested	 in	 the	 RT	 reaction.	 Figure	 6.1a	 shows	 that	 omitting	 carrier	 RNA	drastically	decreases	the	level	of	signal.	No	precipitation	or	purification	steps	are	involved	 in	 the	 reaction,	 so	 this	 loss	 of	 RNA	 signal	 is	 probably	 due	 to	 RNA	adsorption	 onto	 the	 various	 plastic	 surfaces.	 Titrating	 carrier	 RNA	 shows	 a	positive	 dose	 response	which	 plateaued	 at	 2	 µg	 of	 carrier	 per	 extraction.	 This	clearly	 demonstrates	 the	 importance	 of	 including	 at	 least	 some	 carrier	RNA	 in	the	RT	reaction	 for	 low	RNA	titre	samples.	 	RNA	extraction	protocols	normally	include	 carrier	 RNA	 to	 prevent	 irreversible	 adsorption	 onto	 filters	 and	 also	 to	reduce	the	effect	of	any	residual	RNAses.	The	likelihood	of	similar	RNA	depletion	during	 the	 swab	 extraction	 and	 purification	 stage	 has	 led	 to	 the	 decision	 to	include	 the	 carrier	 from	 the	 earliest	 point	 of	 the	 extraction.	 Consultation	with	Illumina	 TechSupport	 confirmed	 that	 the	 inclusion	 of	 excessive	 carrier	 RNA	would	 be	 detrimental	 to	 the	 downstream	 RT	 and	 NGS	 MiSeq	 reactions.	 	 The	amount	of	carrier	 included	was	calculated	so	that	0.5	µg	carrier	RNA	would	be	carried	through	to	the	RT	step	of	the	processing	pipeline.	This	was	adopted	as	a	compromise	 to	 improve	vRNA	 recovery	by	 around	10	 fold,	without	 interfering	with	the	subsequent	sequencing	process. 
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Figure	6.	1	Background	RNA	and	commercial	RTases	effect	on	cDNA	synthesis.		(a)	Quantitative	PCR	was	performed	in	triplicate	on	the	samples	prepared	for	each	amount	of	background	RNA	ranging	from	0.5	to	4	μg.	Revert	Aid	was	used	in	all	conditions.	The	significant	difference	was	tested	between	0	μg	group	and	any	group	from	0.5	to	4	μg.	(*	p<0.05,	two-sample	t-test)	(b)	Quantitative	PCR	was	performed	in	triplicate	on	samples	prepared	from	the	same	template	RNA	with	the	commercial	RT	systems	SuperScript	II,	SuperScript	IV,	Revert	Aid	and	Revert	Aid	H	minus.	The	template	of	negative	control	is	0.5	µg	carrier	RNA	only.		
1.2	Analysis	of	virus	shedding	using	nasal	swabs	from	infected	pigs	The	 barcoded	 viruses	 were	 used	 to	 investigate	 direct	 inoculation	 and	 contact	transmission	parameters	 in	vivo.	 In	animal	experiment	1,	all	donor	and	contact	pigs	 were	 monitored	 daily,	 viral	 shedding	 was	 determined	 by	 qPCR	 and	 viral	composition	was	 defined	 by	 next	 generation	 sequencing	 (NGS)	 of	 the	 barcode	region.	 The	 titer	 of	 viral	 shedding	 from	1-14	d.p.i./d.p.c.	 in	 donor/contact	 pigs	was	initially	measured	by	Drew	Ramsay	at	the	APHA	(data	not	shown).	The	titres	were	expressed	in	terms	of	relative	equivalent	units	(REU)	of	viral	RNA	based	on	the	 cycle	 threshold	 (ct)	 value	 that	 was	 obtained	 for	 each	 sample	 relative	 to	 a	standard	curve	generated	from	a	dilution	series	of	infectious	virus	quantitated	in	
(b)	
(a)	
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standard	 infectivity	 titration	 (TCID50)	 in	 MDCK	 cells.	 Virus	 shedding	 was	detected	 from	 all	 infected	 pigs	 and	 contact	 recipients.	 Peak	 nasal	 shedding	occurred	 between	 2-5	 d.p.i	 in	 donor	 pigs	 (2-3	 REU	 log10)	 and	 1-6	 d.p.c	 (2-3	REU	 log10)	 in	 contact	 pigs,	 followed	 by	 low	 level	 shedding	 (0-1	 REU	 log10)	before	it	ceased	on	day	9	in	donor	pigs	and	day	8	in	contact	pigs.	This	pattern	of	 shedding	 using	 the	 barcoded	 stocks	 was	 essentially	 identical	 to	 that	observed	 in	 earlier	 experiments	 using	 wild-type	 A/swine/England/1353	[185].	Based	on	the	results	described	above,	the	barcode	analysis	was	focused	on	the	swabs	 collected	 from	1-5	 d.p.i/d.p.c.	 Inferred	 titres	 expressed	 in	 terms	 of	 REU	were	 deemed	 inappropriate	 for	 the	 barcode	 study.	 The	 copy	 number	 of	 viral	cDNA	 used	 for	 the	 NGS	 pipeline	 (relative	 to	 a	 standard	 curve	 produced	 using	known	 target	 concentration	 of	 plasmid	DNA	 template)	 for	 the	 triplicate	 swabs	was	determined	by	q-RT	PCR	and	is	shown	in	Figure	6.2.		Donor	pigs	DP1.2	and	DP1.3	 were	 found	 to	 shed	 between	 105	 –	 106	 copies	 (in	 10	 µl,	 the	 amount	entered	the	NGS)	at	the	peak	period	whereas	DP1.1	shed	10-100-fold	 less	than	these	other	 two	pigs.	This	demonstrates	 that	 there	was	a	substantial	degree	of	animal-to-animal	 variability	 even	 when	 a	 standard	 high	 dose	 inoculum	 was	administered.	All	three	contact	pigs	became	infected	(CP1.1-CP1.3)	
	
Figure	6.	2	Genome	copy	number	profile	over	time.	Genome	copy	number	profile	over	time.	Copy	number	value	refers	to	the	mean	number	of	cDNA	genome	copies	that	entered	the	NGS	sequencing	pipeline	for	each	time-point	(to	convert	these	figures	into	mean	genome	copies	per	swab,	multiply	by	factor	of	57).	
DP1.1	
DP1.2	
DP1.3	
CP1.1	
CP1.2	
CP1.3	
		 99	
1.3	Correlation	of	replicate	RNA	extraction,	cDNA	synthesis	and	NGS	
pipeline.	NGS	analysis	of	the	barcodes	from	swab	sample	RNAs	produced	a	large	data	set	with	 each	 individual	 variant	 defined	 by	 its	 ULI	 and	 diversity	 region	 tabulated	with	the	read	frequency	from	the	NGS	for	each	swab	replicate,	for	each	pig	and	on	 each	 day.	 (The	 full	 table	 can	 be	 accessed	 from	 this	 URL	https://drive.google.com/open?id=10_WnWviXoKxH6McY6Io_Gffjrxwc6L7H	)	In	order	to	confirm	the	reproducibility	of	the	barcode	sequence	analysis	pipeline,	two	samples	were	prepared	from	the	same	RNA	source	and	subjected	to	NGS.	As	shown	in	Figure	6.3,	 the	replicates	were	highly	correlated	(Rs=0.99,	Spearman	correlation	 coefficients	 (Rs)).	 There	 were	 59	 variants	 were	 observed	 in	replicate1	 and	 52	 in	 replicate2,	 of	 which	 50	 variants	 were	 represent	 in	 both	replicates.	These	replicates	are	considered	to	be	essential	for	estimation	of	error	rate.	The	high	correlation	of	the	samples	from	the	same	nostril	confirms	that	the	variants	detected	were	real	and	also	this	is	a	robust	substrate	for	later	analysis.	
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Figure	6.	3	Two	replicates	of	sample	CP1.2_day1_swab	were	prepared	from	the	vRNA	stage	to	
examine	variability.	
1.4	Correlation	between	replicate	swabs	and	sequential	days	for	individual	
pigs	Two	 swabs	 were	 collected	 from	 each	 nostril	 in	 this	 first	 pig	 experiment.	However,	 information	 about	 the	 order	 and	 nostril	 position	 was	 not	 recorded.	One	 out	 of	 four	 swabs	 were	 processed	 for	 titration	 of	 viral	 pfu	 titer.	 The	remaining	 three	 swabs	 were	 processed	 through	 the	 NGS	 pipeline.	 The	 results	were	analysed	to	study	the	correlation	between	swab	replicates.	The	top	50	most	abundant	 barcoded	 variants	 within	 each	 swab	 from	 the	 same	 pig	 over	 a	 time	period	 of	 5	 days	 were	 plotted	 using	 the	 plot	 method	 developed	 to	 illustrate	variant	 presence	 and	 abundance	 in	 Figure	 6.4.	 In	 all	 cases	 where	 sequences	from	 three	 swab	 samples	were	 available,	 two	 out	 of	 the	 three	 correlated	well	whereas	the	third	was	similar	but	correlated	significantly	less	well.	Clearly	two	distinct	 viral	 populations	 were	 present	 within	 the	 three	 swab	 replicates.	 To	further	 verify	 this	 observation,	 Spearman	 correlation	 coefficients	 (Rs)	 of	 all	detected	barcoded	variants	amongst	replicate	swabs	were	analysed.	 	As	shown	in	Table	6.1,	 among	 the	28	groups	of	 collected	 samples,	23	groups	have	 three	replicates	and	5	have	only	two	replicates	(due	to	failed	amplifications	on	the	low	titre	 samples).	 Significant	 correlations	 (p	 <	 0.05)	 between	 two	 replicates	were	found	in	19	of	23	groups	that	had	three	replicates	(highlighted	in	green).	Those	four	that	did	not	attain	statistically	significant	correlation	(highlighted	in	yellow)	were	 low	 titre	 samples	 including	 DP1.1_Day2,	 DP1.1_Day4,	 CP1.1_Day3	 and	CP1.3_Day1.	 	Nevertheless,	 these	4	swabs	showed	a	significant	correlation	(p	<	0.05)	 with	 the	 swabs	 collected	 from	 their	 corresponding	 sequential	 days,	 as	shown	 in	 Table	 S6.1.	 These	 results	 suggest	 that	 the	 two	 highly	 correlated	samples	 may	 come	 from	 the	 same	 nostril	 and	 if	 so,	 each	 nostril	 has	 its	 own	established	 population	 of	 variants	 that	 are	maintained	 for	 the	 duration	 of	 the	experiment.	This	was	colloquially	referred	to	as	“the	nostril	effect”.	A	 second	experiment	was	performed	 to	 confirm	 the	 inoculum	bottlenecking	 in	the	 donors	 and	 to	 further	 investigate	 whether	 distinct	 barcoded	 populations	could	 be	 detected	 in	 different	 anatomical	 sites	 (confirming	 and	 expanding	 the	
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“nostril	 effect”).	 	 This	 time,	 careful	 note	 was	 made	 regarding	 the	 order	 and	location	 from	which	 the	 swabs	were	 taken.	 These	 results	 are	 shown	 in	Table	
6.2.2	 and	 Figure	 6.4.	 Due	 to	 the	 significant	 correlation	 between	 the	same/different	nostril(s),	Fisher’s	r	to	z	transformation	was	applied	to	compare	the	 values	 of	 Rs	 between	 the	 same	 and	 different	 nostrils,	 showing	 that	 the	correlation	 of	 swabs	 collected	 from	 the	 same	 nostril	 was	 more	 strongly	correlated	 than	 those	 in	 the	 different	 nostrils	 (p	 <	 0.01,	 Fisher’s	 r	 to	 z	transformation)	 in	 almost	 all	 the	 cases,	 except	 DP2.1_Day1	 and	 DP2.2_Day2	(0.62	vs	0.58;	0.56	vs	0.54).	Moreover,	in	two	pilot	studies	it	was	also	found	that	the	two	nostril	populations	maintained	distinct	over	the	time	period	of	5	days	in	
Tables	6.1	and	6.2,	which	suggests	that	the	viral	population	did	not	mix	across	nostrils	over	the	course	of	the	study.		
Table	6.	1	Correlation	among	nostrils	in	the	first	pig	pilot	study	
Sample	ID	 Swab1	vs	2	 Swab1	vs	3	 Swab2	vs	3	DP1.1_Day2	 -0.701	 0.5	 -0.086	DP1.1_Day3	 0.820***	 -0.173	 0	DP1.1_Day4	 0.062	 0.082	 -0.301	DP1.1_Day5	 0.687*	 0.252	 -0.417	DP1.2_Day1	 0.726***	 -0.006	 -0.006	DP1.2_Day2	 0.037	 0.055	 0.815***	DP1.2_Day3	 -0.185	 0.715***	 0.017	DP1.2_Day4	 0.858***	 0.126	 0.081	DP1.2_Day5	 -0.231	 -0.636*	 0.753***	DP1.3_Day1	 -	 0.159	 -	DP1.3_Day2	 -	 -	 -0.137	DP1.3_Day3	 0.181	 0.264	 0.773***	DP1.3_Day4	 0.118	 0.502**	 0.487***	DP1.3_Day5	 0.564	 0.575	 0.814***	CP1.1_Day2	 -	 -	 0.435**	CP1.1_Day3	 -0.31	 0.147	 -0.112	CP1.1_Day4	 0.11	 0.835***	 0.435**	CP1.1_Day5	 0.785***	 0.542**	 0.415*	CP1.2_Day1	 0.073	 0.3	 1.000***	CP1.2_Day2	 0.638	 0.972***	 -0.077	CP1.2_Day3	 -	 0.291	 -	CP1.2_Day4	 -0.257	 0.255	 0.693**	CP1.2_Day5	 0.177	 0.886***	 0.462	CP1.3_Day1	 -0.394	 0.242	 0.447	CP1.3_Day2	 0.451**	 -0.003	 -0.127	CP1.3_Day3	 -	 0.479***	 -	CP1.3_Day4	 0.341	 0.467	 0.946***	CP1.3_Day5	 0.037	 0.14	 0.938***	
Note:	Spearman	correlation	coefficients	(Rs)	are	used	to	describe	the	correlation	between	swabs.	*	p<0.05”;	**	p<0.01;	***p<0.001.	“-”	refers	to	a	missing	swab	comparison.	Correlation	can	be	verbally	described	as	the	strength	of	the	correlation	using	the	following	guide	for	the	absolute	value	of	Rs:	.00-.19		“very	weak”;	.20-.39	“weak”;	.40-.59	“moderate”;	.60-.79	“strong”;	.80-1.0	“very	strong”.				
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Table	6.	2	Correlation	among	nostrils	in	the	second	pig	pilot	study	
Sample	ID	 Rs_left	same			
(l1vs	l2)	
Rs_differ	
(l1	vs	r1)	
Rs_right	
same(r1	vs	r2)	
Rs_differ	
(l2	vs	r2)	DP2.1_Day1	 0.62***	 0.58***	 0.63***	 0.56***	DP2.1_Day2	 0.59***	 0.51***	 0.56***	 0.54***	DP2.1_Day3	 0.64***	 0.46***	 0.58***	 0.46***	DP2.1_Day4	 0.60***	 0.48***	 0.58***	 0.34***	DP2.2_Day1	 0.41***	 0.24***	 0.60***	 0.40***	DP2.2_Day2	 0.66***	 0.46***	 0.69***	 0.50***	DP2.2_Day3	 0.72***	 0.45***	 0.63***	 0.41***	DP2.2_Day4	 0.68***	 0.30***	 0.69***	 0.33***	DP2.3_Day1	 0.50***	 -	 -	 0.38***	DP2.3_Day2	 -	 0.20***	 0.61***	 -	DP2.3_Day3	 0.74***	 0.41***	 0.60***	 0.41***	DP2.3_Day4	 0.67***	 0.33***	 0.41***	 0.24***	
Note:	Rs_left	same	refers	to	the	Spearman	correlation	coefficients	of	the	left	side	nostril;	Rs_right	same	refers	to	the	right	side	nostril;	l1	and	r1	refers	to	the	first	swabs	collected	from	different	nostrils;	l2	vs	r2		refers	to	the	 second	 swabs	 collected	 from	different	 nostrils.	 *p<0.05”;	 **	p<0.01;***p<0.001.	 “-”refers	 to	 a	missing	swab	 comparison.	 Correlation	 can	 be	 described	 to	 indicate	 the	 strength	 of	 the	 correlation	 using	 the	following	guide	for	the	absolute	value	of	Rs:	 .00-.19	 	“very	weak”;	 .20-.39	“weak”;	 .40-.59	“moderate”;	.60-.79“strong”;	.80-1.0	“very	strong”.		
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Figure	6.	4	Top	50	most	abundant	variants	within	each	swab	from	each	pig	over	a	time	period	4	days	
or	5	days.			Each	scatter	plot	circle	size	and	color	indicates	read	count	for	the	indicated	day.	Each	circle	variant	locates	at	a	specific	position	on	the	y-axis	represents	one	variant,	therefore	the	same	variant	can	be	traced	at	the	same	height	on	y-axis	across	different	post	infection	days.	In	the	first	6	panels,	D	denotes	day	while	S1,	S2	and	S3	refer	to	swab	1,	swab	2	and	swab	3.	Read	count	is	expressed	as	the	log10	(abundance)	for	the	samples	from	the	first	animal	experiment	(DP1.1-1.3	and	CP1.1-1.3).	 	Two	swabs	collected	from	each	nostril	every	day	post-infection	for	the	second	pig	experiment.	L	refers	to	the	left	nostril	while	R	denotes	the	right	nostril.	1	and	2	refer	 to	 the	 first	and	second	swab	collected	 from	each	nostril	 respectively.	As	UMI	primers	were	used	 for	 cDNA	 synthesis	 for	 these	 samples,	 the	 abundance	 of	 each	 variant	 represented	 in	 the	 bottom	 3	panels	are	unaffected	by	subsequent	PCR	amplification	and	the	abundance	color	of	each	variant	is	shown	in	a	linear	scale.	
1.5	Virus	population	correlation	between	different	respiratory	sites		In	order	 to	 examine	how	viral	population	distribution	was	 correlated	between	different	 regions	 of	 the	 airways,	 nasal	 swabs,	 deep	 nasal	 swabs,	 upper	respiratory	tract,	lower	respiratory	tract,	lung	and	BALF	were	compared	for	each	
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pig.	The	successfully	amplified	viral	cDNA	from	nasal	swabs	and	tissue	from	each	pig	 are	 summarised	 in	Figure	6.5.	 	High	 correlation	 coefficients	 (RS	=	0.56-0.61	from	 DP2.1;	 RS	 =0.49-0.66	 from	 DP2.2;	 RS	 =	 0.41-0.66	 from	 DP2.3)	 were	observed	from	nasal	swab	populations	across	4	days	post	inoculation	(the	plots	in	Figure	6.5	compared	the	read	frequency	for	each	variant	for	each	pair	of	days	and	between	 each	 anatomical	 site.	A	 lower	but	 still	 significant	 correlation	was	found	between	deep	nasal	 tissue	and	 the	peripheral	nasal	swabs	on	4	d.p.i.	 (RS	=0.33	 from	DP2.2,	RS	=0.45	 from	DP2.3),	showing	that	 the	populations	 in	 these	sites	were	related.	However,	the	correlation	between	the	rest	of	the	respiratory	sites	was	shown	to	be	only	“weak”	or	“very	weak	“.	These	results	indicate	distinct	viral	populations	were	distributed	at	different	airway	 locations	and	 the	 spatial	distance	affected	the	viral	distribution.		
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Figure	 6.	 5	 Scatterplot	 Matrix	 of	 linear	 dependencies	 between	 different	 samples	 collected	 from	
different	respiratory	sites.		Bivariate	scatter	plots	matrix	shows	pair-wise	linear	correlations	on	the	left	hand	side	below	the	diagonal,	and	histograms	of	counts	vs	abundance	represented	on	 the	diagonal	as	well	as	 the	Spearman	correlation	numerical	 coefficients	described	 in	 the	 corresponding	chart	on	 the	 right	above	 the	diagonal.	 *p<0.05”;	 **	
p<0.01;***p<0.001	 .Linear	 regression	 fit	 is	 shown	 as	 red	 line	 in	 each	 scatter	 plot	which	 x	 and	 y	 are	 the	log10(abundance).	DP2.1	(data	only	available	for	comparison	across	days	for	nasal	swab	samples	and	lung	tissue;	DP2.2	and	DP2.3	data	available	for	multiple	tissues.			
1.6	Estimating	the	transmission	dose		One	of	 the	 key	questions	 –	 transmission	dose	was	 studied	here.	By	 comparing	the	starting	population	in	3	donors	with	those	present	after	transmission	to	the	contact	pigs,	the	possible	size	of	the	initial	direct	contact	transmission	dose	can	be	defined.	As	contact	pigs	were	 introduced	 to	 the	donor	pigs	 from	2	d.p.i,	 the	barcoded	variants	detected	 from	all	 three	swabs	of	donor	pigs	on	2	d.p.i.	were	believed	 to	 be	 the	 starting	 shed	population.	 There	were	 359	 variants	 found	 in	
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donor	 DP1.1,	 806	 variants	 in	 DP1.2	 and	 668	 variants	 in	 DP1.3.	 In	 total	 1750	different	variants	were	observed	from	three	different	donor	pigs	on	2	d.p.i.	Because	 contact	 pigs	were	 co-housed	with	donor	pigs	 from	2	d.p.i,	 the	73-151	barcoded	variants	observed	from	the	contact	pigs	on	1	d.p.c.	were	estimated	as	the	transmission	dose.	Table	6.3	demonstrates	the	number	of	barcoded	variants	observed	from	each	contact	pig	over	a	period	of	5	days.		
Table	6.	3	The	number	of	barcoded	variants	found	in	each	contact	pig	
d.p.c	 CP1.1	 																		CP1.2	 CP1.3	Day1	 /	 73	 151	Day2	 136		 81	 167	Day3	 123		 88	 133	Day4	 60		 49	 61	Day5	 73	 45	 71	
1.7	On-going	transmission	in	vivo	(super-infection)	As	 the	 virus	 can	 be	 traced,	 the	 analysis	 of	 how	 the	 barcoded	 variants	 changes	over	 the	 infection	period	can	be	performed.	The	 focus	was	put	on	 the	detailed	analysis	of	barcoded	variants	in	the	contact	pigs.	In	order	to	compare	the	change	of	 each	 variant	 over	 five	 days,	 the	 abundance	 was	 normalized	 by	 viral	 copy	numbers	 (frequency	 of	 each	 variant	 ×	 the	 viral	 total	 copy	 numbers	 recovered	from	 each	 pig)	 shown	 in	 the	 Figure	 6.6.	 Generally,	 a	 subset	 of	 variants	 that	newly	occurred	(especially	on	2-3	d.p.c)	was	observed	on	each	consecutive	post	contact	 day.	 These	 new	 variants	 contained	 both	 abundant	 and	 rare	 variants	(large	and	small	size	circles).	The	rare	variants	could	have	been	under-sampled	on	the	previous	days,	while	some	variants	with	high	abundance	within	the	newly	occurring	 population	 were	 less	 likely	 to	 be	 missed	 by	 under-sampling	 on	 the	previous	day	 (in	particular	 the	abundant	variants	 that	 appeared	on	 the	3	d,p,c	but	 disappeared	 on	 two	 preceding	 days	 consecutively	 (Figure	 6.6)).	 Two	explanations	were	 proposed	 as	 below	 for	 the	 abundant	 variants	within	 newly	occurring	population:	1)	Viral	variant	adaptation.	Some	variants	might	adapt	on	the	pigs	 and	 change	 their	 fitness,	 resulting	 in	 an	 increase	 in	 abundance	on	 the	following	 days;	 and	 2)	 The	 newly	 occurring	 variants	 could	 be	 the	 result	 of	ongoing	transmission	events.	Also,	this	explanation	can	also	be	applied	to	some	variants	that	were	found	at	low	abundance	on	1	d.p.c	or	2	d.p.c	and	then	became	more	abundant	in	the	following	days.		
		 110	
In	order	to	further	understand	the	newly	occurring	variants	on	the	contact	pigs,	the	relationship	between	new	variants	and	the	origin	of	those	in	the	donor	pigs	was	analysed.	It	was	assumed	that	all	the	variants	have	equal	ability	to	transmit	to	 the	 other	 pig.	 The	 variants	 in	 contact	 pig	 at	 each	 post	 infection	 day	 were	considered	to	be	related	to	the	variants	present	within	the	two	preceding	days	in	donor	pigs.	For	example,	as	contact	pigs	were	introduced	to	donor	pigs	on	2	d.p.i,	variants	in	the	contact	pigs	on	1	d.p.c	were	compared	to	the	variants	in	the	donor	pigs	on	2-3	d.p.i.	to	define	the	abundance	relationship	and	origin	of	infection.	Firstly,	each	variant	present	in	each	contact	pig	was	plotted	in	Figure	6.6a.	The	size	of	each	circle	indicates	the	abundance	of	the	variant	in	the	contact	pig.	The	newly	 occurring	 variants	were	 then	 coloured	with	 the	 abundance	 of	 the	 same	variant	present	 in	 the	donor	pigs.	 In	Figure	6.6a,	most	of	 the	newly	occurring	variants	on	1-2	d.p.c	were	shown	to	have	high	abundance	colour	(yellow	or	red)	in	donor	pigs.	But	this	phenomenon	was	not	obvious	on	3-4	d.p.c.	Notably,	some	abundant	variants	within	new	variants	in	contact	pigs	also	were	found	the	high	abundance	in	the	donor	pigs.	This	could	be	an	abundant	variant	in	the	donor	pig	that	 is	 repeatedly	 topping-up	 the	 same	 variant	 in	 the	 contact	 pig,	 suggesting	highly	 abundant	 variants	were	more	 successful	 at	 establishing	 the	 infection	 in	contact	pigs.	This	analysis	only	included	three	donor	pigs	as	infectious	sources,	but	the	contact	pigs	were	possibly	“donors	“to	each	other	as	well,	as	they	were	co-housed	together	during	the	transmission.	The	number	of	the	newly	occurring	variants	showing	high	abundance	colours	in	donor	pigs	was	reduced	on	3-4	d.p.c,	which	draws	the	question	regarding	whether	the	contact	pigs	also	play	a	role	as	infectious	origin.	This	will	be	discussed	at	the	end	of	this	section.	Secondly,	 in	 order	 to	 trace	 the	 infectious	 origin	 in	 newly	 occurring	 variants,	every	 variant	 was	 coloured	 by	 origin,	 shown	 in	 Figure	 6.6b.	 Due	 to	 the	overlapping	variants	present	in	each	donor	pig,	the	probability	was	assigned	to	each	donor	pig	according	to	normalised	viral	copies.	For	example,	if	one	variant	was	detected	 in	one	contact	pig,	and	this	variant	was	also	detected	90	reads,	9	reads	and	1	read	in	DP1.1,	DP1.2	and	DP1.3,	respectively,	then	the	possibility	of	donor	pig	DP1.1	 infect	 this	 contact	pig	was	 assigned	as	90%,	while	DP1.2	was	assign	as	9%	and	DP1.3	was	assigned	as	1%.	By	looking	at	the	variants	present	in	
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a	 contact	 pig	 on	 a	 certain	 day,	 the	 variants	 were	 assigned	 more	 than	 70%	probability	 in	a	donor	and	 then	 this	donor	was	defined	as	an	 infectious	origin.	Then,	the	number	of	newly	occurring	variants	was	analysed	and	compared	with	those	in	the	donor	pigs	at	different	post	infection	days.	If	on-going	transmission	did	not	occur,	variants	present	at	2-3	d.p.i	(the	day	contact	pigs	were	introduced	and	the	day	after)	should	be	the	 infection	source	 for	all	 contact	pigs.	 In	Figure	
6.6b,	the	new	variants	in	contact	pigs	were	coloured	based	on	viral	populations	in	donors	on	2-3d.p.i.		As	seen	from	this	figure,	some	of	the	variants	are	shown	as	“no	donor”.	However,	when	 the	newly	occurring	 variants	were	 compared	with	the	variants	present	 in	 the	2	preceding	days	 in	donor	pigs	 (for	example	newly	occurring	 variants	 on	 day	 2	 d.p.c	 vs	 variants	 from	 3-4	 d.p.i	 in	 donor	 pig),	 the	number	of	variants	shown	as	“no	donor”	were	reduced.	In	detail,	46,	30	and	51	variants	 present	 at	 2	 d.p.c	 in	 contact	 pigs	 were	 not	 present	 in	 the	 viral	population	on	2-3	d.p.i	in	donor	pigs.	This	number	reduced	from	46	to	11,	30	to	9,	51	to	15	when	they	were	compared	to	the	viral	population	on	3-4	d.p.i	in	donor	pigs.	 However,	 this	 phenomenon	 was	 not	 obvious	 when	 the	 viral	 populations	present	at	3	d.p.c	was	compared	to	2-3	d.p.i	or	4-5	d.p.i.	Specifically,	the	number	of	variants	in	contact	pigs	without	a	donor	pig	origin	dropped	from	10	to	6,	2	to	1	and	 24	 to	 23	 in	 contact	 pigs.	 This	 finding	 indicates	 that	 newly	 occurring	 viral	population	 was	 more	 related	 to	 the	 viral	 population	 within	 the	 2	 proceeding	days	 in	donor	pigs	 than	 the	 starting	 viral	 population	 in	donor	pigs,	 suggesting	the	possibility	of	super-infection	that	could	last	for	2	days.	Moreover,	 from	 Figure	 6.6,	 only	 a	 subset	 of	 variants	 was	 successfully	transmitted	on	sequential	days.	By	tracing	the	newly	occurring	viral	population	every	day,	I	found	that	the	viral	population	decreased	obviously	on	the	next	day	but	kept	a	relatively	stable	number	at	the	later	time	points	(for	example,	the	new	viral	population	 found	on	2	d.p.c	dropped	on	3d.p.c	but	maintained	 the	similar	numbers	on	4	d.p.c	and	5	d.p.c	in	CP1.1	and	CP1.2.	The	similar	story	happened	to	the	new	occurring	variants	found	on	3	d.p.c	 in	CP1.3).	Several	 factors	including	the	 interference	 of	 environmental	 virus	 and	 the	 probability	 of	 establishing	 a	successful	infection	or	immune	response	could	cause	this	phenomenon.			
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	 		(a)	
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		 (b)	
Figure	6.	6(a-b).	The	variant	composition	on	each	contact	pig	over	a	period	of	5	days.		Each	circle	represents	a	unique	variant	and	is	located	at	a	specific	position	on	the	y-axis	and	the	size	of	the	circle	represents	the	abundance	of	 that	variant	 in	donor	pigs.	(a)	the	new	occurring	variants	was	colored	according	 to	 the	 same	 variants’	 abundance	 in	 donor	 pigs.	 (b)	 the	 color	 of	 each	 newly	 occurring	 variant	indicates	the	infectious	source.		
                  
     70%<x<0 DP1.3 DP1.2 DP1.1 No donor 
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As	 all	 pigs	 were	 co-housed	 together,	 the	 three	 contact	 pigs	 could	 also	 act	 as	donor	 pigs	 for	 each	 other	 and	 therefore	 were	 analysed	 as	 possible	 infectious	sources.		The	newly	occurring	variants	were	compared	to	those	variants	present	on	 the	 2	 preceding	 days	 in	 all	 possible	 infectious	 sources.	 The	 relative	contribution	of	each	donor	pig	to	superinfection	of	a	contact	pig	is	presented	in	
Figure	6.7.	As	explained	above,	the	pig	in	which	the	variants	had	more	than	70%	probability	was	defined	as	infectious	source.	It	can	be	seen	that	DP1.2	and	DP1.3	were	 the	 main	 donors	 to	 cause	 a	 new	 infection.	 The	 majority	 of	 the	 variants	detected	from	the	contact	pigs	could	be	traced	back	to	a	specific	donor.	In	details,	DP1.2	transmitted	the	most	variants	to	each	contact	pig,	of	which	34	-	51(+5)	to	each	 contact	 pig	 on	 1	 d.p.c,	 30(+20)	 -	 66(+16)	 on	 2	 d.p.c,	 4(+1)-31(+23)	 on	 3	d.p.c	and	1(+1)	-	1(9)	on	4	d.p.c	for	all	contact	pigs.	DP	1.3	shed	the	second	most	variants	 to	 each	 contact	 pig	 including	 20-45(+5)	 variants	 on	 1	 d.p.c,	 7(+20)	 -	31(+7)	 on	 2	 d.p.c,	 0(+1)	 -35(+7)	 on	 3	 d.p.c	 and	 2(+1)	 -	 2(+9).	 The	 number	 of	variants	with	multiple	 donors	 is	 shown	 in	 the	brackets.	DP	1.1	 and	 all	 contact	pigs	did	not	contribute	an	obvious	number	of	variants	to	each	contact	pig	across	4	days.		Notably,	 variants	 exchanged	 between	 CP1.1	 and	 CP1.3	 were	 observed	 on	 2-3	d.p.c.	 Inevitably	 the	 variants	 in	 the	 contact	 pigs	 were	 also	 in	 the	 donors.	Therefore,	 it	 has	 become	 clearly	 necessary	 to	 study	 whether	 the	 infectious	source	 of	 these	 exchanged	 variants	 is	 a	 donor	 pig	 or	 a	 contact	 pig.	 So	 the	correlation	of	the	transmitted	variants	was	compared	with	donor	pigs,	and	CP1.1	or	CP1.3	(variants	from	2	preceding	days).	It	can	be	seen	from	Table	6.4	that	the	correlation	 between	 contact	 pigs	 1.1	 and	 1.3	 was	 higher	 than	 when	 it	 was	compared	 with	 any	 donor	 pigs	 on	 2	 d.p.c.	 suggesting	 contact	 pigs	 can	 be	 the	infectious	sources.	On	2	d.p.c	(4	d.p.i),	the	titer	of	virus	started	to	drop	in	donor	pigs	while	a	high	viral	titer	was	observed	in	contact	pigs	(Figure	6.2).	The	viral	variants	in	the	donor	pigs	began	to	be	cleared	but	the	one	that	has	successfully	established	 in	 the	 contact	 pigs	 started	 to	 boost	 the	 yield	 and	 became	 a	 new	infectious	source.	The	correlation	between	contact	pigs	on	2-3	d.p.c	also	suggests	on-going	transmission.	This	together	with	numerous	new	variants	occurring	on	2-3d.p.c	 suggests	 that	 the	 time	 window	 of	 on-going	 transmission	 is	 around	 2	days.	
		 117	
	
Table	6.	4	The	correlation	(Rs)	of	newly	occurring	variants	with	donors	and	recipients	
		
	
	 CP	1.3_2d.p.c	 CP	1.1_2d.p.c	 CP	1.3_3d.p.c	 CP	1.1_3d.p.c	DP1.1	 0.39	 0.49	 -0.03	 -0.17	DP1.2	 0.56	 0.4	 0.44	 0.31	DP1.3	 0.47	 0.41	 0.82	 0	CP1.1	 0.94	 /	 0.94	 0.89	CP1.3	 /	 0.76	 /	 /	
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Figure	6.7	The	summarized	transmission	source	of	the	newly	occurring	variants	on	each	day	after	
contact	with	donor	pigs.			Yellow	 circles	 represent	 the	 potential	 infectious	 sources	 for	 a	 contact	 pig	 at	 different	 d.p.c.	 Red	 circles	indicate	a	specific	contact	pig.	The	arrow	thickness	is	the	weight	of	the	probability	that	the	variants	found	in	the	contact	pig	are	derived	from	the	indicated	donor.	The	number	of	these	variants	were	shed	is	shown	on	the	 grey	 line.	 To	note,	 the	number	of	 variants	 is	 the	number	of	 new	barcoded	variants	 on	 each	day	 in	 a	contact	pig.	Number	below	each	graph	is	the	total	number	of	new	variants/number	of	variants	with	a	single	donor/number	of	variants	with	multiple	donors/number	of	variants	without	a	donor.	
1.8	Inoculation	bottleneck		As	mentioned	above,	 around	300-800	variants	were	detected	 from	each	donor	pig.	 This	 unexpected	observation	 indicates	 that	 the	diversity	 in	 the	donor	pigs	was	 lower	 than	 expected,	 as	 around	 6000	 variants	 were	 detected	 in	 the	inoculum,	 suggesting	 that	 there	 is	 a	 severe	 “direct	 inoculation”	 bottleneck.	However,	the	second	pig	experiment	was	then	repeated	to	detect	the	population	
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size	 of	 barcoded	 virus	 from	 donors	 and	 revealed	 approximately	 2000-3500	variants,	 as	 shown	 in	 Table	 6.5.	 (The	 improvement	 of	 this	 pilot	 study	 was	mentioned	in	Chapter	2)	
Table	6.	5	The	number	of	barcoded	variants	detected	on	the	donor	pigs	
d.p.i	 DP1.1	 DP1.2	 DP1.3	 DP2.1	 DP2.2	 DP2.3	
Day1	 /	 610	 618	 3165	 2782	 2419	
Day2	 359	 806	 668	 3379	 2656	 2813	
Day3	 489	 592	 482	 2971	 2532	 3393	
Day4	 291	 412	 348	 3240	 2479	 3409	
Day5	 262	 473	 383	 	 	 	The	reduction	 in	viral	diversity	 from	inoculation	of	 the	donor	pigs	put	 forward	another	question	as	to	whether	the	rescued	virus	requires	certain	mutations	to	infect	pigs	more	efficiently.	Therefore	 the	whole	genomic	 sequence	 (WGS)	of	barcoded	 viruses	 in	 the	 stock	 and	 donor	 pigs	 (from	 DP1.3	 1-3	 d.p.i.)	 was	undertaken.	Table	6.6	shows	the	genotypic	differences	in	amino	acids	between	stocks	and	donor	pigs	1-3	d.p.i.	Three	consistent	mutations	were	observed	in	five	stocks,	 but	only	 the	mutation	on	Seg5:	486	was	observed	on	1-3d.p.i.	 in	DP1.3	whereas	the	mutation	Seg3:	406	and	Seg5:	72	were	not	passed	successfully	into	the	donor	pigs.	Strikingly,	two	significant	mutations	of	around	23%	synonymous	change	were	observed	on	donor	DP1.3	on	3	d.p.i.	The	rest	of	detected	mutations	ranged	 <15%	 were	 detected	 once	 but	 disappeared	 on	 the	 following	 day.	 No	nucleotide	changed	consistently	or	accumulatively	at	any	specific	position	in	the	donor	pig	for	3	days.	Moreover,	three	abundant	deletions	were	observed	in	the	stocks	and	some	deletions	were	found	to	be	transient	on	one	day	in	the	donor.	These	deletions/mutations	disappeared	immediately	on	the	next	day,	suggesting	that	the	deletions	and	mutations	made	up	a	significant	proportion	to	reduce	viral	diversity	during	viral	replication	and	reassortment.		
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Table	6.	6	Mutation	>5%	in	viral	stock	and	donor	pigs	
Segment	 aa	Position	 wt	 Mutation	 DBCV1	 DBCV2	 DBCV3	 DBCV4	 DBCV5	 DP1.3_D1	 DP1.3_D2	 DP1.3_D3	
1	 432	 A(His)	 G(Arg)	 0.40%	 0.30%	 0.50%	 0.40%	 0.40%	 8.20%	 0.50%	 0.20%	
1	 437	 T(His)	 C(His)	 0.10%	 0.10%	 0.00%	 0.10%	 0.10%	 0.30%	 0.00%	 23.10%	1	 692	 A	 Deletion	 0.10%	 1.00%	 0.10%	 5.20%	 0.20%	 0.00%	 0.10%	 0.10%	2	 10	 A	 Deletion	 0.50%	 1.70%	 0.50%	 14.20%	 0.70%	 0.00%	 4.90%	 0.00%	2	 137	 A(Gln)	 G(Pro)	 0.10%	 0.10%	 0.10%	 0.10%	 0.10%	 12.70%	 0.00%	 0.00%	
2	 444	 C(Ser)	 A(Ser)	 0.30%	 0.10%	 0.10%	 0.10%	 0.10%	 7.60%	 0.30%	 1.10%	2	 515	 C(Ser)	 A(Tyr)	 0.10%	 0.10%	 0.10%	 0.20%	 0.00%	 6.30%	 0.00%	 0.20%	2	 678	 C	 Deletion	 0.10%	 0.20%	 0.10%	 0.20%	 0.10%	 0.00%	 5.30%	 0.30%	2	 733	 G	 Deletion	 0.10%	 0.10%	 0.20%	 9.80%	 0.10%	 0.40%	 0.10%	 0.70%	
3	 172	 A(Lys)	 G(Lys)	 0.10%	 0.10%	 0.00%	 0.10%	 0.10%	 0.00%	 0.00%	 5.30%	
3	 193	 G(Gln)	 A(Gln)	 0.20%	 0.10%	 0.10%	 0.10%	 0.10%	 10.90%	 0.00%	 0.00%	3	 344	 A(Glu)	 G(Gly)	 0.20%	 0.20%	 0.10%	 0.20%	 0.20%	 12.00%	 0.00%	 1.80%	3	 377	 A	 Deletion	 0.10%	 0.10%	 0.10%	 0.10%	 0.10%	 0.00%	 5.60%	 0.30%	3	 406	 T(Trp)	 A(Arg)	 6.50%	 12.00%	 13.60%	 4.20%	 7.90%	 0.00%	 0.00%	 0.20%	
3	 464	 C(Tyr)	 T(Tyr)	 0.10%	 0.10%	 0.10%	 0.10%	 0.00%	 0.00%	 0.20%	 5.10%	3	 658	 T	 Deletion	 0.30%	 0.40%	 0.20%	 0.30%	 0.30%	 6.50%	 0.10%	 1.10%	3	 662	 C(Ser)	 A(Stop)	 0.10%	 0.10%	 0.10%	 0.10%	 0.00%	 7.90%	 0.00%	 0.00%	4	 42	 A	 Deletion	 0.10%	 0.30%	 0.10%	 0.10%	 0.00%	 11.10%	 0.00%	 0.00%	
4	 113	 C(Ile)	 				A(Ile)	 0.10%	 0.10%	 0.10%	 0.10%	 0.10%	 6.20%	 0.00%	 0.40%	
4	 136	 G(Lys)	 		T(Asn)	 0.10%	 0.50%	 0.10%	 0.10%	 0.10%	 5.10%	 1.20%	 3.10%	4	 146	 A(Asn)	 		G(Ser)	 0.20%	 0.10%	 0.10%	 0.10%	 0.10%	 6.80%	 0.10%	 0.10%	
4	 222	 A(Arg)	 		G(Gly)	 0.10%	 0.20%	 0.10%	 0.10%	 0.10%	 9.50%	 0.00%	 0.20%	
4	 405	 A(Thr)	 C(Thr)	 0.10%	 0.10%	 0.10%	 0.10%	 0.10%	 5.50%	 0.00%	 0.00%	4	 434	 A(Asp)	 G(Gly)	 0.10%	 0.40%	 0.10%	 0.20%	 0.10%	 6.60%	 0.20%	 0.20%	
5	 72	 A(Asp)	 		C(Ala)	 7.70%	 15.10%	 11.60%	 8.30%	 11.20%	 0.60%	 0.60%	 0.80%	
5	 486	 T(Ser)	 G(Ala)	 7.70%	 7.20%	 6.50%	 6.90%	 4.40%	 4.50%	 4.80%	 6.10%	
6	 378	 C(Asn)	 T(Asn)	 0.10%	 0.10%	 0.10%	 0.10%	 0.10%	 2.20%	 1.80%	 23.00%	
Note:		The	mutations	have	been	reported	in	literatures	are	highlighted	in	bold.	Lethal	changes	such	as	deletions	are	highlighted	in	red.	Silent	mutations	are	highlighted	in	italicise.	Mutation	frequency	in	the	corresponding	stock	or	post	infection	day	also	listed	in	grey	colour.	
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2.	Discussion	
2.1	District	populations	in	different	airway	sites	A	high	correlation	between	two	swabs	was	observed	 from	the	 first	pilot	study,	suggesting	 that	 these	 swabs	might	 come	 from	 the	 same	 nostril	 by	 challenging	pigs	 with	 barcoded	 viruses,	 although	 the	 swabs	 did	 not	 necessarily	 provide	information	 regarding	 nostril	 sources.	 To	 confirm	 this	 observation,	 two	 swabs	collected	from	each	known	nostril	were	carried	out	in	the	second	pig	experiment.	This	analysis	also	depicts	a	higher	correlation	of	swabs	collected	from	the	same	nostril	compared	to	the	other	nostril.	The	results	from	the	two	pig	experiments	suggest	 that	 the	 viral	 populations	 present	 in	 the	 left	 and	 right	 nostril	 swab	samples	 from	 the	pigs	 contained	distinct	populations.	As	 shown	 in	Figure	6.8,	the	 pig	 nose	 is	 long	 and	 its	 sputum	 separates	 the	 nasal	 cavity	 very	well.	 This	structure	prevents	mucus	from	mixing	between	the	two	nostrils.	Once	the	virus	is	trapped	in	the	epithelial	mucus	of	the	nasal	cavity,	 the	mucociliary	clearance	mechanism	 starts	 to	 remove	 the	 pathogens	 [186],	 and	 then	 other	 non-specific	immune	defence	(interferon,	macrophages,	etc.)	could	be	activated	to	eliminate	the	virus	locally	and	prevent	local	spread,	resulting	in	discrete	populations	in	the	separated	spaces.		Interestingly,	with	increasing	time	after	the	primary	inoculation	the	correlation	between	viral	populations	from	the	two	nostrils	(Rs)	did	not	show	an	increasing	trend.	 	Two	pig	experiments	also	show	that	 free	mixing	from	one	nostril	 to	the	other	did	not	readily	occur	during	the	peak	virus	shedding	period.		
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Figure	6.8.	Cross	section	of	the	nasal	cavity	of	pig.		Download	 from	 http://slideplayer.com/slide/10025248/,“Pig	 anatomy”	 by	 Dr.	 Suraj	 kumar	 and	 Yolmari	Cruz.		As	 mentioned	 in	 the	 Introduction	 section,	 the	 same	 strain	 of	 SIV	 showed	different	 preferable	 attachment	 at	 different	 respiratory	 tract	 sites	 in	 the	 pigs.	The	 difference	 between	 tissues	 could	 have	 an	 important	 impact	 on	 viral	replication	and	evolution.	However,	to	the	best	of	my	knowledge,	there	have	not	been	 previous	 studies	 that	 have	 investigated	 viral	 population	 distribution	 in	different	 respiratory	 tract	 sites	 using	 NGS.	 Therefore,	 the	 developed	 barcoded	viruses	comprising	a	large	number	of	known	variants	have	provided	a	useful	tool	for	 studying	 viral	 distribution.	 The	 viral	 population	 from	 the	 same	 tissues	 in	different	 pigs	 show	 poor	 correlation,	 suggesting	 distinct	 viral	 populations	 in	different	 sites.	 Varble	 et	 al.	 [108]	 detected	 significant	 correlation	 in	 viral	populations	 between	nasal	washes	 but	 not	 in	 the	 bronchus	 (two	discrete	 viral	populations	were	also	detected	in	the	two	tissues),	which	is	consistent	with	the	present	 findings.	 As	 reported	 in	 another	 oseltamivir-resistant	 influenza	 study,	different	variants	of	resistant	virus	were	observed	in	the	right	and	left	lung	[101]	
2.2	The	typical	transmission	size	from	donor	to	recipient	in	direct	contact	Pigs’	natural	living	environment	(co-housing	the	naïve	pigs	with	the	donors)	was	mimicked	to	study	how	the	virus	 is	 transmitted	among	pig	populations.	One	of	the	important	parameters	of	transmission	is	to	define	a	transmission	dose.	In	the	present	 study,	 73	 -151	 variants	 could	 be	 transmitted	 from	 the	 donor	 pigs	 to	contact	 pigs.	 The	 analysis	 of	 individual	 pigs	 shows	 there	 were	 300-800	different	variants	 in	donor	pigs	on	2	d.p.i.	As	 for	contact	pigs,	 the	analysis	of	viral	 populations	 demonstrates	 the	 possibility	 of	 super-infection,	 although	 a	fitness	 change	 cannot	 be	 excluded.	 As	 mentioned	 in	 section	 2.7,	 the	 super-infection	 time	window	was	 estimated	 to	 be	 around	2	days	 post	 contact	with	donors.	Within	that	time	period,	DP1.2	and	DP1.3	transmitted	the	variants	to	contact	pigs,	around	30-60	on	2	d.p.c	and	20-50	variants	on	3	d.p.c.	A	similar	finding	was	previously	reported	by	Varble	et	al.	[108]	and	Frise	et	al.	[116]	in	direct	 contact	 ferret	 experiments.	 In	 Varble	 et	 al.’s	 study,	 100	 traceable	variants	were	 used	 and	7-24	 variants	were	 found	 to	 transmit	 from	donor	 to	contact	 recipient.	Murcia	 et	al.	 also	 reported	 that	 there	was	 a	 strikingly	 loose	
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transmission	bottlenecks	in	their	equine	and	pig	studies	[109-111].	Overall,	this	has	demonstrated	that	there	 is	a	 loose	bottleneck	in	the	natural	environment	of	pigs.	Loose	transmission	doesn’t	significantly	impact	the	variant	frequencies.	The	 composition	 of	 the	 founding	 population	 in	 the	 recipient	 more	 closely	matches	 that	 present	 in	 the	 donor	 at	 the	 time	 of	 transmission,	 benefiting	 the	maintenance	of	the	diversity	within	the	viral	population.			In	 addition,	1700	different	 variants	observed	 in	 the	 three	 contact	pigs,	 each	of	them	was	 defined	with	 around	 300,	 600	 and	 800	 different	 variants.	 It	 can	 be	seen	that	there	was	less	overlapped	variants	in	three	donors.	When	virus	infects	a	pig,	it	seems	that	there	is	stochastic	mechanism	of	virus	settling	down	and	then	replication.	 It	 is	 tempting	 to	 speculate	 that	 similar	 to	 the	 left	 and	 right	 nostril	observation,	 distinct	 populations	 in	 each	 anatomical	 location	 are	 established	independently	 upon	 direct	 inoculation	 and	 relatively	 little	 cross-site	 mixing	occurs.		
2.3	Ongoing	transmission		Another	observation	in	the	transmission	study	was	the	super-infection	among	pigs.	 Two	 previous	 studies	 have	 also	 indicated	 the	 super-infection	 in	 ferret	studies	 [108,	 116].	 In	 this	 study,	 four	 analysis	 listed	 below	 suggests	 the	possibility	 of	 super-infection	 and	 the	 time	 window	 of	 2	 days,	 although	 the	possibility	 of	 environmental	 contamination	 and	 fitness	 change	 could	 not	 be		excluded:	 1)	 the	 newly	 occurring	 variants	 including	 very	 high	 abundance	variants	that	were	less	likely	to	be	under-sampled	were	observed	mainly	at	1-3	d.p.c;	 2)	most	 of	 	 newly	 occurring	 variants	 on	1-2	d.p.c	 showed	 the	 same	high	abundance	 colour	 (yellow	 or	 red)	 as	 donor	 pigs;	 3)	 newly	 occurring	 viral	populations	were	more	 related	 to	 the	 viral	 population	within	 the	 2	 preceding	days	 in	 donor	 pigs	 than	 the	 starting	 viral	 population	 of	 donor	 pigs;	 and	 4)	infection	between	contact	pigs	were	observed	between	2-3	d.p.c	.		Additionally,	only	a	small	number	of	newly	occurring	variants	were	successfully	maintained	to	the	next	day.	This	result	reveals	that	the	bottleneck	occurred	in	a	microenvironment	 at	 the	 beginning	 of	 infection,	 as	 a	 large	 number	 of	 variants	shed	successfully	to	a	new	pig	but	only	a	small	portion	of	them	were	amplified	in	
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subsequent	 day	 samples.	 This	 also	 indicates	 a	 bottleneck	 of	 establishing	 a	successful	 rate	 within	 the	 host.	 Natural	 barriers,	 such	 as	 mucus	 and	 immune	responses	may	 play	 an	 important	 role	 in	 this,	 though	 under-sampling	 and	 the	effect	 of	 environmental	 virus	 (such	 as	 some	 barcoded	 virus	 in	 the	 pig	 faeces	were	 collected)	 could	not	 be	 excluded.	 The	 interferon	 system	and	non-specific	inhibitor	are	 two	earliest	known	host	defences,	which	are	responsible	 for	viral	infection	within	hours	[187].	A	non-specific	 inhibitor	could	flow	to	the	 infected	area	 and	 suppress	 the	 local	 virus	 growth,	 while	 some	 of	 viral	 variants	 could	escape	to	relocate	and	replicate	[188].	This	could	eliminate	some	of	the	variants	and	thus	result	in	the	disappearance	of	these	variants	in	the	following	days.		Moreover,	 the	 total	 number	of	 variants	was	 found	 to	decrease	dramatically	 on	day	 3	 or	 4	 d.p.c.	 (Table	 6.5)	 One	 explanation	 could	 be	 that	 virus	 specific	cytotoxic	 T	 lymphocytes	 (CTLs),	 believed	 to	 prevent	 viral	 multiplication,	occurring	as	early	as	3	to	4	days	after	initiation	of	a	viral	infection	[187].		These	three	observations	together	strongly	suggest	complex	transmission	events	within	 pig	 populations.	 Ongoing	 transmission	 occurred	 for	 2	 days.	 During	 this	time	 period,	 non-specific	 immune	 responses	 started	 to	 clear	 viruses	 locally.	Whilst	viral	titer	remained	at	a	similar	 level	(2-3	REU	log10)	 in	the	contact	pigs	on	 2-3	 d.p.i/d.p.c,	 the	 virus	 populations	maintained	 dynamic	 equilibrium	with	some	 variants	 disappearing	 while	 new	 infections	 appeared.	 With	 increasing	infection	 days	 to	 3-4	 days,	 the	 specific	 immune	 response	 began	 to	 activate	 to	reduce	the	number	of	viruses.	By	day	4,	transmissions	probably	did	not	occur.		The	 infectious	 source	 analysis	 describes	 a	 complexity	 of	 transmission	 in	 the	natural	 pig	 living	 environment.	 The	 contact	 pigs	 can	 be	 infected	 each	 other,	suggesting	that	flu	virus	could	transmit	from	side	round,	forward,	backward	to	their	recipients	within	the	pig	population.	That	is	to	say,	all	 the	pigs	could	be	“donor”	 and	 “recipient”	 at	 the	 same	 time	 during	 virus	 transmission.	 In	 this	case,	some	unfit	variants	could	gain	fitness	on	the	other	pigs	and	transfer	back	to	increase	viral	diversity.	Therefore,	these	multiple	transmission	events	could	enlarge	 the	 viral	 diversity	 and	 reassortment,	 which	 drives	 the	 concern	 that	
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infection	occurs	as	waves	and	increases	the	virus	circulating	time	in	the	large	pig	population.		
2.4	Inoculation	bottleneck		Unexpectedly,	 there	 was	 a	 significant	 reduction	 in	 viral	 diversity	 from	inoculation	 stock	 to	donor	pigs.	Approximately	6000	genotype	variants	were	detected	in	the	viral	inoculum	while	only	part	of	this	population	succeeded	in	establishing	productive	infection	in	donors	in	two	animal	experiments.	Whole	genomic	sequencing	results	demonstrated	that	no	sustained	aa	coding	changes	occurred	within	DP1.3	during	days	1-3	d.p.i.	Therefore,	this	finding	eliminates	the	 concern	 that	 the	 rescued	 virus	 requires	 certain	mutations	 to	 infect	 pigs	more	efficiently.	However,	the	coding	changes	and	deletions	were	detected	in	the	 stock	 virus	 but	 became	 absent	 in	 the	 donor	 pigs,	 indicating	 that	 these	mutations	 could	 be	 responsible	 for	 the	 loss	 of	 some	 diversity	 due	 to	 a	reduction	 of	 infection	 efficiency	 in	 donor	 pigs.	 Moreover,	 most	 of	 the	 14	mutations	observed	in	the	donor	pig	on	1	d.p.i	were	swept	away	or	diminished	on	2	d.p.i	(e.g.	seg1:	aa432,	seg4:	aa146	and	seg4:	aa222).	2	out	of	14	mutations	[189]	 [190]	were	 reported	 to	 reduce	viral	 infectivity	 and	both	were	 lost	 from	1d.p.i.	in	the	analysis.	Overall,	the	spike	in	frequency	of	these	variants	in	DP1.3	on	 1	 d.p.i	 suggests	 that	 it	 could	 be	 a	 founder-effect	 of	 the	 initial	 infection,	followed	by	selective	elimination.	Only	one	mutation	(seg5:	aa486)	occurring	to	all	five	stocks	persisted	1-3	d.p.i	in	the	donor	pig,	but	mutation	did	not	increase	in	abundance,	indicating	this	was	a	neutral	phenotypic	change.			The	second	pilot	study	found	that	more	virus	could	be	detected	in	donor	pigs.	Technical	 problems[100]	 may	 have	 dramatically	 reduced	 the	 viral	 diversity	detected	 after	 inoculation,	 such	 as	 not	 using	 carrier	 RNA	 in	 the	 viral	 RNA	extraction	 in	 the	 first	 experiment.	 The	 carrier	 RNA	was	 not	 used	 in	 the	 first	study	carried	out	by	our	collaborators	because	it	may	interfere	with	later	NGS	sequencing.	 It	was	shown	 that	 the	yield	could	be	 increased	10-fold	when	 the	carrier	 RNA	 was	 present	 during	 extraction	 and	 the	 RT	 step,	 suggesting	 the	importance	of	carrier	RNA	during	viral	extraction.	Therefore	anther	pig	study	was	 designed	 to	 re-assess	 inoculation	 efficiency.	 Some	 modifications	 were	
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applied	 to	 the	 sample	 preparation.	 In	 the	 first	 pilot	 study,	 each	 swab	 was	diluted	in	2	ml	and	only	140	ul	was	extracted	for	the	experiment.	In	the	second	pilot	study,	all	vRNA	 from	each	swab	was	extracted	by	Trizol,	which	boosted	around	10	times	the	viral	yield	detected	by	our	collaborators.	The	second	pilot	study,	 in	 which	 around	 2000-3000	 variants	 were	 detected	 in	 donor	 pigs,	reveals	 the	 improved	ability	 to	define	more	variants	 in	donor	pigs.	However,	the	around	1700	different	variants	detected	 from	donor	pigs	 in	pilot	 study	1	were	 sufficient	 to	 detect	whether	 there	was	 a	 loose	 or	 tight	 bottleneck	 from	donor	to	contact	pigs.	
3.	Conclusion	This	 chapter	 has	 investigated	 a	 few	 important	 factors	 including	 spatial	structure,	 transmitted	 dose	 between	 animals,	 possibility	 of	 on-going	transmission	 events	 and	 virus	 shedding	 within	 a	 herd	 of	 pigs	 during	transmission.	Distinct	viral	populations	have	been	found	at	different	respiratory	sites,	 even	 distributed	 differently	 in	 different	 nostrils.	 When	 the	 contact	 pigs	were	co-housed	with	the	donor	pigs,	a	complex	transmission	sequence	of	event	was	observed.	Donor	pigs	could	continuously	infect	contacted	pigs	for	around	2	days,	 and	 all	 pigs	 could	 act	 as	 “donors”	 or	 “recipients”	 during	 transmission	within	the	pig	population.	 In	direct	contact	 transmission,	70-150	variants	were	found	 in	 a	 contact	 pig	when	 it	 co-housed	with	 3	 donor	pigs,	 and	 round	 30-60	variants	on	2	d.p.c.	 and	20-50	variants	on	3	d.p.c.	were	 shed	 from	 individual	donor	to	a	contact	pig,	suggesting	that	there	is	a	loose	transmission	dose	among	pigs.		
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Chapter	7	
General	discussion	
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1.	Discussion	
The	introduction	of	genetically	inserted	unique	sequence	tags	(“barcodes”)	into	viral	 genomes	 is	 a	 powerful	 tool	 for	 studying	 replication	 and	 transmission	dynamics	 in	vitro	 and	 in	vivo.	 This	 thesis	 describes	 the	 production	 and	 use	 of	barcoded	influenza	viruses.		
1.1	Why	did	I	generate	a	large	number	of	barcoded	viruses?	There	are	predominantly	three	routes	of	 flu	transmission:	respiratory	droplets,	aerosol	transmission	and	direct	contact	with	secretions	of	infected	individuals	or	contaminated	fomites	[191].	For	the	successful	establishment	of	influenza	virus	replication	some	criteria	should	be	met.	For	example,	 the	virus	must	 reach	 the	target	cells	of	the	new	host	in	sufficient	numbers	(transmission	doses)	to	cause	an	initial	infection	[191].	Some	studies	based	on	ferrets	have	demonstrated	that	the	 bottleneck	 size	was	wider	 during	 direct	 contact	 than	 aerosol	 transmission	[108,	116].	A	previous	human	study	estimated	that	typical	aerosol	transmission	doses	of	100-200	infectious	virions	was	required	for	successful	infection	during	the	H1N1	2009	pandemic,	by	detecting	the	shared	SNVs	in	donor-recipient	pairs	[192].	Virus	transmission	doses	can	also	be	implied	from	barcoded	virus	studies	even	when	 the	number	of	 variants	used	 is	 fewer	 than	 the	 typical	 transmission	size.	 However,	 the	 most	 accurate	 estimate	 is	 obtained	 when	 the	 number	 of	variants	 exceeds	 the	 typical	 transmission	 dose	 size.	 This	 also	 enhances	 the	sensitivity	 to	 detect	 super-infection	 events	 and	 higher	 resolution	 tissue	compartmentalization	 phenomena.	 Therefore,	 in	 this	 study,	 a	 large	 number	 of	barcoded	 viruses	 are	 required	 to	 investigate	 the	 typical	 transmission	 dose	 in	direct	contact	amongst	co-housed	pigs.		
1.2	The	advantages	and	disadvantages	of	the	barcode	system		Previous	 studies	 have	 struck	 a	 comparison	 between	 the	 analytical	 potential	 of	the	 system	 and	 the	 logistics	 of	 preparing	 libraries	 with	 a	 large	 number	 of	barcodes.	 For	 example,	 Varble	 inserted	 over	 100	 22nt	 barcodes	 into	 influenza	virus	 using	 an	 effective	 strategy	 involving	 restructuring	 the	 splicing	 signals	 of	segment	 7	 to	 allow	 the	 insertion	 of	 barcodes	 between	 the	 NS1	 and	NEP	 open	
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reading	 frames	 and	 defined	 each.	 The	 advantage	 of	 this	 approach	 is	 that	 each	known	barcoded	virus	can	be	mixed	equivalently	 to	 form	the	starting	material.	However,	 this	 is	a	 labour-intensive	approach	involving	construction	and	rescue	of	 many	 individual	 clones.	 Additionally,	 another	 limitation	 of	 this	 approach	 is	that	it	is	restricted	to	those	segments	that	tolerate	such	rearrangement	without	detriment	to	the	virus.		Our	strategy	exploits	codon	degeneracy	and	tolerance	of	synonymous	mutations	demonstrated	by	variation	in	the	natural	population.	I	combined	the	benefits	of	using	 specific	 error-correctable	 barcodes	 to	 provide	 definitive	 source	identification	(the	ULI	component)	with	a	high	density	of	synonymous	variation	(the	 diversity	 region)	 within	 a	 single	 element	 capable	 of	 being	 efficiently	amplified	and	sequenced	by	 Illumina	NGS.	 In	 this	design,	 the	“unique	 identifier	region”	 could	 be	 identified	 in	 a	 virus	 population	 while	 the	 “diversity	 region”	could	allow	me	to	count	the	identified	viruses	within	a	viral	population.	This	has	made	 it	 logistically	 simple	 to	 generate	 thousands	of	 distinct	 variants	 (with	 the	capacity	 to	generate	many	tens	of	 thousands	 if	 required).	The	approach	can	be	applied	to	any	single,	or	any	combination	of	the	8	virus	segments	(and	indeed	to	any	virus	for	which	sufficient	natural	sequence	variation	is	known).		In	 two	 pilot	 animal	 studies,	 the	 inoculum	 is	 composed	 of	 a	 mixture	 of	 all	 5	libraries.	This	has	allowed	variants	 to	 compete	against	 each	other	and	 then	be	analysed	 to	 determine	 if	 particular	 ULIs	 or	 variants	 unexpectedly	 altered	 in	frequency/presence.	 This	 did	 potentially	 compromise	 the	 ability	 to	 trace	 the	pigs’	responsible	for	transmission,	as	each	pig	was	infected	with	an	overlapping	mixture	of	all	5	libraries.	Nevertheless,	even	with	this	confounding	factor,	it	was	still	 possible	 to	 trace	 the	 donors,	 and	 also	 produce	 a	 reasonably	 accurate	estimate	of	the	transmission	dose	and	observe	super-infection	events.		In	future	studies,	mixing	 the	 libraries	won’t	be	warranted	and	 individual	donor	pigs	can	each	receive	a	unique	library,	which	should	substantially	improve	the	analytical	power	of	the	system.		However,	 the	 limitation	 of	 this	 system	was	 that	 the	members	 of	 the	 barcoded	variant	 population	were	 not	mixed	 as	 expectedly.	 The	 random	 combination	 of	
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introduced	 synonymous	 substitutions	 has	 the	 risk	 of	 generating	 dominant	barcoded	 variants	 in	 the	 mixed	 population.	 Also,	 the	 genotype	 of	 produced	barcoded	 variants	 is	 unknown	 and	 needed	 to	 be	 confirmed	 by	 NGS.	 But	 PCR	artefacts	and	NGS	sequencing	errors	contribute	to	the	difficulty	of	distinguishing	the	genuine	variants,	especially	for	low	abundant	variants.	
1.3	Is	it	essential	to	use	such	large	number	of	variants?		As	more	variants	are	included	in	a	study,	the	data	becomes	more	complicated	to	analyse	 and	 interpret.	 Currently	 13	wobble	 positions	were	 chosen	 to	 define	 a	barcoded	 variant.	 The	 inoculation	 bottleneck	 was	 observed	 from	 inoculum	 to	donor	pigs	and	the	typical	transmission	dose	was	defined	as	30-60	on	2	d.p.c	and	20-50	 on	 3	 d.p.c	 between	 single	 donor	 –	 recipient	 transmission,	 when	 6000	variants	were	prepared	 for	 the	experiment.	 If	 the	wobble	positions	 included	 in	the	 analysis	 dropped	 from	 13	 to	 6,	 there	 would	 be	 100	 barcoded	 variants	 in	theory.	Re-analysing	 the	 same	data	 set	by	using	6	positions	has	 found	 that	 the	inoculation	 bottleneck	was	 not	 obvious	 and	 the	 typical	 transmission	 dose	was	around	 10.	 Next,	 the	 barcoded	 system	 will	 be	 optimized	 to	 define	 number	 of	barcodes	that	will	not	affect	the	analysis	result	but	become	more	user-friendly.	
1.4	Bioinformatics	data	analysis	The	greatest	challenge	of	 this	study	was	 to	define	an	appropriate	method	 for	the	 analysis	 of	 the	 NGS	 data.	 Sequencing	 based	 techniques	 depend	 on	 the	amplification	 to	 increase	 the	 amount	 of	 samples.	 A	 lot	 of	 artificial	mutations	can	 be	 generated	 during	 the	 amplification.	 A	 high	 similarity	 in	 the	 diversity	region	 has	 made	 it	 difficult	 to	 distinguish	 the	 real	 variants,	 especially	 for	starting	 templates	with	 low	 viral	 loads.	 Prior	 to	 testing	 the	 entire	 set	 of	 the	swab	samples,	 the	 cDNA	synthesis	without	 carrier	RNA	was	amplified	 for	32	cycles	 to	 reach	 the	 required	 amount	 of	 DNA	 for	 NGS	 and	 the	 stock	 samples	were	 amplified	 by	 25	 cycles.	 These	 different	 amplification	 cycles	 will	 have	caused	 different	 percentages	 of	 the	 artificial	 variants.	 The	 pattern	 match	analysis	 demonstrates	 a	 large	 number	 of	 low	 read	 frequency	 “shadow	variants”	 in	 the	 data-set	 (i.e.	 variants	 within	 one	 nucleotide	 change	 of	 an	abundant	variant).	A	minimal	spanning	network	was	used	to	plot	the	variants	
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for	 stocks	 and	 swabs.	 It	 is	 clear	 that	 there	 were	 a	 number	 of	 sub-variants	surrounding	 the	 dominant	 variants,	 the	majority	 of	which	 had	 few	 sequence	reads,	 indicating	artificial	variants	may	have	arisen	spontaneously	during	the	PCR	amplification	stage.	This	problem	was	likely	to	be	more	severe	when	the	starting	 titre	 of	 the	 virus	 swab	was	 low.	 Therefore	 carrier	 RNA	was	 used	 to	increase	 the	 starting	 amount	 of	 vRNA.	 Meanwhile,	 a	 method	 for	 selectively	filtering	 out	 these	 variants	 was	 required.	 The	 pattern	 match	 method	 and	DADA2	showed	similar	results	when	used	to	analyse	the	stock	virus	(25	cycles	amplification)	 but	 different	 results	 for	 the	 swab	 analyses	 (32	 cycles	amplification).	The	swabs	collected	from	the	first	pilot	study	were	analysed	by	DADA2	 because	 DADA2	 performed	 better	 in	 removing	 artefacts	 than	 the	pattern	match	method.		The	 analysis	 of	 minimal	 spanning	 network	 of	 the	 samples	 processed	 by	pattern	 match	 has	 revealed	 that	 a	 few	 of	 the	 potentially	 artificial	 variants	remained.	These	variants	shared	a	common	character	which	was	one	genetic	distance	 from	the	 top	5	dominant	variants.	 	Therefore,	a	script	written	by	Dr	Lajos	 Kalmer	 was	 applied	 to	 further	 remove	 the	 variants	 which	 were	 <2	genetic	distances	from	the	dominant	variants	after	pattern	analysis.	A	similar	result	was	 obtained	 after	DADA2	 analysis	 and	pattern	match	 pulsing	 further	filter	shadow	variants.	DADA2	was	applied	to	analyse	the	inoculum	and	all	the	swab	 samples	 from	 the	 first	 pilot	 study	 to	 ensure	 that	 the	 results	 were	 not	affected	by	different	analytical	approaches.	At	the	same	time,	in	order	to	provide	a	much	more	discriminating	and	robust	method	 for	 efficient	 removal	 of	 duplicates	 and	 artefacts,	 UMIs	 were	incorporated	into	the	cDNA	synthesis	primer	used	for	tagging	each	vRNA	prior	to	library	amplification	in	the	second	pilot	study.	The	high	correlations	of	the	variants,	between	replicates	and	successive	days,	suggested	that	the	improved	sample	preparation	and	analysis	method	have	produced	more	reliable	data.	So	far,	 all	 implemented	 analysis	 methods	 are	 heuristic	 approaches	 to	distinguishing	 the	 real	 variants.	 The	main	 purpose	 of	 this	 study	was	 to	 seek	appropriate	probabilistic	methods	 that	can	be	applied	 to	determine	 the	most	likely	set	of	genuine	variants.	Therefore,	 the	 focus	has	been	put	on	screening	
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the	 relatively	 high	 abundance	 variants	 and	maximally	 removing	 the	 artificial	variants.	 It	 should	 be	 pointed	 out	 that	 the	 pattern	 match	 analysis	 script	requires	further	development.		
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Supplementary	document	
	
		ULI-1	 GGCTACCATGCGAACAACTCCACCGACACT	(Hamming	code	000000000)	ULI-2	 GGCTACCATGCGAACAATTCAACTGACACT	(Hamming	code	000000111)	ULI-3	 GGCTACCATGCAAATAACTCCACTGACACT	(Hamming	code	000011001)		ULI-4	 GGCTACCATGCAAATAATTCAACCGACACT	(Hamming	code	000011110)	ULI-5	 GGCTATCATGCGAATAACTCAACCGACACT	(Hamming	code	000101010)	
Figure	S3.1a	Section	of	a	chromatogram	from	viral	seg_4	barcode	area,	showing	ULI	region	for	ULI1-5			
		ULI-1	 TCGACCCTCCCTAGGAGGTCCGGAGCC	(Hamming	code	000000000)	ULI-2	 TCGACCCTCCCTAGAAGATCTGGAGCC	(Hamming	code	000000111)	ULI-3	 TCGACCCTTCCGAGGAGGTCTGGAGCC	(Hamming	code	000011001)		ULI-4	 TCGACCCTTCCGAGAAGATCCGGAGCC	(Hamming	code	000011110)	ULI-5	 TCGACTCTCCCGAGGAGATCCGGAGCC	(Hamming	code	000101010)	
Figure	S3.1b	Section	of	a	chromatogram	from	viral	seg_5	barcode	area,	showing	ULI	region	for	ULI1-5		
Figure	 S3.1	 a-b	 Sanger	 sequencing	 chromatograms	 showing	 cognate	 Hamming	 codes	 embedded	 as	synonymous	codons	 in	segments	4	and	5.	Green	bars	 indicate	 the	 locations	of	 the	varied	bases.	Each	ULI	differs	from	all	the	other	by	3	positions.		
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			(a)	Section	of	a	chromatogram	including	URI	and	DR	region	from	viral	segment	1	of	rescued	DBCV1_1353	matches	the	expected	sequences:		ARGTDTTRCATTTGACYCAAGGRACVTGYTGGGAACARATGTATACTCCAGGHGGRGAAGTGAGRAATGAYGATGTTGAYCAAAGCTTGATCATCGCTGCCAGGAACATTGTTAGGAGA						
	(b)	Section	of	a	chromatogram	including	URI	and	DR	region	from	viral	segment	1	of	rescued	DBCV2_1353	matches	the	expected	sequences:	ARGTDTTRCATTTGACYCAAGGRACVTGYTGGGAACARATGTATACTCCAGGHGGRGAAGTGAGRAATGAYGATGTTGAYCAAAGCTTGATCATCGCTGCCAGGAACATAGTAAGAAGA	
				
	(c)	Section	of	a	chromatogram	including	URI	and	DR	region	from	viral	segment	1	of	rescued	DBCV3_1353	matches	the	expected	sequences:	ARGTDTTRCATTTGACYCAAGGRACVTGYTGGGAACARATGTATACTCCAGGHGGRGAAGTGAGRAATGAYGATGTTGAYCAAAGCTTGATCATCGCTGCTAGAAACATTGTTAGAAGA					(d)	Section	of	a	chromatogram	including	URI	and	DR	region	from	viral	segment	1	of	rescued	DBCV4_1353	matches	the	expected	sequences:	ARGTDTTRCATTTGACYCAAGGRACVTGYTGGGAACARATGTATACTCCAGGHGGRGAAGTGAGRAATGAYGATGTTGAYCAAAGCTTGATCATCGCTGCTAGAAACATAGTAAGGAGA		
						(e)	Section	of	a	chromatogram	including	URI	and	DR	region	from	viral	segment	1	of	rescued	DBCV5_1353	DBCV3	matches	the	expected	sequences:	ARGTDTTRCATTTGACYCAAGGRACVTGYTGGGAACARATGTATACTCCAGGHGGRGAAGTGAGRAATGAYGATGTTGAYCAAAGCTTGATCATCGCAGCCAGAAACATTGTAAGGAGA	
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Figure	S3.2a-e	demonstrates	that	viral	sequence	of	DBCV1-5_1353	in	ULI	region	and	DR	region	of	modified	Segment	1	by	Sanger	sequencing.	The	introduced	mutations	within	URI	and	DR	region	were	highlighted	in	green	color.	Three	introduced	nucleotides	within	DR	were	highlighter	in	blue.	
	
Table	S3.1.1.	Two	oligonucleotides	templates	were	synthesized	by	Sigma-Aldrich	
Plasmids extracting from individual clone        Sequencing of oligos 
F gtgtgtacattgargtdttrcatttgacycaaggracvtgytgggaacaratgtayactccagg                               
A*                                          tgggaacaratgtayactccaggvggrgaagtgagraatgaygatgttgayca  
1        gtgtgtacattgatgttttgcatttgactcaaggaacatgctgggaacaaatgtatactccaggaggagaagtgagaaatgatgatgttgatca   
2 gtgtgtacattgaggtttta-atttgactcaagggacgtgttgggaacagatgtacattccaggcggagaagtgagaaatgatgatgttgatca                                                                           
3 gtgtgtacattgaggttttgcatttgactctaggaacctgttggttacaaatgtatactccaggtggggaagtgagaaatgacgatgttgatca 
4 gtgtgtacattgaattattgcatttgactcaagggacatgttgggaacagatgtatactc-aggaggggaagtgagaaatgacgatgttgatca 
5  gtgtgtacattgtggttttgcttttgacccaagggacatactgggaacaaatgtatactccaggcggggaagtgagaaatgacgatgttgacca                  
6         gtgtgtac-ttgtggttttgcatttgactcaaggaacctgctgggaacaaatgtatactccaggaggggaagtgaggaatgatgatgttgacca 
Note:	 Each	oligo	was	around	60	bp	 (63bp	and	53bp)	and	was	purified	by	HPLC.	After	 cloning	 them	 into	seg_1	 barcode	 1	 plasmid	 and	 sequencing	 6	 individual	 clones	 from	 the	 transformation,	 it	was	 found	 that	none	 of	 the	 six	 sequences	were	 completely	 correct.	 The	wobble	 positions	 are	marked	 in	 yellow	 and	 the	mutated	 positions	 &	 deletions	 found	 are	 marked	 in	 red.	 From	 the	 sequencing	 results,	 the	 errors	 were	randomly	present	 in	 the	 synthetic	oligos.	There	were	 three	oligos	each	containing	one	mutation	position	and	two	oligos	with	multiple	mutations	and	deletions.	The	remaining	one	had	one	deletion	in	the	forward	template.	The	forward	primer	(F)	is	shown	in	5’-3’	orientation.	*The	antisense	strand	primer	sequence	(A)	is	displayed	as	its	reverse	complement	for	clarity.	
Table	S3.1.2.	Two	oligonucleotides	templates	were	re	synthesized	by	Sigma-Aldrich.	
Plasmids extracting from individual clone        Sequencing of oligos 
   F       gtgtgtacattgargtdttrcatttgacycaaggracvtgytgggaacaratgtayactccagg  
   A                                                tgggaacaratgtayactccaggvggrgaagtgagraatgaygatgttgayca                                                                               
   1       gtgtgtacattgaagtgttgcatttgactcaaggaacatgctgggaacagatgtatactccaggaggggaagtgaggaatgatgatgttgatca          
   2       gtgtgtacattgaagttttacatttgactcaagggacatgttgggaacaaatgtatactccaggaggggaagtgagaaacgacgatgttgatca 
   3       gtgtgtaca------------------------------------------------ctccaggaggagaagtgagaaatgacgttgt-gacca 
   4       gtgtgtaca------------------------------------------------ctccgggtggggaagtgaggaatgatgatgttgatca 
   5       gtgtgtacattgaggtattacatttgacccaagggacatgttgggaacagatgtatactccaggaggagaagtgaggaatgacgatgttgatca 
   6       gtgtgtaca------------------------------------------------ctccaggcggagaagtgagaaatgatga-gttgacca 
Note:	Each	oligo	was	around	60	bp	and	was	HPLC	purified.	According	to	the	second	results,	three	of	the	six	samples	have	identical,	significantly	long	length	deletions.	This	was	an	artefact	due	to	one	wobble	position	variant	generating	a	digestion	site	of	BsrGI	(underlined)that	was	used	for	cloning	the	oligos.		Nevertheless,	each	of	 these	had	unwanted	mutations	 indicating	synthesis	errors	were	still	 a	problem.	Of	 the	 three	 full-length	inserts,	two	were	correct.		All	of	the	errors	clustered	in	the	antisense	oligo,	suggesting	that	the	sense	oligo	 (F)	 might	 have	 been	 satisfactory.	 However,	 because	 it	 contained	 the	 unwanted	 wobble-generated	BsrGI	site	it	was	necessary	to	resynthesize	both	anyway.	 
Table	S3.1.3	Two	oligonucleotides	templates	were	synthesized	by	Sigma-Aldrich	
Plasmids extracting from individual clone        Sequencing of oligos 
F  gtgtgtacattgargtdttrcatttgacycaaggracvtgytgggaacaratgtatactccagg 
A                                           tgggaacaratgtatactccaggvggrgaagtgagraatgaygatgttgayca 
1      gtgtgtacattgaggtg---catttgactcaaggaaccagctgggaacaaatgtatactccaggaggagaagtgaggaatgatgatgt-gacca 
2      gtgtgtacattgaggtg---catttgactcaagggacgagctgggaacaaatgtatactccaggaggagaagtgagaaatgatgatgttgatca 
3      gtgtgtacattgaagtt---catttgactcaaggaacaagttgggaacaaatgtatactccaggaggagaagtgagaaatgatgatgttgatca 
4      gtgtgtacattgaagtt---catttgactcaagggaccagttgggaacagat-tatactccaggtggagaagtgaggaatgatgatgttgacca 
5      gtgtgtacattgaagtt---catttgactcaaggaacaagttgggaacaaatgtatactccaggtggagaagtgagaaatgatgatgttgacca 
6      gtgtgtacattgaggtt---catttgactcaaggaacaagttgggaacagatgtatactccaggcggggaagtgaggaatgacgatgttgacca 
Note:	Each	of	the	oligos	was	PAGE	purified.	T	highlighted	in	read	was	edited	from	Y	to	T	in	order	to	remove	unwanted	BsrGI	site.	After	sequencing	six	samples,	all	six	clones	had	a	three	nucleotide	deletion	at	the	same	position	and	had	one	base	changed	from	T	to	A	in	the	forward	primer.		The	customer	order	was	checked	but	no	 such	 errors	were	 present	 and	 the	 sequence	 on	 the	 oligo	 invoice	 and	 tube	was	 correct,	 indicating	 the	error	probably	occurred	during	synthesis.	For	the	antisense	(A)	primer,	one	of	the	six	samples	had	a	single	nt	 deletion.	An	unexpected	T	was	 also	present	 in	 one	 of	 the	wobble	 positions	 for	 two	of	 the	 clones	 (the	wobble	position	nucleotide	V	should	be	A/C/G,	but	A/T/C	was	present	in	this	position).					
Table	S3.1.4.	Two	oligonucleotides	templates	were	re-synthesized	by	Sigma-Aldrich		
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    F gtgtgtacattgargtdttrcatttgacycaaggracvtgytgggaacaratgtatactccagg  
    A                                           tgggaacaratgtatactccaggvggrgaagtgagraatgaygatgttgayca                                                                               
    1 gtgtgtacattgaagtgttgcatttgactcaaggaacatgctgggaacagatgtatactccaggaggagaagtgaggaatgatgatgttgatca 
    2      gtgtgtacattgaggttttacatttgactcaagggacatgttgggaagaaatgtatactccaggaggggaagtgagaaatgacgatgttgatca                     
    3      gtgtgtacattgaagtgttacatttgacccaagggacttgttgggaagaaatgtatactccaggaggggaagtgagaaatgacgatgttgatca 
    4      gtgtgtacattgaagtattacatttgactcaagggacatgctggtaagaaatgtatactccaggaggggaagtgaggaatgacgatgttgacca 
    5      gtgtgtacattgaagtattacatttgactcaagggacatgttggtaacaaatgtatactccaggaggggaagtgaggaatgacgatgttgatca 
    6      gtgtgtacattgaagtgttgcatttgactcaaggaacgtgttgggaacagatgtatactccaggaggagaagtgaggaatgatgatgttgatca 
Note:	From	the	sequence	results,	two	of	the	six	samples	were	correct.		Two	mutations	were	present	in	the	remaining	four	clones.	Both	were	located	in	the	overlap	between	the	two	oligos.	C	mutated	to	a	G	in	three	cases	and	G	mutated	to	T	in	two	cases,		but	there	was	no	consistent	pattern.	
Table	S3.1.5.	An	alternative	strategy	was	synthesized	by	Thermofisher	Scientific		
 gtgtgtacattgargtdttrcatt                                               ptgagraatgaygatgttgayca  
                                ptgacycaaggracvtgytgggaacaratgtatactccagghggrgaag                                                                                                                                                             
1 gtgtgtacattgaggttttgcatttgacccaagggacgtgttgggaacagatgtatactccaggcggagaagtgaggaatgacgatgttgatca 
2 gtgtgtacattgaagtattacatttgactcaaggaacatgttgggaacagatgtatactccaggtggggaagtgaggaatgacgatgttgatca 
3 gtgtgtacattgaggtattacatttgacccaaggaacgtgttgggaacagatgtatactc-aggcggagaagtgaggaatgacgatgttgatca 
4 gtgtgtacattgaagtgttacatttgacccaaggaacgtgctgggaacagatgtatactccaggaggggaagtgagaaatgatgatgttgatca 
5 gtgtgtacattgaggttttacatttgactcaagggacatgctgggaacagatgtat-ctccaggtggagaagtgagaaatgatgatgttgacca 
6 gtgtgtacattgaagtgttgcatttgactcaaggaacctgttgggaacaaatgtatactccaggcggggaagtgagaaatgatgatgttgatca 
Note:	An	alternative	 strategy	was	designed	so	 that	 the	 total	121	bp	 length	 required,	was	 split	 into	 three	parts	 that	 were	 synthesized	 by	 Thermo	 Scientific	 Method.	 The	 three	 oligos	 (two	 of	 which	 were	 5’	phosphorylated	(p))	were	splinted	 together	using	a	complementary	clamp	oligo	and	then	 ligated	prior	 to	being	amplified	by	PCR	to	generate	DS	DNA.This	reduced	the	oligo	sizes	down	to	<50	bp.	Four	out	of	the	six	clones	were	 correct.	 Two	 clones	 had	 different	 single	 nt	 deletions	 present	 in	 the	 region	 specified	 by	 the	second	synthetic	oligo.	
Table	S3.1.6.	Two	oligonucleotides	templates	were	synthesized	by	the	Sigma	Aldrich	for	the	third	time.	
F gtgtgtacattgargtdttrcatttgacycaaggracvtgytgggaacaratgtatactccagg  
A                                          tgggaacaratgtatactccaggvggrgaagtgagraatgaygatgttgayca                                                                               
    1 gtgtgtacattgaggtgttgcatttgactcaaggaacgtgttgggaacagatgtatactccaggcggggaagtgaggaatgacgatgttgacca 
    2 gtgtgtacattgaagttttacatttgacccaaggaacatgctgggaacaaatgtatactccaggaggagaagtgagaaatgacgatgttgacca 
    3 gtgtgtacattgaggttttgcatttgactcaagggacatgttgggaacagatgtatactccaggaggagaagtgagaaatgacgatgttgacca 
    4 gtgtgtacattgaggtgttacatttgactcaagggacatgttgggaacagatgtatactccaggcggggaagtgaggaatgacgatgttgacca 
    5 gtgtgtacattgaagttttacntttgacccaagggacctgttgggaacaaatgtatactccaggcggggaagtgagaaatgacgatgttgacca 
    6 gtgtgtacattgaagtgttgcatttgactcaagggacctgctgggaacagatgtatactccaggaggggaagtgagaaatgatgatgttgatca 
Note:	All	six	samples	matched	the	expected	sequence.			Example	of	adding	restriction	enzyme	sites	on	Seg_8	
BsmBICGTCTCAGGGGagcaaaagCAGGGTGACAAAAACATAATGGACTCCAACACCATGTCAAGCTTT
CAGGTAGACTGTTTCCTTTGGCATATCCGCAAGCGATTTGCAGACAATGGATTGGGTGATGCCCCATTC
CTTGATCGGCTCCGCCGAGATCAAAAGTCCTTAAAAGGAAGAGGCAACACCCTTGGCCTCGATATCGAA
ACAGCCACTCTTGTTGGGAAACAAATCGTGGAATGGATCTTGAAAGAGGAATCCAGCGAGACACTTAGA
ATGACAATTGCATCTGTGCCTACTTCGCGCTACCTTTCTGACATGACCCTCGAGGAAATGTCACGAGAC
TGGTTCATGCTCATGCCTAGGCAAAAGATAATAGGCCCTCTTTGCGTGCGATTGGACCAGGCGGTCATG
GAAAAGAACATAGTACTGAAAGCGAACTTCAGTGTAATCTTTAACCGATTAGAGACCTTGATACTACTA
AGGGCTTTCACTGAGGAGGGAGCAATAGTTGGAGAAATTTCACCATTACCTTCTCTTCCAGGACATACT
TATGAGGATGTCAAAAATGCAGTTGGGGTCCTCATCGGAGGACTTGAATGGAATGGTAACACGGTTCGA
GTCTCTGAAAATATACAGAGATTCGCTTGGAGAAACTGTGATGAGAATGGGAGACCTTCACTACCTCCA
GAGCAGAAATGAAAAGTGGCGAGAGCAATTGGGACAGAAATTTGAGGAAATAAGGTGGTTAATTGAAGA
AATGCGGCACAGATTGAAAGCGGCAGAGAATAGTTTCGAACAAATAACATTTATGCAAGCCTTACAACT
ACTGCTTGAAGTAGAACAAGAGATAAGAGCTTTCTCGTTTCAGCTTATTTAATGATAAAAAACACCCTT
GTTTCTACTAATATGAGACGBsmBI 
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Figure S5.1 Barcoded variants (>30 abundance) present in each P3 viral stock. (a-e) DBCV1-5. The circle size 
indicates the abundance of the variant. Number of strings linked two circles indicates the genetic distance between 
the two barcoded variants 
	
	
	
	
	
	
		 143	
	
	
Table	S6.1.	Correlation	of	swabs	between	sequential	days		in	the	first	pig	study	
Sample	ID	 Rs	DP1.1D2_2	vs	DP1.1D3_1	 0.782***	DP1.1D3_1	vs	DP1.1D4_2	 0.478**	DP1.1D4_3	vs	DP1.1D5_3	 0.892*	DP1.3D1-1	vs	DP1.3D2-1	 0.596***	DP1.3D2-3	vs	DP1.3D3-1	 0.883***	CP1.1D2_3	vs	CP1.1D3_3	 0.612**	CP1.1D3_3	vs	CP1.1D4_3	 0.773***	CP1.2D2_1	vs	CP1.2D3_2	 0.950***	CP1.2D3_2	vs	CP1.2D4_2	 0.850***	CP1.3D1_2	vs	CP1.3D2_2	 0.640***	CP1.3D2_2	vs	CP1.3D3_2	 0.753***	CP1.3D3_3	vs	CP1.3D4_3	 0.560***	
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Appendix	
1.	PERL	script	used	for	analysis	viral	stock		
use Data::Dumper; 
 
@barcds = ('BC1', 'BC2', 'BC3', 'BC4', 'BC5'); 
#                               #  #  #     #  #  # 
%barcodes = ('BC1' => 'GATCATCGCTGCCAGGAACATTGTTAGG', 
             'BC2' => 'GATCATCGCTGCCAGGAACATAGTAAGA', 
             'BC3' => 'GATCATCGCTGCTAGAAACATTGTTAGA', 
             'BC4' => 'GATCATCGCTGCTAGAAACATAGTAAGG', 
             'BC5' => 'GATCATCGCAGCCAGAAACATTGTAAGG'); 
#                               #  #  #     #  #  # 
@varinf = gen_var(); 
$ref = 
"[AG]GT[AGT]TT[AG]CATTTGAC[CT]CAAGG[AG]AC[ACG]TG[CT]TGGGAACA[A
G]ATGTATACTCCAGG[ACT]GG[GA]GAAGTGAG[AG]AATGA[CT]GATGTTGA[CT]CA
AAGCTTGATCATCGC[AT]GC[CT]AG[AG]AACAT[AT]GT[AT]AG[AG]"; 
$oref = 
'AGTGTTGCACTTAACCCAAGGGACGTGCTGGGAGCAGATGTATACTCCAGGAGGAGAAGTG
AGAAATGATGATGTTGACCAAAGCTTGATTATCGCTGCTAGAAACATAGTAAGAAGAGC'; 
 
 
$opt = shift(@ARGV); 
 
 
if ($opt eq 'nomatchseq') { #To find the sequences that are 
not matching with the variable sequence: No. of reads, 
sequence 
    open(F, shift(@ARGV)); 
    $max = 0; 
    $pass = 0; 
    $min = shift(@ARGV); 
    while (<F>) { 
        if ($pass == 1) { 
            chomp; 
            $_ =~ s/\r//; 
            if ($_ !~ /$ref/) { 
                $ids_gs{$_}++; 
                $cnt_gs++; 
                if ($ids_gs{$_} > $max) { 
                    $max = $ids_gs{$_}; 
                } 
                 
            } 
            $pass = 0; 
        } 
        if (/^@/) { 
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            $pass = 1; 
        } 
         
    } 
    close(F); 
    $cnt = 0; 
    for $num ($min..$max){ 
        for $key (keys %ids_gs){ 
            if ($ids_gs{$key} == $num) { 
                print $num."\t".$key."\n"; 
                $cnt++; 
            } 
        } 
    } 
    print "Number of individual non-matching 
sequences:".$cnt."\n"; 
} 
 
 
 
if ($opt eq 'top10') { #To find the 10 most frequent variants 
in two different passages, and see their change 
    $aktbc = shift(@ARGV); 
    open(F, shift(@ARGV)); 
    $pass = 0; 
    while (<F>) { 
        if ($pass == 1) { 
            chomp; 
            $_ =~ s/\r//; 
            if ($_ =~ /$barcodes{$aktbc}/) { 
                if ($_ =~ /($ref)/) { 
                    $ids_gs{id_var($1)}[0]++; 
                } 
            } 
            $pass = 0; 
        } 
        if (/^@/) { 
            $pass = 1; 
        } 
         
    } 
    close(F); 
    open(G, shift(@ARGV)); 
    while (<G>) { 
        if ($pass == 1) { 
            chomp; 
            $_ =~ s/\r//; 
            if ($_ =~ /$barcodes{$aktbc}/) { 
                if ($_ =~ /($ref)/) { 
                    $ids_gs{id_var($1)}[1]++; 
                } 
            } 
            $pass = 0; 
        } 
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        if (/^@/) { 
            $pass = 1; 
        } 
    } 
     
    $max = 0; 
    $premax = 1000000; 
    for (0..10){ 
        for $var (keys %ids_gs){ 
            if ($ids_gs{$var}[0] > $max && $ids_gs{$var}[0] <= 
$premax && $seen{$var} != 1) { 
                $max = $ids_gs{$var}[0]; 
                $tmp = $max; 
                $tmpk = $var; 
                
            } 
             
        } 
         print ">".$tmpk."\n".$tmpk."\t"."\n"; 
         print 
$tmpk."\t".$ids_gs{$tmpk}[0]."\t".$ids_gs{$tmpk}[1]."\t"."\n"; 
        $seen{$tmpk}=1; 
        $premax = $tmp; 
        $max = 0; 
    } 
    print "\n"; 
    $max = 0; 
    $premax = 1000000; 
    undef %seen; 
    for (0..2500){ 
        for $var (keys %ids_gs){ 
            if ($ids_gs{$var}[1] > $max && $ids_gs{$var}[1] <= 
$premax  && $seen{$var} != 1) { 
                $max = $ids_gs{$var}[1]; 
                $tmp = $max; 
                $tmpk = $var; 
                 
            } 
             
        } 
        print 
$tmpk."\t"."\t".$ids_gs{$tmpk}[0]."\t"."\t".$ids_gs{$tmpk}[1].
"\t"."\n"; 
        $seen{$tmpk}=1; 
        $premax = $tmp; 
        $max = 0; 
    } 
     
     
     
    #print Dumper(@varinf); 
    #print Dumper(%ids_gs); 
    close(G); 
} 
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if ($opt eq 'extvarpos') { #To extract variants from a fastq 
file corr: it will print out all reads of a variant if the 
total number of reads of that particular variant is >= than 
the threshold uncorr: it will print out all variants with 
reads >= than the threshold only once  
    $aktbc = shift(@ARGV); 
    $corr = shift(@ARGV); 
    $tr = shift(@ARGV); 
    open(F, shift(@ARGV)); 
    $pass = 0; 
    while (<F>) { 
        if ($pass == 1) { 
            chomp; 
            $_ =~ s/\r//; 
             
            if ($_ =~ /$barcodes{$aktbc}/) { 
                if ($_ =~ /($ref)/) { 
                    $varseq = id_var($1); 
                    $varseq =~ s/-BC.//; 
                    $hash{$varseq}++; 
                    if ($corr eq 'corr' && $hash{$varseq} == 
$tr) { 
                        for (1..$tr){ 
                            print $varseq."\n"; 
                        } 
                    } 
                    if ($corr eq 'corr' && $hash{$varseq} > 
$tr) { 
                        print $varseq."\n"; 
                    } 
                    if ($corr eq 'uncorr' && $hash{$varseq} == 
$tr) { 
                        print $varseq."\n"; 
                    } 
                } 
            } 
             
        } 
        if (/^@/) { 
            $pass = 1; 
        } 
         
    } 
    close(F); 
} 
 
if ($opt eq 'freqvarpos') { #To extract the numerical 
frequencies from the files created by the previous module 
(extvarpos) 
    open(F, shift(@ARGV)); 
    while (<F>) { 
        chomp; 
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        $_ =~ s/\r//; 
        @pos = split(/|/, $_); 
        $cnt++; 
        for $p (0..12){ 
            $freq{$p}{$pos[$p]}++; 
        } 
    } 
    print sprintf('%.3f', $freq{0}{'A'} / 
$cnt)."\t".sprintf('%.3f', $freq{0}{'G'} / 
$cnt)."\t".sprintf('%.3f', $freq{1}{'A'} / 
$cnt)."\t".sprintf('%.3f', $freq{1}{'G'} / 
$cnt)."\t".sprintf('%.3f', $freq{1}{'T'} / 
$cnt)."\t".sprintf('%.3f', $freq{2}{'A'} / 
$cnt)."\t".sprintf('%.3f', $freq{2}{'G'} / 
$cnt)."\t".sprintf('%.3f', $freq[193]{'C'} / 
$cnt)."\t".sprintf('%.3f', $freq[193]{'T'} / 
$cnt)."\t".sprintf('%.3f', $freq{4}{'A'} / 
$cnt)."\t".sprintf('%.3f', $freq{4}{'G'} / 
$cnt)."\t".sprintf('%.3f', $freq{5}{'A'} / 
$cnt)."\t".sprintf('%.3f', $freq{5}{'C'} / 
$cnt)."\t".sprintf('%.3f', $freq{5}{'G'} / 
$cnt)."\t".sprintf('%.3f', $freq{6}{'C'} / 
$cnt)."\t".sprintf('%.3f', $freq{6}{'T'} / 
$cnt)."\t".sprintf('%.3f', $freq{7}{'A'} / 
$cnt)."\t".sprintf('%.3f', $freq{7}{'G'} / 
$cnt)."\t".sprintf('%.3f', $freq{8}{'A'} / 
$cnt)."\t".sprintf('%.3f', $freq{8}{'C'} / 
$cnt)."\t".sprintf('%.3f', $freq{8}{'T'} / 
$cnt)."\t".sprintf('%.3f', $freq{9}{'A'} / 
$cnt)."\t".sprintf('%.3f', $freq{9}{'G'} / 
$cnt)."\t".sprintf('%.3f', $freq{10}{'A'} / 
$cnt)."\t".sprintf('%.3f', $freq{10}{'G'} / 
$cnt)."\t".sprintf('%.3f', $freq{11}{'C'} / 
$cnt)."\t".sprintf('%.3f', $freq{11}{'T'} / 
$cnt)."\t".sprintf('%.3f', $freq{12}{'C'} / 
$cnt)."\t".sprintf('%.3f', $freq{12}{'T'} / $cnt)."\n"; 
} 
 
 
 
if ($opt eq 'vardist') { #To calculte how many variants 
present in the fastq files with different read numbers 
    $aktbc = shift(@ARGV); 
    open(F, shift(@ARGV)); 
    $tr = shift(@ARGV); 
    $max = 0; 
    $pass = 0; 
    while (<F>) { 
        if ($pass == 1) { 
            chomp; 
            $_ =~ s/\r//; 
            if ($_ =~ /$barcodes{$aktbc}/) { 
                if ($_ =~ /($ref)/) { 
                    $ids_gs{$1}++; 
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                    if ($ids_gs{$1} > $max) { 
                        $max = $ids_gs{$1}; 
                    } 
                    $cnt_gs++; 
                     
                } 
                 
                 
            } 
            $pass = 0; 
        } 
        if (/^@/) { 
            $pass = 1; 
        } 
    } 
    close(F); 
    for $i (1..$max){ 
        $cnt = 0; 
        for $key (keys %ids_gs){ 
            if ($ids_gs{$key} == $i) { 
                $cnt++; 
                $cnt_tot++; 
                if ($i >= $tr) { 
                    $cnt_tot5++; 
                } 
                 
            } 
             
        } 
        if ($cnt > 0) { 
            print "$i\t$cnt\n"; 
        } 
        else { 
            print "$i\t-\n"; 
        } 
         
         
    } 
    print STDERR 
$cnt_gs."\t".$cnt_tot."\t".$cnt_tot5."\t".$max."\n"; 
} 
 
if ($opt eq 'matchfreq') { #To count the total number of reads 
in a fastq file together with the read numbers of matching and 
non-matching reads (to the reference) 
    open(F, shift(@ARGV)); 
    $pass = 0; 
    while (<F>) { 
        if ($pass == 1) { 
            chomp; 
            $_ =~ s/\r//; 
            $cnt_tr++; 
            if ($_ =~ /$ref/) { 
                $ids_gs{$subseq}++; 
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                $cnt_gs++; 
            } 
            else { 
                $ids_ns{$subseq}++; 
                $cnt_ns++; 
            } 
             
            $pass = 0; 
        } 
        if (/^@/) { 
            $pass = 1; 
        } 
         
    } 
    close(F); 
    print "Total number of reads: $cnt_tr\n"; 
    print "Total number of matching reads: $cnt_gs (". 
sprintf('%.3f', ($cnt_gs/$cnt_tr)) .")\n"; 
    print "Total number of non-matching reads: $cnt_ns (". 
sprintf('%.3f', ($cnt_ns/$cnt_tr)) .")\n"; 
} 
 
if ($opt eq 'bcfreq') { #To count the frequencies of different 
barcodes in a fastq file 
    open(F, shift(@ARGV)); 
    $pbc = shift(@ARGV); 
    $pass = 0; 
    while (<F>) { 
        if ($pass == 1) { 
            chomp; 
            $_ =~ s/\r//; 
            if (/($ref)/) { 
                $cnt++; 
                $subseq = $1; 
                for $bc (@barcds){ 
                    if ($subseq =~ /$barcodes{$bc}/) { 
                        $akt_bc{$bc}++; 
                        push(@{$bc_seqs{$bc}}, $subseq); 
                        $mbc++; 
                    } 
                } 
            } 
            $pass = 0; 
        } 
        if (/^@/) { 
            $pass = 1; 
        } 
         
    } 
    close(F); 
    print STDERR "Total number of matching reads: $cnt\n"; 
    print STDERR "Total number of matching reads with good 
barcode: $mbc (". sprintf('%.3f', ($mbc/$cnt)) .")\n"; 
    for $bc (@barcds){ 
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        print STDERR "Total number of regions with $bc 
barcode: ".$akt_bc{$bc}." (". sprintf('%.3f', 
($akt_bc{$bc}/$mbc)) .")\n"; 
  print $seq."\n"; 
  } 
  } 
  
     
 
 
if ($opt eq 'refind') { #To find the common variants 
(cumulatively) between passages (between two fastq files 
    $aktbc = shift(@ARGV); 
    $tr = shift(@ARGV); 
    open(F, shift(@ARGV)); 
    while (<F>) { 
        if ($pass == 1) { 
            chomp; 
            $_ =~ s/\r//; 
            if ($_ =~ /$barcodes{$aktbc}/) { 
                if ($_ =~ /($ref)/) { 
                    $ids_gs{$1}[0]++; 
                    $cnt_gs[0]++; 
                } 
            } 
            $pass = 0; 
        } 
        if (/^@/) { 
            $pass = 1; 
        } 
         
    } 
    close(F); 
    open(G, shift(@ARGV)); 
    while (<G>) { 
        if ($pass == 1) { 
            chomp; 
            $_ =~ s/\r//; 
            if ($_ =~ /$barcodes{$aktbc}/) { 
                if ($_ =~ /($ref)/) { 
                    $ids_gs{$1}[1]++; 
                    $cnt_gs[1]++; 
                } 
            } 
            $pass = 0; 
        } 
        if (/^@/) { 
            $pass = 1; 
        } 
    } 
    close(G); 
     
    for $reads (2..40){ # if you want to change the minimal 
read number in file 1, than change the first number 
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        $cnt1 = $cnt2 = 0; 
        for $key (keys %ids_gs){ 
            if ($ids_gs{$key}[0] > $reads) { 
                $cnt1++; 
                if ($ids_gs{$key}[1] >= $tr) { # $tr is the 
minimal read number in file 2 (can be set as an argument) 
                    $cnt2++; 
                } 
            } 
             
        } 
        print $reads."\t".$cnt1."\t".$cnt2."\t". $cnt2 / $cnt1 
."\n"; 
    } 
} 
 
if ($opt eq 'scatterplot') { #To visualise the read number 
difference of the common variant between two fastq files 
    $aktbc = shift(@ARGV); 
    $tr = shift(@ARGV); 
    open(F, shift(@ARGV)); 
    while (<F>) { 
        if ($pass == 1) { 
            chomp; 
            $_ =~ s/\r//; 
            if ($_ =~ /$barcodes{$aktbc}/) { 
                if ($_ =~ /($ref)/) { 
                    $ids_gs{$1}[0]++; 
                    $cnt_gs[0]++; 
                } 
            } 
            $pass = 0; 
        } 
        if (/^@/) { 
            $pass = 1; 
        } 
         
    } 
    close(F); 
    open(G, shift(@ARGV)); 
    while (<G>) { 
        if ($pass == 1) { 
            chomp; 
            $_ =~ s/\r//; 
            if ($_ =~ /$barcodes{$aktbc}/) { 
                if ($_ =~ /($ref)/) { 
                    $ids_gs{$1}[1]++; 
                    $cnt_gs[1]++; 
                } 
            } 
            $pass = 0; 
        } 
        if (/^@/) { 
            $pass = 1; 
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        } 
    } 
    close(G); 
     
 
    for $key (keys %ids_gs){ 
        if ($ids_gs{$key}[0] > $tr && $ids_gs{$key}[1] > $tr) 
{ 
            print $ids_gs{$key}[0]."\t".$ids_gs{$key}[1]."\n"; 
        } 
    } 
 
} 
 
if ($opt eq 'compfreq') { #To count the number of common and 
individual variants in thwo fastq files, and also print out 
their frequency: 
    $aktbc = shift(@ARGV); 
    $tr = shift(@ARGV); 
    open(F, shift(@ARGV)); 
    while (<F>) { 
        if ($pass == 1) { 
            chomp; 
            $_ =~ s/\r//; 
            if ($_ =~ /$barcodes{$aktbc}/) { 
                if ($_ =~ /($ref)/) { 
                    $ids_gs{$1}[0]++; 
                    $cnt_gs[0]++; 
                } 
            } 
            $pass = 0; 
        } 
        if (/^@/) { 
            $pass = 1; 
        } 
         
    } 
    close(F); 
    open(G, shift(@ARGV)); 
    while (<G>) { 
        if ($pass == 1) { 
            chomp; 
            $_ =~ s/\r//; 
            if ($_ =~ /$barcodes{$aktbc}/) { 
                if ($_ =~ /($ref)/) { 
                    $ids_gs{$1}[1]++; 
                    $cnt_gs[1]++; 
                } 
            } 
            $pass = 0; 
        } 
        if (/^@/) { 
            $pass = 1; 
        } 
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    } 
    close(G); 
    $po = shift(@ARGV); 
    for $key (keys %ids_gs){ 
        if ($ids_gs{$key}[0] >= $tr && $ids_gs{$key}[1] >= 
$tr) { 
            $cnt_comm++; 
            if ($po eq 'both') { 
                print (id_var($key)."\t". ($ids_gs{$key}[1] / 
$cnt_gs[1]) ."\t". ($ids_gs{$key}[0] / $cnt_gs[0]) ."\n"); 
            } 
        } 
        if ($ids_gs{$key}[0] >= $tr && $ids_gs{$key}[1] < $tr) 
{ 
            $cnt_only1++; 
            if ($po eq 'u1') { 
                print id_var($key)."\t". $ids_gs{$key}[0] 
."\n"; 
            } 
             
        } 
        if ($ids_gs{$key}[1] >= $tr && $ids_gs{$key}[0] < $tr) 
{ 
            $cnt_only2++; 
            if ($po eq 'u2') { 
                print id_var($key)."\t". $ids_gs{$key}[1] 
."\n"; 
            } 
        } 
         
         
    } 
    print STDERR "With a read count threshold of $tr\n"; 
    print STDERR "$cnt_comm common variants detected\n"; 
    print STDERR "$cnt_only1 variants detected only in sample 
1\n"; 
    print STDERR "$cnt_only2 variants detected only in sample 
2\n"; 
} 
 
 
sub id_var { 
    $query = $_[0]; 
    $ret_str = ''; 
    for $pos (@{$varinf[0]}){ 
        $ret_str .= substr($query, $pos-1, 1); 
    } 
    $valid = 0; 
    for $bc (keys %barcodes){ 
        if ($query =~ /$barcodes{$bc}/) { 
            $ret_str .= "-".$bc; 
            $valid = 1; 
        } 
    } 
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    if ($valid == 0) { 
        $ret_str .= "-NBC"; 
    } 
     
    return $ret_str; 
} 
 
sub gen_var { 
    $var = 
"[AG]GT[AGT]TT[AG]CATTTGAC[CT]CAAGG[AG]AC[ACG]TG[CT]TGGGAACA[A
G]ATGTATACTCCAGG[ACT]GG[GA]GAAGTGAG[AG]AATGA[CT]GATGTTGA[CT]CA
AAGCTTGATCATCGCAGCCAGAAACATAGTAAGA"; 
    @pos = split(/\[|\]/, $var); 
    shift(@pos); 
    $poscnt = 0; 
    $st = 1; 
    $varnum = 1; 
    $ref = ''; 
    @vars = (''); 
    while ($akt = shift(@pos)) { 
        if ($st == 0) { 
            $ref .= $akt; 
            $poscnt += length($akt); 
        } 
        if ($st == 1) { 
            @sub = split(/|/, $akt); 
            $ref .= $sub[0]; 
            $varnum = $varnum * ($#sub + 1); 
            $poscnt++; 
            @{$varpos{$poscnt}} = @sub; 
            push (@varkey, $poscnt); 
            @varseq_temp = (); 
            for $subseq (@sub){ 
                for $varseq (@vars){ 
                    push(@varseq_temp, $varseq.$subseq); 
                } 
            } 
            @vars = @varseq_temp; 
        } 
        if ($st == 0) { 
            $st = 1; 
        } 
        else { 
            $st = 0; 
        } 
    } 
    return \@varkey, \@vars; 
} 
 
sub mean { 
 my $result; 
 foreach (@_){ 
  $result += $_; 
 } 
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 return $result / ($#_ + 1) ; 
}	
2.PERL	 script	 used	 for	 analysis	 the	 animal	 pilot	 2	 study.	 The	
barcoded	variants	were	UMIs	tagged.	
#!/usr/bin/perl 
 
use Data::Dumper; 
 
@barcds = ('BC1', 'BC2', 'BC3', 'BC4', 'BC5'); 
#                               #  #  #     #  #  # 
%barcodes = ('BC1' => 'GATCATCGCTGCCAGGAACATTGTTAGG', 
             'BC2' => 'GATCATCGCTGCCAGGAACATAGTAAGA', 
             'BC3' => 'GATCATCGCTGCTAGAAACATTGTTAGA', 
             'BC4' => 'GATCATCGCTGCTAGAAACATAGTAAGG', 
             'BC5' => 'GATCATCGCAGCCAGAAACATTGTAAGG'); 
#                               #  #  #     #  #  # 
@varinf = gen_var(); 
$ref = 
"[AG]GT[AGT]TT[AG]CATTTGAC[CT]CAAGG[AG]AC[ACG]TG[CT]TGGGAACA[A
G]ATGTATACTCCAGG[ACT]GG[GA]GAAGTGAG[AG]AATGA[CT]GATGTTGA[CT]CA
AAGCTTGATCATCGC[AT]GC[CT]AG[AG]AACAT[AT]GT[AT]AG[AG]"; 
$oref = 
'AGTGTTGCACTTAACCCAAGGGACGTGCTGGGAGCAGATGTATACTCCAGGAGGAGAAGTG
AGAAATGATGATGTTGACCAAAGCTTGATTATCGCTGCTAGAAACATAGTAAGAAGAGC'; 
$c_beg = 'TGACCACTCGGCGGTCTGCCAAAGT'; 
$c_mid = 'CAGGCAGTGTTTATATTGA'; 
 
 
$opt = shift(@ARGV); 
 
 
#display statistics about the first 25bps constant seqence and 
lists the non-matching variants 
if ($opt eq "stat_beg"){  
    open(F, shift(@ARGV)); 
    $cnt1 = $cnt2 = 0; 
    while (<F>) { 
        chomp; 
        @fl = split(' ', $_); 
        if (substr($fl[9], 0, 25) eq $c_beg){ 
            $cnt2++; 
        } 
        else{ 
            print (substr($fl[9], 0, 25)."\n"); 
        } 
        $cnt1++; 
    } 
    print STDERR $cnt2."/".$cnt1." (". $cnt2/$cnt1 .") reads 
has perfect 25bp beginning (sequence before random tag).\n"; 
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} 
 
#display statistics about the 19bps constant seqence (between 
the random tag and the variable region) and lists the non-
matching variants 
if ($opt eq "stat_mid"){  
    open(F, shift(@ARGV)); 
    $cnt1 = $cnt2 = 0; 
    while (<F>) { 
        chomp; 
        @fl = split(' ', $_); 
        if (substr($fl[9], 35, 19) eq $c_mid){ 
            $cnt2++; 
        } 
        else{ 
            print (substr($fl[9], 0, 25)."\n"); 
        } 
        $cnt1++; 
    } 
    print STDERR $cnt2."/".$cnt1." (". $cnt2/$cnt1 ." reads 
has perfect 19bp constant seqence (between the random tag and 
the variable region).\n"; 
} 
 
#display the variant, number of reads, number of reads with 
unique 10pb random sequence and the number of reads with the 
max read random tag  
if ($opt eq "num_reads"){  
    open(F, shift(@ARGV)); 
    $cnt1 = $cnt2 = 0; 
    while (<F>) { 
        chomp; 
        @fl = split(' ', $_); 
        if (substr($fl[9], 35, 19) eq $c_mid && substr($fl[9], 
0, 25) eq $c_beg){ 
            $cnt1++; 
            if ($fl[9] =~ /($ref)/) { 
                $varseq = id_var($1); 
                $hash{$varseq}{'all'}++; 
                $hash{$varseq}{'rand'}{substr($fl[9], 25, 
10)}++; 
            } 
            else{ 
                $cnt2++; 
            } 
             
        } 
    } 
    for $id (keys %hash){ 
        $numu = $max = 0; 
        for $id2 (keys %{$hash{$id}{'rand'}}){ 
            $numu++; 
            if ($hash{$id}{'rand'}{$id2} > $max){ 
                $max = $hash{$id}{'rand'}{$id2}; 
		 158	
            } 
        } 
        print $id ."\t". $hash{$id}{'all'} ."\t". $numu ."\t". 
$max ."\n"; 
    } 
    print STDERR $cnt2."/".$cnt1." (". $cnt2/$cnt1 .") reads 
doesn't match the reference sequence (after filtering out 
those that doesn't match with the constant regions).\n"; 
} 
 
#display diversity according to the random sequence for only 
one variant 
if ($opt eq "var_div"){  
    open(F, shift(@ARGV)); 
    $t_var = shift(@ARGV); 
    while (<F>) { 
        chomp; 
        @fl = split(' ', $_); 
        if (substr($fl[9], 35, 19) eq $c_mid && substr($fl[9], 
0, 25) eq $c_beg){ 
            if ($fl[9] =~ /($ref)/) { 
                $varseq = id_var($1); 
                $hash{$varseq}{'all'}++; 
                $hash{$varseq}{'rand'}{substr($fl[9], 25, 
10)}++; 
            } 
        } 
    } 
 
    for $id (keys %hash){ 
        if ($id eq $t_var){ 
            for $id2 (keys %{$hash{$id}{'rand'}}){ 
                print $id2 ."\t". $hash{$id}{'rand'}{$id2} 
."\n"; 
            } 
             
        } 
    } 
} 
 
#create datafile for MDS plot 
#usage: pr_pilot.pl gen_div <output file of the num_reads 
module> <Barcode id like BC5 or just simply BC if you want to 
analyse all> <output prefix> 
if ($opt eq "gen_div"){ 
    @standards = ('AAAAAAAAAAAAA', 'CCCCCCCCCCCCC', 
'GGGGGGGGGGGGG', 'TTTTTTTTTTTTT'); 
    open(F, shift(@ARGV)); 
    $bc = shift(@ARGV); 
    $out = shift(@ARGV); 
    $pass = 0; 
    while(<F>){ 
        @fl = split(' ', $_); 
        if ($fl[1] > 4 && $fl[0] =~ /$bc/){ 
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            ($varid, undef) = split('-',$fl[0]); 
            $le = length($varid); 
            $rd{$varid}{$varid} = 0; 
            if ($pass == 1){ 
                for $ov (@varlist){ 
                    $res = ($varid ^ $ov) =~ tr/\0//c; 
                    $rd{$varid}{$ov} = $res / $le; 
                    $rd{$ov}{$varid} = $res / $le; 
                } 
            } 
            else { 
                $pass = 1; 
            } 
            push(@varlist, $varid); 
            $rc{$varid}{'ucorr'} = $fl[1]; 
            $rc{$varid}{'corr'} = $fl[2]; 
             
        } 
    } 
    close(F); 
    print STDERR ("Number of variants to compare: ". 
($#varlist+1) . "\n"); 
    open(M, ">".$out.".mat"); 
    open(L, ">".$out.".lst"); 
    for $id1 (@varlist){ 
        $line = ''; 
        for $id2 (@varlist){ 
            $line .= $rd{$id1}{$id2} ."\t"; 
        } 
        $line =~ s/\t$//; 
        print M $line."\n"; 
        print L $id1 ."\t". $rc{$id1}{'ucorr'} ."\t". 
$rc{$id1}{'corr'}."\n"; 
    } 
    close(M); 
    close(L); 
} 
 
#extract the list of real diversity filtered by identifier, 
reference sequence and variable region 
if ($opt eq "real_vars"){ 
    open(F, shift(@ARGV)); 
    $tr1 = shift(@ARGV); 
    $tr2 = shift(@ARGV); 
    while (<F>) { 
        chomp; 
        @fl = split(' ', $_); 
        if (substr($fl[9], 35, 19) eq $c_mid && substr($fl[9], 
0, 25) eq $c_beg){ 
            $cnt1++; 
            if ($fl[9] =~ /($ref)/) { 
                $varseq = id_var($1); 
                $var_ids{$varseq}{substr($fl[9], 25, 10)}++; 
                $idents{substr($fl[9], 25, 10)}{$varseq}++; 
		 160	
                $read_cnt{$varseq}++; 
                $read_cnt{substr($fl[9], 25, 10)}++; 
            } 
        } 
    } 
    print STDERR "Number of variants: ". scalar(keys %var_ids) 
."\n"; 
    print STDERR "Number of identifiers: ". scalar(keys 
%idents) ."\n"; 
    print 
"VARIANT_ID\tN_TOTAL_READS\tN_DIFFERENT_ID_REGS\tEXCL1\tEXCL2\
tEXCL3\n"; 
    %excl1_ids = (); 
    print STDERR "Filtering out highly similar identifiers for 
the same variants.\n"; 
    $cnt_dis = 0; 
    for $id1 (keys %var_ids){ 
        $cnt_dis++; 
        $excl2{$id1}=0; 
        $excl2num{$id1}=0; 
        $excl3{$id1}=0; 
        $excl3num{$id1}=0; 
        if ($read_cnt{$id1} > 1){ 
            $cnt = 0; 
            $idstr = ''; 
            $excl1 = 0; 
            $excl1num = 0; 
            for $id2 (keys %{$var_ids{$id1}}){ 
                $cnt++; 
                for $id3 (keys %{$var_ids{$id1}}){ 
                    if ($excl1_ids{$id1}{$id2} != 1 && 
$excl1_ids{$id1}{$id3} != 1 && $id2 ne $id3){ 
                        $comp = ($id2 ^ $id3) =~ tr/\0//c; 
                        if ($comp < 2){ 
                            if ($var_ids{$id1}{$id2} > 
$var_ids{$id1}{$id3}){ 
                                $excl1++; 
                                $excl1num += 
$var_ids{$id1}{$id3}; 
                                $excl1_ids{$id1}{$id3} = 1; 
                            } 
                            if ($var_ids{$id1}{$id2} < 
$var_ids{$id1}{$id3}){ 
                                $excl1++; 
                                $excl1num += 
$var_ids{$id1}{$id2}; 
                                $excl1_ids{$id1}{$id2} = 1; 
                            } 
                        } 
                    } 
                } 
            } 
             
            $varline{$id1} =  
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$id1."\t".$read_cnt{$id1}."\t".$cnt."\t".$excl1."(".$excl1num.
")"; 
            #$idstr =~ s/,$//; 
            #print $idstr; 
            #print "\n"; 
        } 
        print STDERR "\r".$cnt_dis." done..."; 
    } 
    print STDERR "\nFiltering out highly similar variants for 
the same identifier.\n"; 
    $cnt_dis = 0; 
    for $id1 (keys %idents){ 
        $cnt_dis++; 
        for $id2 (keys %{$idents{$id1}}){ 
            for $id3 (keys %{$idents{$id1}}){ 
                if ($excl1_ids{$id2}{$id1} != 1 && 
$excl1_ids{$id3}{$id1} != 1 && $id2 ne $id3){ 
                    ($sid2, $bc2) = split('-', $id2); 
                    ($sid3, $bc3) = split('-', $id3); 
                    $comp = ($sid2 ^ $sid3) =~ tr/\0//c; 
                    if ($comp < 2 && $bc2 eq $bc3){ 
                        if ($var_ids{$id2}{$id1} > 
($var_ids{$id3}{$id1} * 5)){ 
                            #print STDERR 
$id1."\t".$id2."\n".$id1."\t".$id3."\n\n"; 
                            $excl2{$id3}++; 
                            $excl2num{$id3} += 
$var_ids{$id3}{$id1}; 
                            $excl1_ids{$id3}{$id1} = 1; 
                        } 
                        if (($var_ids{$id2}{$id1} * 10) < 
$var_ids{$id3}{$id1}){ 
                            #print STDERR 
$id1."\t".$id2."\n".$id1."\t".$id3."\n\n"; 
                            $excl2{$id2}++; 
                            $excl2num{$id2} += 
$var_ids{$id2}{$id1}; 
                            $excl1_ids{$id2}{$id1} = 1; 
                        } 
                    } 
                    if ($comp == 2 && $bc2 eq $bc3){ 
                        if ($var_ids{$id2}{$id1} > 
($var_ids{$id3}{$id1} * 10)){ 
                            #print STDERR 
$id1."\t".$id2."\n".$id1."\t".$id3."\n\n"; 
                            $excl2{$id3}++; 
                            $excl2num{$id3} += 
$var_ids{$id3}{$id1}; 
                            $excl1_ids{$id3}{$id1} = 1; 
                        } 
                        if (($var_ids{$id2}{$id1} * 10) < 
$var_ids{$id3}{$id1}){ 
                            #print STDERR 
$id1."\t".$id2."\n".$id1."\t".$id3."\n\n"; 
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                            $excl2{$id2}++; 
                            $excl2num{$id2} += 
$var_ids{$id2}{$id1}; 
                            $excl1_ids{$id2}{$id1} = 1; 
                        } 
                    } 
                    if ($comp == 0 && $bc2 ne $bc3){ 
                        if ($var_ids{$id2}{$id1} > 
($var_ids{$id3}{$id1} * 10)){ 
                            #print STDERR 
$id1."\t".$id2."\n".$id1."\t".$id3."\n\n"; 
                            $excl2{$id3}++; 
                            $excl2num{$id3} += 
$var_ids{$id3}{$id1}; 
                            $excl1_ids{$id3}{$id1} = 1; 
                        } 
                        if (($var_ids{$id2}{$id1} * 10) < 
$var_ids{$id3}{$id1}){ 
                            #print STDERR 
$id1."\t".$id2."\n".$id1."\t".$id3."\n\n"; 
                            $excl2{$id2}++; 
                            $excl2num{$id2} += 
$var_ids{$id2}{$id1}; 
                            $excl1_ids{$id2}{$id1} = 1; 
                        } 
                    } 
                } 
            } 
        } 
        print STDERR "\r".$cnt_dis." done..."; 
    } 
    print STDERR "\nFiltering out highly similar variants with 
highly similar identifier.\n"; 
    $cnt_dis = 0; 
    for $id1 (keys %var_ids){ 
        $cnt_dis++; 
        for $id2 (keys %var_ids){ 
            if ($id1 ne $id2){ 
                ($sid1, $bc1) = split('-', $id1); 
                ($sid2, $bc2) = split('-', $id2); 
                $comp = ($sid1 ^ $sid2) =~ tr/\0//c; 
                if ($comp == 1){ 
                    for $id3 (keys %{$var_ids{$id1}}){ 
                        for $id4 (keys %{$var_ids{$id2}}){ 
                            if ($id3 ne $id4){ 
                                $comp = ($id3 ^ $id4) =~ 
tr/\0//c; 
                                if ($comp == 1 && 
$excl1_ids{$id1}{$id3} != 1 && $excl1_ids{$id2}{$id4} != 1){ 
                                    if ($var_ids{$id1}{$id3} > 
($var_ids{$id2}{$id4} * 10)){ 
                                        $excl3{$id2}++; 
                                        $excl3num{$id2} += 
$var_ids{$id2}{$id4}; 
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                                        $excl1_ids{$id2}{$id4} 
= 1; 
                                    } 
                                    if (($var_ids{$id1}{$id3} 
* 10) < $var_ids{$id2}{$id4}){ 
                                        $excl3{$id1}++; 
                                        $excl3num{$id1} += 
$var_ids{$id1}{$id3}; 
                                        $excl1_ids{$id1}{$id3} 
= 1; 
                                    } 
                                } 
                            } 
                        } 
                    } 
                } 
            } 
        } 
        print STDERR "\r".$cnt_dis." done..."; 
    } 
    print STDERR "\nPrinting out results.\n"; 
    for $id1 (keys %varline){ 
        print 
$varline{$id1}."\t".$excl2{$id1}."(".$excl2num{$id1}.")\t".$ex
cl3{$id1}."(".$excl3num{$id1}.")\n"; 
    } 
} 
 
sub id_var { 
    $query = $_[0]; 
    $ret_str = ''; 
    for $pos (@{$varinf[0]}){ 
        $ret_str .= substr($query, $pos-1, 1); 
    } 
    $valid = 0; 
    for $bc (keys %barcodes){ 
        if ($query =~ /$barcodes{$bc}/) { 
            $ret_str .= "-".$bc; 
            $valid = 1; 
        } 
    } 
    if ($valid == 0) { 
        $ret_str .= "-NBC"; 
    } 
     
    return $ret_str; 
} 
 
sub gen_var { 
    $var = 
"[AG]GT[AGT]TT[AG]CATTTGAC[CT]CAAGG[AG]AC[ACG]TG[CT]TGGGAACA[A
G]ATGTATACTCCAGG[ACT]GG[GA]GAAGTGAG[AG]AATGA[CT]GATGTTGA[CT]CA
AAGCTTGATCATCGCAGCCAGAAACATAGTAAGA"; 
    @pos = split(/\[|\]/, $var); 
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    shift(@pos); 
    $poscnt = 0; 
    $st = 1; 
    $varnum = 1; 
    $ref = ''; 
    @vars = (''); 
    while ($akt = shift(@pos)) { 
        if ($st == 0) { 
            $ref .= $akt; 
            $poscnt += length($akt); 
        } 
        if ($st == 1) { 
            @sub = split(/|/, $akt); 
            $ref .= $sub[0]; 
            $varnum = $varnum * ($#sub + 1); 
            $poscnt++; 
            @{$varpos{$poscnt}} = @sub; 
            push (@varkey, $poscnt); 
            @varseq_temp = (); 
            for $subseq (@sub){ 
                for $varseq (@vars){ 
                    push(@varseq_temp, $varseq.$subseq); 
                } 
            } 
            @vars = @varseq_temp; 
        } 
        if ($st == 0) { 
            $st = 1; 
        } 
        else { 
            $st = 0; 
        } 
    } 
    return \@varkey, \@vars; 
} 
 
sub mean { 
 my $result; 
 foreach (@_){ 
  $result += $_; 
 } 
 return $result / ($#_ + 1) ; 
} 
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